{ "version": "2.2", "instance": { "form6-k.htm ex99-1.htm": { "nsprefix": "CSCI", "nsuri": "http://cosciensbio.com/20260331", "dts": { "schema": { "local": [ "csci-20260331.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd", "https://www.xbrl.org/dtr/type/2024-01-31/types.xsd", "https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/dimensions-ea/rol_ifrs_ea-dim_2025-03-27.xsd", "https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/dimensions/rol_full_ifrs-dim_2025-03-27.xsd", "https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd", "https://xbrl.sec.gov/dei/2025/dei-2025.xsd" ] }, "calculationLink": { "local": [ "csci-20260331_cal.xml" ] }, "definitionLink": { "local": [ "csci-20260331_def.xml" ], "remote": [ "https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/dimensions-ea/dim_ifrs_ea_2025-03-27_role-995000.xml", "https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/dimensions/dim_full_ifrs_2025-03-27_role-995000.xml" ] }, "labelLink": { "local": [ "csci-20260331_lab.xml" ] }, "presentationLink": { "local": [ "csci-20260331_pre.xml" ] }, "inline": { "local": [ "ex99-1.htm", "form6-k.htm" ] } }, "keyStandard": 147, "keyCustom": 65, "axisStandard": 10, "axisCustom": 0, "memberStandard": 12, "memberCustom": 11, "hidden": { "total": 165, "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full": 96, "http://cosciensbio.com/20260331": 62, "http://xbrl.sec.gov/dei/2025": 7 }, "contextCount": 128, "entityCount": 1, "segmentCount": 23, "elementCount": 334, "unitCount": 5, "baseTaxonomies": { "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full": 579, "http://xbrl.sec.gov/dei/2025": 17 }, "report": { "R1": { "role": "http://cosciensbio.com/role/Cover", "longName": "00000001 - Document - Cover", "shortName": "Cover", "isDefault": "true", "groupType": "document", "subGroupType": "", "menuCat": "Cover", "order": "1", "firstAnchor": { "contextRef": "From2026-01-01to2026-03-31", "name": "dei:DocumentFiscalYearFocus", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "span", "p", "body", "html" ], "reportCount": 1, "baseRef": "form6-k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2026-01-01to2026-03-31", "name": "dei:DocumentFiscalYearFocus", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "span", "p", "body", "html" ], "reportCount": 1, "baseRef": "form6-k.htm", "first": true, "unique": true } }, "R2": { "role": "http://cosciensbio.com/role/InterimConsolidatedStatementsOfFinancialPosition", "longName": "00000002 - Statement - Condensed Interim Consolidated Statements of Financial Position (Unaudited)", "shortName": "Condensed Interim Consolidated Statements of Financial Position (Unaudited)", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "2", "firstAnchor": { "contextRef": "AsOf2026-03-31", "name": "ifrs-full:CashAndCashEquivalents", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "ex99-1.htm", "first": true }, "uniqueAnchor": { "contextRef": "AsOf2026-03-31", "name": "ifrs-full:CurrentAssetsOtherThanAssetsOrDisposalGroupsClassifiedAsHeldForSaleOrAsHeldForDistributionToOwners", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "ex99-1.htm", "unique": true } }, "R3": { "role": "http://cosciensbio.com/role/InterimConsolidatedStatementsOfChangesInShareholdersEquity", "longName": "00000003 - Statement - Condensed Interim Consolidated Statements of Changes in Shareholders' Equity (Unaudited)", "shortName": "Condensed Interim Consolidated Statements of Changes in Shareholders' Equity (Unaudited)", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "3", "firstAnchor": { "contextRef": "AsOf2024-12-31_ifrs-full_IssuedCapitalMember", "name": "ifrs-full:EquityAttributableToOwnersOfParent", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "ex99-1.htm", "first": true }, "uniqueAnchor": { "contextRef": "AsOf2024-12-31_custom_ContributedSurplusMember", "name": "ifrs-full:EquityAttributableToOwnersOfParent", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "ex99-1.htm", "unique": true } }, "R4": { "role": "http://cosciensbio.com/role/InterimConsolidatedStatementsOfIncomeLossAndComprehensiveIncomeLoss", "longName": "00000004 - Statement - Condensed Interim Consolidated Statements of Income (Loss) and Comprehensive Income (Loss) (Unaudited)", "shortName": "Condensed Interim Consolidated Statements of Income (Loss) and Comprehensive Income (Loss) (Unaudited)", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "4", "firstAnchor": { "contextRef": "From2026-01-01to2026-03-31", "name": "ifrs-full:Revenue", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "ex99-1.htm", "first": true }, "uniqueAnchor": { "contextRef": "From2026-01-01to2026-03-31", "name": "ifrs-full:RevenueFromInterest", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "ex99-1.htm", "unique": true } }, "R5": { "role": "http://cosciensbio.com/role/InterimConsolidatedStatementsOfCashFlows", "longName": "00000005 - Statement - Condensed Interim Consolidated Statements of Cash Flows (Unaudited)", "shortName": "Condensed Interim Consolidated Statements of Cash Flows (Unaudited)", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "5", "firstAnchor": { "contextRef": "From2026-01-01to2026-03-31", "name": "ifrs-full:ProfitLoss", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "ex99-1.htm", "first": true }, "uniqueAnchor": { "contextRef": "From2026-01-01to2026-03-31", "name": "CSCI:DeconsolidationOfGermanSubsidiaries", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "ex99-1.htm", "unique": true } }, "R6": { "role": "http://cosciensbio.com/role/BusinessOverview", "longName": "999006 - Disclosure - Business overview", "shortName": "Business overview", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "6", "firstAnchor": { "contextRef": "From2026-01-01to2026-03-31", "name": "ifrs-full:DisclosureOfBasisOfPreparationOfFinancialStatementsExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "ex99-1.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2026-01-01to2026-03-31", "name": "ifrs-full:DisclosureOfBasisOfPreparationOfFinancialStatementsExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "ex99-1.htm", "first": true, "unique": true } }, "R7": { "role": "http://cosciensbio.com/role/BasisOfPresentation", "longName": "999007 - Disclosure - Basis of presentation", "shortName": "Basis of presentation", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "7", "firstAnchor": { "contextRef": "From2026-01-01to2026-03-31", "name": "ifrs-full:DisclosureOfBasisOfConsolidationExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "ex99-1.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2026-01-01to2026-03-31", "name": "ifrs-full:DisclosureOfBasisOfConsolidationExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "ex99-1.htm", "first": true, "unique": true } }, "R8": { "role": "http://cosciensbio.com/role/Revenue", "longName": "999008 - Disclosure - Revenue", "shortName": "Revenue", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "8", "firstAnchor": { "contextRef": "From2026-01-01to2026-03-31", "name": "ifrs-full:DisclosureOfRevenueExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "ex99-1.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2026-01-01to2026-03-31", "name": "ifrs-full:DisclosureOfRevenueExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "ex99-1.htm", "first": true, "unique": true } }, "R9": { "role": "http://cosciensbio.com/role/Inventories", "longName": "999009 - Disclosure - Inventories", "shortName": "Inventories", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "9", "firstAnchor": { "contextRef": "From2026-01-01to2026-03-31", "name": "ifrs-full:DisclosureOfInventoriesExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "ex99-1.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2026-01-01to2026-03-31", "name": "ifrs-full:DisclosureOfInventoriesExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "ex99-1.htm", "first": true, "unique": true } }, "R10": { "role": "http://cosciensbio.com/role/PrepaidExpensesAndOtherAssets", "longName": "999010 - Disclosure - Prepaid expenses and other assets", "shortName": "Prepaid expenses and other assets", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "10", "firstAnchor": { "contextRef": "From2026-01-01to2026-03-31", "name": "ifrs-full:DisclosureOfPrepaymentsAndOtherAssetsExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "ex99-1.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2026-01-01to2026-03-31", "name": "ifrs-full:DisclosureOfPrepaymentsAndOtherAssetsExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "ex99-1.htm", "first": true, "unique": true } }, "R11": { "role": "http://cosciensbio.com/role/PropertyAndEquipment", "longName": "999011 - Disclosure - Property and equipment", "shortName": "Property and equipment", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "11", "firstAnchor": { "contextRef": "From2026-01-01to2026-03-31", "name": "ifrs-full:DisclosureOfPropertyPlantAndEquipmentExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "ex99-1.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2026-01-01to2026-03-31", "name": "ifrs-full:DisclosureOfPropertyPlantAndEquipmentExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "ex99-1.htm", "first": true, "unique": true } }, "R12": { "role": "http://cosciensbio.com/role/AccountsPayableAndAccruedLiabilities", "longName": "999012 - Disclosure - Accounts payable and accrued liabilities", "shortName": "Accounts payable and accrued liabilities", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "12", "firstAnchor": { "contextRef": "From2026-01-01to2026-03-31", "name": "ifrs-full:DisclosureOfTradeAndOtherPayablesExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "ex99-1.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2026-01-01to2026-03-31", "name": "ifrs-full:DisclosureOfTradeAndOtherPayablesExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "ex99-1.htm", "first": true, "unique": true } }, "R13": { "role": "http://cosciensbio.com/role/EmployeeFutureBenefits", "longName": "999013 - Disclosure - Employee future benefits", "shortName": "Employee future benefits", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "13", "firstAnchor": { "contextRef": "From2026-01-01to2026-03-31", "name": "ifrs-full:DisclosureOfEmployeeBenefitsExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "ex99-1.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2026-01-01to2026-03-31", "name": "ifrs-full:DisclosureOfEmployeeBenefitsExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "ex99-1.htm", "first": true, "unique": true } }, "R14": { "role": "http://cosciensbio.com/role/Warrants", "longName": "999014 - Disclosure - Warrants", "shortName": "Warrants", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "14", "firstAnchor": { "contextRef": "From2026-01-01to2026-03-31", "name": "CSCI:DisclosureWarrantsExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "ex99-1.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2026-01-01to2026-03-31", "name": "CSCI:DisclosureWarrantsExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "ex99-1.htm", "first": true, "unique": true } }, "R15": { "role": "http://cosciensbio.com/role/ShareholdersEquity", "longName": "999015 - Disclosure - Shareholders\u2019 equity", "shortName": "Shareholders\u2019 equity", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "15", "firstAnchor": { "contextRef": "From2026-01-01to2026-03-31", "name": "ifrs-full:DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "ex99-1.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2026-01-01to2026-03-31", "name": "ifrs-full:DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "ex99-1.htm", "first": true, "unique": true } }, "R16": { "role": "http://cosciensbio.com/role/SupplementalDisclosureOfCashFlowInformation", "longName": "999016 - Disclosure - Supplemental disclosure of cash flow information", "shortName": "Supplemental disclosure of cash flow information", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "16", "firstAnchor": { "contextRef": "From2026-01-01to2026-03-31", "name": "ifrs-full:DisclosureOfCashFlowStatementExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "ex99-1.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2026-01-01to2026-03-31", "name": "ifrs-full:DisclosureOfCashFlowStatementExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "ex99-1.htm", "first": true, "unique": true } }, "R17": { "role": "http://cosciensbio.com/role/NetIncomeLossPerShare", "longName": "999017 - Disclosure - Net income (loss) per share", "shortName": "Net income (loss) per share", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "17", "firstAnchor": { "contextRef": "From2026-01-01to2026-03-31", "name": "ifrs-full:DisclosureOfIncomeTaxExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "ex99-1.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2026-01-01to2026-03-31", "name": "ifrs-full:DisclosureOfIncomeTaxExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "ex99-1.htm", "first": true, "unique": true } }, "R18": { "role": "http://cosciensbio.com/role/SegmentInformation", "longName": "999018 - Disclosure - Segment information", "shortName": "Segment information", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "18", "firstAnchor": { "contextRef": "From2026-01-01to2026-03-31", "name": "ifrs-full:DisclosureOfEntitysReportableSegmentsExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "ex99-1.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2026-01-01to2026-03-31", "name": "ifrs-full:DisclosureOfEntitysReportableSegmentsExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "ex99-1.htm", "first": true, "unique": true } }, "R19": { "role": "http://cosciensbio.com/role/DiscontinuedOperations", "longName": "999019 - Disclosure - Discontinued operations", "shortName": "Discontinued operations", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "19", "firstAnchor": { "contextRef": "From2026-01-01to2026-03-31", "name": "ifrs-full:DisclosureOfDiscontinuedOperationsExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "ex99-1.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2026-01-01to2026-03-31", "name": "ifrs-full:DisclosureOfDiscontinuedOperationsExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "ex99-1.htm", "first": true, "unique": true } }, "R20": { "role": "http://cosciensbio.com/role/CommitmentsAndContingencies", "longName": "999020 - Disclosure - Commitments and Contingencies", "shortName": "Commitments and Contingencies", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "20", "firstAnchor": { "contextRef": "From2026-01-01to2026-03-31", "name": "ifrs-full:DisclosureOfCommitmentsAndContingentLiabilitiesExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "ex99-1.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2026-01-01to2026-03-31", "name": "ifrs-full:DisclosureOfCommitmentsAndContingentLiabilitiesExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "ex99-1.htm", "first": true, "unique": true } }, "R21": { "role": "http://cosciensbio.com/role/BasisOfPresentationPolicies", "longName": "999021 - Disclosure - Basis of presentation (Policies)", "shortName": "Basis of presentation (Policies)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "policies", "menuCat": "Policies", "order": "21", "firstAnchor": { "contextRef": "From2026-01-01to2026-03-31", "name": "ifrs-full:DescriptionOfAccountingPolicyForDiscontinuedOperationsExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ifrs-full:DisclosureOfBasisOfConsolidationExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "ex99-1.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2026-01-01to2026-03-31", "name": "ifrs-full:DescriptionOfAccountingPolicyForDiscontinuedOperationsExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ifrs-full:DisclosureOfBasisOfConsolidationExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "ex99-1.htm", "first": true, "unique": true } }, "R22": { "role": "http://cosciensbio.com/role/RevenueTables", "longName": "999022 - Disclosure - Revenue (Tables)", "shortName": "Revenue (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "22", "firstAnchor": { "contextRef": "From2026-01-01to2026-03-31", "name": "CSCI:DisclosureOfDetailedInformationAboutDeferredRevenueExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ifrs-full:DisclosureOfRevenueExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "ex99-1.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2026-01-01to2026-03-31", "name": "CSCI:DisclosureOfDetailedInformationAboutDeferredRevenueExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ifrs-full:DisclosureOfRevenueExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "ex99-1.htm", "first": true, "unique": true } }, "R23": { "role": "http://cosciensbio.com/role/InventoriesTables", "longName": "999023 - Disclosure - Inventories (Tables)", "shortName": "Inventories (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "23", "firstAnchor": { "contextRef": "From2026-01-01to2026-03-31", "name": "CSCI:DisclosureOfInventoryExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ifrs-full:DisclosureOfInventoriesExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "ex99-1.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2026-01-01to2026-03-31", "name": "CSCI:DisclosureOfInventoryExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ifrs-full:DisclosureOfInventoriesExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "ex99-1.htm", "first": true, "unique": true } }, "R24": { "role": "http://cosciensbio.com/role/PrepaidExpensesAndOtherAssetsTables", "longName": "999024 - Disclosure - Prepaid expenses and other assets (Tables)", "shortName": "Prepaid expenses and other assets (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "24", "firstAnchor": { "contextRef": "From2026-01-01to2026-03-31", "name": "CSCI:DisclosureOfPrepaidExpensesAndOtherCurrentAssetsExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ifrs-full:DisclosureOfPrepaymentsAndOtherAssetsExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "ex99-1.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2026-01-01to2026-03-31", "name": "CSCI:DisclosureOfPrepaidExpensesAndOtherCurrentAssetsExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ifrs-full:DisclosureOfPrepaymentsAndOtherAssetsExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "ex99-1.htm", "first": true, "unique": true } }, "R25": { "role": "http://cosciensbio.com/role/PropertyAndEquipmentTables", "longName": "999025 - Disclosure - Property and equipment (Tables)", "shortName": "Property and equipment (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "25", "firstAnchor": { "contextRef": "From2026-01-01to2026-03-31", "name": "CSCI:DisclosureOfPropertyPlantAndEquipmentsExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ifrs-full:DisclosureOfPropertyPlantAndEquipmentExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "ex99-1.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2026-01-01to2026-03-31", "name": "CSCI:DisclosureOfPropertyPlantAndEquipmentsExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ifrs-full:DisclosureOfPropertyPlantAndEquipmentExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "ex99-1.htm", "first": true, "unique": true } }, "R26": { "role": "http://cosciensbio.com/role/AccountsPayableAndAccruedLiabilitiesTables", "longName": "999026 - Disclosure - Accounts payable and accrued liabilities (Tables)", "shortName": "Accounts payable and accrued liabilities (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "26", "firstAnchor": { "contextRef": "From2026-01-01to2026-03-31", "name": "CSCI:DisclosureOfDetailedInformationAboutPayablesAndAccruedLiabilitiesExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ifrs-full:DisclosureOfTradeAndOtherPayablesExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "ex99-1.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2026-01-01to2026-03-31", "name": "CSCI:DisclosureOfDetailedInformationAboutPayablesAndAccruedLiabilitiesExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ifrs-full:DisclosureOfTradeAndOtherPayablesExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "ex99-1.htm", "first": true, "unique": true } }, "R27": { "role": "http://cosciensbio.com/role/EmployeeFutureBenefitsTables", "longName": "999027 - Disclosure - Employee future benefits (Tables)", "shortName": "Employee future benefits (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "27", "firstAnchor": { "contextRef": "From2026-01-01to2026-03-31", "name": "ifrs-full:DisclosureOfNetDefinedBenefitLiabilityAssetExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ifrs-full:DisclosureOfEmployeeBenefitsExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "ex99-1.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2026-01-01to2026-03-31", "name": "ifrs-full:DisclosureOfNetDefinedBenefitLiabilityAssetExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ifrs-full:DisclosureOfEmployeeBenefitsExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "ex99-1.htm", "first": true, "unique": true } }, "R28": { "role": "http://cosciensbio.com/role/WarrantsTables", "longName": "999028 - Disclosure - Warrants (Tables)", "shortName": "Warrants (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "28", "firstAnchor": { "contextRef": "From2026-01-01to2026-03-31", "name": "CSCI:DisclosureOfWarrantsActivityReclassifiedIntoEquityExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "CSCI:DisclosureWarrantsExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "ex99-1.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2026-01-01to2026-03-31", "name": "CSCI:DisclosureOfWarrantsActivityReclassifiedIntoEquityExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "CSCI:DisclosureWarrantsExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "ex99-1.htm", "first": true, "unique": true } }, "R29": { "role": "http://cosciensbio.com/role/ShareholdersEquityTables", "longName": "999029 - Disclosure - Shareholders\u2019 equity (Tables)", "shortName": "Shareholders\u2019 equity (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "29", "firstAnchor": { "contextRef": "From2026-01-01to2026-03-31", "name": "ifrs-full:DisclosureOfClassesOfShareCapitalExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ifrs-full:DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "ex99-1.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2026-01-01to2026-03-31", "name": "ifrs-full:DisclosureOfClassesOfShareCapitalExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ifrs-full:DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "ex99-1.htm", "first": true, "unique": true } }, "R30": { "role": "http://cosciensbio.com/role/SupplementalDisclosureOfCashFlowInformationTables", "longName": "999030 - Disclosure - Supplemental disclosure of cash flow information (Tables)", "shortName": "Supplemental disclosure of cash flow information (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "30", "firstAnchor": { "contextRef": "From2026-01-01to2026-03-31", "name": "CSCI:DisclosureofChangesInOperatingAssetsAndLiabilitiesTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ifrs-full:DisclosureOfCashFlowStatementExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "ex99-1.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2026-01-01to2026-03-31", "name": "CSCI:DisclosureofChangesInOperatingAssetsAndLiabilitiesTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ifrs-full:DisclosureOfCashFlowStatementExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "ex99-1.htm", "first": true, "unique": true } }, "R31": { "role": "http://cosciensbio.com/role/NetIncomeLossPerShareTables", "longName": "999031 - Disclosure - Net income (loss) per share (Tables)", "shortName": "Net income (loss) per share (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "31", "firstAnchor": { "contextRef": "From2026-01-01to2026-03-31", "name": "ifrs-full:EarningsPerShareExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ifrs-full:DisclosureOfIncomeTaxExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "ex99-1.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2026-01-01to2026-03-31", "name": "ifrs-full:EarningsPerShareExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ifrs-full:DisclosureOfIncomeTaxExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "ex99-1.htm", "first": true, "unique": true } }, "R32": { "role": "http://cosciensbio.com/role/DiscontinuedOperationsTables", "longName": "999032 - Disclosure - Discontinued operations (Tables)", "shortName": "Discontinued operations (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "32", "firstAnchor": { "contextRef": "From2026-01-01to2026-03-31", "name": "CSCI:DisclosureOfAssetsAndLiabilitiesOfDisposalGroupClassifiedAsHeldForSaleAndDiscontinuedOperationsExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ifrs-full:DisclosureOfDiscontinuedOperationsExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "ex99-1.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2026-01-01to2026-03-31", "name": "CSCI:DisclosureOfAssetsAndLiabilitiesOfDisposalGroupClassifiedAsHeldForSaleAndDiscontinuedOperationsExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ifrs-full:DisclosureOfDiscontinuedOperationsExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "ex99-1.htm", "first": true, "unique": true } }, "R33": { "role": "http://cosciensbio.com/role/BusinessOverviewDetailsNarrative", "longName": "999033 - Disclosure - Business overview (Details Narrative)", "shortName": "Business overview (Details Narrative)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "33", "firstAnchor": { "contextRef": "From2026-01-01to2026-03-31", "name": "ifrs-full:ProfitLossFromContinuingOperations", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "ex99-1.htm", "first": true }, "uniqueAnchor": { "contextRef": "From2026-01-01to2026-03-31", "name": "CSCI:PercentageOfTariffsIssued", "unitRef": "Pure", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "span", "p", "ifrs-full:DisclosureOfBasisOfPreparationOfFinancialStatementsExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "ex99-1.htm", "unique": true } }, "R34": { "role": "http://cosciensbio.com/role/SummaryOfDeferredRevenueDetails", "longName": "999034 - Disclosure - Summary of deferred revenue (Details)", "shortName": "Summary of deferred revenue (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "34", "firstAnchor": { "contextRef": "AsOf2025-12-31", "name": "ifrs-full:CurrentContractLiabilities", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "CSCI:DisclosureOfDetailedInformationAboutDeferredRevenueExplanatory", "ifrs-full:DisclosureOfRevenueExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "ex99-1.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2025-12-31", "name": "ifrs-full:CurrentContractLiabilities", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "CSCI:DisclosureOfDetailedInformationAboutDeferredRevenueExplanatory", "ifrs-full:DisclosureOfRevenueExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "ex99-1.htm", "first": true, "unique": true } }, "R35": { "role": "http://cosciensbio.com/role/ScheduleOfInventoriesDetails", "longName": "999035 - Disclosure - Schedule of inventories (Details)", "shortName": "Schedule of inventories (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "35", "firstAnchor": { "contextRef": "AsOf2026-03-31", "name": "ifrs-full:RawMaterials", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "CSCI:DisclosureOfInventoryExplanatory", "ifrs-full:DisclosureOfInventoriesExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "ex99-1.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2026-03-31", "name": "ifrs-full:RawMaterials", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "CSCI:DisclosureOfInventoryExplanatory", "ifrs-full:DisclosureOfInventoriesExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "ex99-1.htm", "first": true, "unique": true } }, "R36": { "role": "http://cosciensbio.com/role/RevenueDetailsNarrative", "longName": "999036 - Disclosure - Revenue (Details Narrative)", "shortName": "Revenue (Details Narrative)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "36", "firstAnchor": { "contextRef": "From2026-01-01to2026-03-31", "name": "ifrs-full:RevenueFromSaleOfGoodsRelatedPartyTransactions", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "span", "p", "ifrs-full:DisclosureOfRevenueExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "ex99-1.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2026-01-01to2026-03-31", "name": "ifrs-full:RevenueFromSaleOfGoodsRelatedPartyTransactions", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "span", "p", "ifrs-full:DisclosureOfRevenueExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "ex99-1.htm", "first": true, "unique": true } }, "R37": { "role": "http://cosciensbio.com/role/SummaryOfPrepaidExpensesAndOtherCurrentAssetsDetails", "longName": "999037 - Disclosure - Summary of prepaid expenses and other current assets (Details)", "shortName": "Summary of prepaid expenses and other current assets (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "37", "firstAnchor": { "contextRef": "AsOf2026-03-31", "name": "ifrs-full:CurrentPrepaidExpenses", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "CSCI:DisclosureOfPrepaidExpensesAndOtherCurrentAssetsExplanatory", "ifrs-full:DisclosureOfPrepaymentsAndOtherAssetsExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "ex99-1.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2026-03-31", "name": "ifrs-full:CurrentPrepaidExpenses", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "CSCI:DisclosureOfPrepaidExpensesAndOtherCurrentAssetsExplanatory", "ifrs-full:DisclosureOfPrepaymentsAndOtherAssetsExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "ex99-1.htm", "first": true, "unique": true } }, "R38": { "role": "http://cosciensbio.com/role/ScheduleOfPropertyAndEquipmentDetails", "longName": "999038 - Disclosure - Schedule of property and equipment (Details)", "shortName": "Schedule of property and equipment (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "38", "firstAnchor": { "contextRef": "AsOf2025-12-31", "name": "ifrs-full:PropertyPlantAndEquipment", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "ex99-1.htm", "first": true }, "uniqueAnchor": { "contextRef": "AsOf2026-03-31_custom_EquipmentsMember", "name": "ifrs-full:PropertyPlantAndEquipment", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "CSCI:DisclosureOfPropertyPlantAndEquipmentsExplanatory", "ifrs-full:DisclosureOfPropertyPlantAndEquipmentExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "ex99-1.htm", "unique": true } }, "R39": { "role": "http://cosciensbio.com/role/InventoriesDetailsNarrative", "longName": "999039 - Disclosure - Inventories (Details Narrative)", "shortName": "Inventories (Details Narrative)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "39", "firstAnchor": { "contextRef": "From2026-01-01to2026-03-31", "name": "CSCI:InventoriesExpensedToCostOfGoodsSold", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "span", "p", "ifrs-full:DisclosureOfInventoriesExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "ex99-1.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2026-01-01to2026-03-31", "name": "CSCI:InventoriesExpensedToCostOfGoodsSold", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "span", "p", "ifrs-full:DisclosureOfInventoriesExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "ex99-1.htm", "first": true, "unique": true } }, "R40": { "role": "http://cosciensbio.com/role/SummaryOfDetailedInformationAboutAccountsPayableAndAccruedLiabilitiesDetails", "longName": "999040 - Disclosure - Summary of detailed information about accounts payable and accrued liabilities (Details)", "shortName": "Summary of detailed information about accounts payable and accrued liabilities (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "40", "firstAnchor": { "contextRef": "AsOf2026-03-31", "name": "ifrs-full:TradeAndOtherCurrentPayablesToTradeSuppliers", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "CSCI:DisclosureOfDetailedInformationAboutPayablesAndAccruedLiabilitiesExplanatory", "ifrs-full:DisclosureOfTradeAndOtherPayablesExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "ex99-1.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2026-03-31", "name": "ifrs-full:TradeAndOtherCurrentPayablesToTradeSuppliers", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "CSCI:DisclosureOfDetailedInformationAboutPayablesAndAccruedLiabilitiesExplanatory", "ifrs-full:DisclosureOfTradeAndOtherPayablesExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "ex99-1.htm", "first": true, "unique": true } }, "R41": { "role": "http://cosciensbio.com/role/SummaryOfNetDefinedBenefitLiabilityAssetDetails", "longName": "999041 - Disclosure - Summary of net defined benefit liability asset (Details)", "shortName": "Summary of net defined benefit liability asset (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "41", "firstAnchor": { "contextRef": "AsOf2025-12-31", "name": "ifrs-full:LiabilityAssetOfDefinedBenefitPlans", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "ifrs-full:DisclosureOfNetDefinedBenefitLiabilityAssetExplanatory", "ifrs-full:DisclosureOfEmployeeBenefitsExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "ex99-1.htm", "first": true }, "uniqueAnchor": { "contextRef": "AsOf2024-12-31", "name": "ifrs-full:LiabilityAssetOfDefinedBenefitPlans", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "ifrs-full:DisclosureOfNetDefinedBenefitLiabilityAssetExplanatory", "ifrs-full:DisclosureOfEmployeeBenefitsExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "ex99-1.htm", "unique": true } }, "R42": { "role": "http://cosciensbio.com/role/PropertyAndEquipmentDetailsNarrative", "longName": "999042 - Disclosure - Property and equipment (Details Narrative)", "shortName": "Property and equipment (Details Narrative)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "42", "firstAnchor": { "contextRef": "From2025-01-012025-03-31", "name": "CSCI:DepreciatedAssets", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "span", "p", "ifrs-full:DisclosureOfPropertyPlantAndEquipmentExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "ex99-1.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2025-01-012025-03-31", "name": "CSCI:DepreciatedAssets", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "span", "p", "ifrs-full:DisclosureOfPropertyPlantAndEquipmentExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "ex99-1.htm", "first": true, "unique": true } }, "R43": { "role": "http://cosciensbio.com/role/SummaryOfWarrantsActivityReclassifiedEquityDetails", "longName": "999043 - Disclosure - Summary of warrants activity reclassified equity (Details)", "shortName": "Summary of warrants activity reclassified equity (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "43", "firstAnchor": { "contextRef": "AsOf2025-12-31", "name": "CSCI:ClassOfWarrantOrRightOutstanding1", "unitRef": "Shares", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "td", "tr", "table", "CSCI:DisclosureOfWarrantsActivityReclassifiedIntoEquityExplanatory", "CSCI:DisclosureWarrantsExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "ex99-1.htm", "first": true }, "uniqueAnchor": { "contextRef": "AsOf2025-12-31", "name": "CSCI:WarrantsAndRightOutstanding", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "CSCI:DisclosureOfWarrantsActivityReclassifiedIntoEquityExplanatory", "CSCI:DisclosureWarrantsExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "ex99-1.htm", "unique": true } }, "R44": { "role": "http://cosciensbio.com/role/ScheduleOfWarrantsOutstandingDetails", "longName": "999044 - Disclosure - Schedule of warrants outstanding (Details)", "shortName": "Schedule of warrants outstanding (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "44", "firstAnchor": { "contextRef": "AsOf2026-03-31", "name": "CSCI:ClassOfWarrantOrRightOutstanding1", "unitRef": "Shares", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "td", "tr", "table", "CSCI:DisclosureOfWarrantsActivityReclassifiedIntoEquityExplanatory", "CSCI:DisclosureWarrantsExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "ex99-1.htm", "first": true }, "uniqueAnchor": { "contextRef": "From2026-01-01to2026-03-31", "name": "CSCI:WeightedAverageRemainingContractualLifeOfOutstandingShareWarrant2019", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "td", "tr", "table", "CSCI:DisclosureOfRangeOfExercisePricesOfOutstandingShareWarrantsExplanatory", "CSCI:DisclosureWarrantsExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "ex99-1.htm", "unique": true } }, "R45": { "role": "http://cosciensbio.com/role/SummaryOfShareCapitalDetails", "longName": "999045 - Disclosure - Summary of share capital (Details)", "shortName": "Summary of share capital (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "45", "firstAnchor": { "contextRef": "AsOf2025-12-31", "name": "ifrs-full:EquityAttributableToOwnersOfParent", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "ex99-1.htm", "first": true }, "uniqueAnchor": { "contextRef": "AsOf2025-12-31_ifrs-full_IssuedCapitalMember", "name": "ifrs-full:NumberOfSharesIssued", "unitRef": "Shares", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "td", "tr", "table", "ifrs-full:DisclosureOfClassesOfShareCapitalExplanatory", "ifrs-full:DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "ex99-1.htm", "unique": true } }, "R46": { "role": "http://cosciensbio.com/role/SummaryOfNumberAndWeightedAverageExercisePricesOfOptionsDetails", "longName": "999046 - Disclosure - Summary of number and weighted average exercise prices of options (Details)", "shortName": "Summary of number and weighted average exercise prices of options (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "46", "firstAnchor": { "contextRef": "AsOf2025-12-31", "name": "ifrs-full:NumberOfOutstandingShareOptions", "unitRef": "Shares", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "td", "tr", "table", "ifrs-full:DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsExplanatory", "ifrs-full:DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "ex99-1.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2025-12-31", "name": "ifrs-full:NumberOfOutstandingShareOptions", "unitRef": "Shares", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "td", "tr", "table", "ifrs-full:DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsExplanatory", "ifrs-full:DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "ex99-1.htm", "first": true, "unique": true } }, "R47": { "role": "http://cosciensbio.com/role/SummaryOfChangesInOperatingAssetsAndLiabilitiesDetails", "longName": "999047 - Disclosure - Summary of changes in operating assets and liabilities (Details)", "shortName": "Summary of changes in operating assets and liabilities (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "47", "firstAnchor": { "contextRef": "From2026-01-01to2026-03-31", "name": "ifrs-full:AdjustmentsForDecreaseIncreaseInTradeAndOtherReceivables", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "CSCI:DisclosureofChangesInOperatingAssetsAndLiabilitiesTableTextBlock", "ifrs-full:DisclosureOfCashFlowStatementExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "ex99-1.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2026-01-01to2026-03-31", "name": "ifrs-full:AdjustmentsForDecreaseIncreaseInTradeAndOtherReceivables", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "CSCI:DisclosureofChangesInOperatingAssetsAndLiabilitiesTableTextBlock", "ifrs-full:DisclosureOfCashFlowStatementExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "ex99-1.htm", "first": true, "unique": true } }, "R48": { "role": "http://cosciensbio.com/role/SummaryOfPertinentDataRelatingToComputationOfBasicAndDilutedNetLossPerShareDetails", "longName": "999048 - Disclosure - Summary of pertinent data relating to computation of basic and diluted net loss per share (Details)", "shortName": "Summary of pertinent data relating to computation of basic and diluted net loss per share (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "48", "firstAnchor": { "contextRef": "From2026-01-01to2026-03-31", "name": "ifrs-full:ProfitLossFromContinuingOperations", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "ex99-1.htm", "first": true }, "uniqueAnchor": { "contextRef": "From2026-01-012026-03-31_custom_StockOptionsAndDeferredStockUnitsMember", "name": "ifrs-full:NumberOfPotentialOrdinarySharesThatAreAntidilutiveInPeriodPresented", "unitRef": "Shares", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "td", "tr", "table", "ifrs-full:EarningsPerShareExplanatory", "ifrs-full:DisclosureOfIncomeTaxExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "ex99-1.htm", "unique": true } }, "R49": { "role": "http://cosciensbio.com/role/ShareholdersEquityDetailsNarrative", "longName": "999049 - Disclosure - Shareholders\u2019 equity (Details Narrative)", "shortName": "Shareholders\u2019 equity (Details Narrative)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "49", "firstAnchor": { "contextRef": "From2026-01-01to2026-03-31", "name": "CSCI:CompensationExpenses", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "span", "p", "ifrs-full:DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "ex99-1.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2026-01-01to2026-03-31", "name": "CSCI:CompensationExpenses", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "span", "p", "ifrs-full:DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "ex99-1.htm", "first": true, "unique": true } }, "R50": { "role": "http://cosciensbio.com/role/SegmentInformationDetailsNarrative", "longName": "999050 - Disclosure - Segment information (Details Narrative)", "shortName": "Segment information (Details Narrative)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "50", "firstAnchor": { "contextRef": "From2026-01-012026-03-31_custom_OneCustomerMember", "name": "ifrs-full:PercentageOfEntitysRevenue", "unitRef": "Pure", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "span", "p", "ifrs-full:DisclosureOfEntitysReportableSegmentsExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "ex99-1.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2026-01-012026-03-31_custom_OneCustomerMember", "name": "ifrs-full:PercentageOfEntitysRevenue", "unitRef": "Pure", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "span", "p", "ifrs-full:DisclosureOfEntitysReportableSegmentsExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "ex99-1.htm", "first": true, "unique": true } }, "R51": { "role": "http://cosciensbio.com/role/ScheduleOfDiscontinuedAssetsAndLiabilitiesDetails", "longName": "999051 - Disclosure - Schedule of discontinued assets and liabilities (Details)", "shortName": " Schedule of discontinued assets and liabilities (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "51", "firstAnchor": { "contextRef": "AsOf2026-03-31", "name": "ifrs-full:CashAndCashEquivalents", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "ex99-1.htm", "first": true }, "uniqueAnchor": { "contextRef": "AsOf2026-03-27_ifrs-full_DiscontinuedOperationsMember", "name": "ifrs-full:CashAndCashEquivalents", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "CSCI:DisclosureOfAssetsAndLiabilitiesOfDisposalGroupClassifiedAsHeldForSaleAndDiscontinuedOperationsExplanatory", "ifrs-full:DisclosureOfDiscontinuedOperationsExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "ex99-1.htm", "unique": true } }, "R52": { "role": "http://cosciensbio.com/role/ScheduleOfDiscontinuedProfitOrLossDetails", "longName": "999052 - Disclosure - Schedule of discontinued profit or loss (Details)", "shortName": "Schedule of discontinued profit or loss (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "52", "firstAnchor": { "contextRef": "From2026-01-01to2026-03-31", "name": "ifrs-full:Revenue", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "ex99-1.htm", "first": true }, "uniqueAnchor": { "contextRef": "From2026-01-012026-03-31_ifrs-full_DiscontinuedOperationsMember", "name": "ifrs-full:Revenue", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "CSCI:DisclosureOfStatementOfProfitOrLossFromDiscontinuedOperationsExplanatory", "ifrs-full:DisclosureOfDiscontinuedOperationsExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "ex99-1.htm", "unique": true } }, "R53": { "role": "http://cosciensbio.com/role/ScheduleOfDiscontinuedCashFlowsDetails", "longName": "999053 - Disclosure - Schedule of discontinued cash flows (Details)", "shortName": " Schedule of discontinued cash flows (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "53", "firstAnchor": { "contextRef": "From2026-01-01to2026-03-31", "name": "ifrs-full:CashFlowsFromUsedInOperatingActivities", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "ex99-1.htm", "first": true }, "uniqueAnchor": { "contextRef": "From2026-01-012026-03-31_ifrs-full_DiscontinuedOperationsMember", "name": "ifrs-full:CashFlowsFromUsedInOperatingActivities", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "CSCI:DisclosureOfCashFlowsFromDiscontinuedOperationsExplanatory", "ifrs-full:DisclosureOfDiscontinuedOperationsExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "ex99-1.htm", "unique": true } }, "R54": { "role": "http://cosciensbio.com/role/DiscontinuedOperationsDetailsNarrative", "longName": "999054 - Disclosure - Discontinued operations (Details Narrative)", "shortName": "Discontinued operations (Details Narrative)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "54", "firstAnchor": { "contextRef": "From2026-01-01to2026-03-31", "name": "ifrs-full:ProfitLossFromDiscontinuedOperations", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "ex99-1.htm", "first": true }, "uniqueAnchor": null }, "R55": { "role": "http://cosciensbio.com/role/CommitmentsAndContingenciesDetailsNarrative", "longName": "999055 - Disclosure - Commitments and Contingencies (Details Narrative)", "shortName": "Commitments and Contingencies (Details Narrative)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "55", "firstAnchor": { "contextRef": "From2026-01-01to2026-03-31", "name": "CSCI:AnnualRoyaltyPercentage", "unitRef": "Pure", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "span", "p", "ifrs-full:DisclosureOfCommitmentsAndContingentLiabilitiesExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "ex99-1.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2026-01-01to2026-03-31", "name": "CSCI:AnnualRoyaltyPercentage", "unitRef": "Pure", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "span", "p", "ifrs-full:DisclosureOfCommitmentsAndContingentLiabilitiesExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "ex99-1.htm", "first": true, "unique": true } } }, "tag": { "CSCI_AccruedPayrollTaxAndOtherStatutoryLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "http://cosciensbio.com/20260331", "localname": "AccruedPayrollTaxAndOtherStatutoryLiabilities", "crdr": "credit", "calculation": { "http://cosciensbio.com/role/SummaryOfDetailedInformationAboutAccountsPayableAndAccruedLiabilitiesDetails": { "parentTag": "ifrs-full_CurrentAccruedExpensesAndOtherCurrentLiabilities", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://cosciensbio.com/role/SummaryOfDetailedInformationAboutAccountsPayableAndAccruedLiabilitiesDetails" ], "lang": { "en-us": { "role": { "label": "Payroll tax and other statutory liabilities", "documentation": "Accrued payroll tax and other statutory liabilities." } } }, "auth_ref": [] }, "CSCI_AccruedResearchAndDevelopmentCosts": { "xbrltype": "monetaryItemType", "nsuri": "http://cosciensbio.com/20260331", "localname": "AccruedResearchAndDevelopmentCosts", "crdr": "credit", "calculation": { "http://cosciensbio.com/role/SummaryOfDetailedInformationAboutAccountsPayableAndAccruedLiabilitiesDetails": { "parentTag": "ifrs-full_CurrentAccruedExpensesAndOtherCurrentLiabilities", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://cosciensbio.com/role/SummaryOfDetailedInformationAboutAccountsPayableAndAccruedLiabilitiesDetails" ], "lang": { "en-us": { "role": { "label": "Accrued research and development costs", "documentation": "Accrued research and development costs." } } }, "auth_ref": [] }, "CSCI_AccumulatedDepreciationMember": { "xbrltype": "domainItemType", "nsuri": "http://cosciensbio.com/20260331", "localname": "AccumulatedDepreciationMember", "presentation": [ "http://cosciensbio.com/role/ScheduleOfPropertyAndEquipmentDetails" ], "lang": { "en-us": { "role": { "label": "Accumulated depreciation [member]", "documentation": "Accumulated depreciation [member]" } } }, "auth_ref": [] }, "ifrs-full_AccumulatedOtherComprehensiveIncome": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "AccumulatedOtherComprehensiveIncome", "crdr": "credit", "calculation": { "http://cosciensbio.com/role/InterimConsolidatedStatementsOfFinancialPosition": { "parentTag": "ifrs-full_EquityAttributableToOwnersOfParent", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://cosciensbio.com/role/InterimConsolidatedStatementsOfFinancialPosition" ], "lang": { "en-us": { "role": { "label": "Accumulated other comprehensive loss" } } }, "auth_ref": [ "r249" ] }, "ifrs-full_AccumulatedOtherComprehensiveIncomeMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "AccumulatedOtherComprehensiveIncomeMember", "presentation": [ "http://cosciensbio.com/role/InterimConsolidatedStatementsOfChangesInShareholdersEquity" ], "lang": { "en-us": { "role": { "label": "Accumulated other comprehensive income [member]" } }, "en": { "role": { "documentation": "This member stands for accumulated other comprehensive income. [Refer: Other comprehensive income]" } } }, "auth_ref": [ "r245" ] }, "ifrs-full_ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetDefinedBenefitLiabilityAsset": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetDefinedBenefitLiabilityAsset", "crdr": "debit", "presentation": [ "http://cosciensbio.com/role/SummaryOfNetDefinedBenefitLiabilityAssetDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Actuarial loss (gain) from changes in financial assumptions", "label": "Decrease (increase) in net defined benefit liability (asset) resulting from actuarial gains (losses) arising from changes in financial assumptions" } }, "en": { "role": { "documentation": "The decrease (increase) in a net defined benefit liability (asset) resulting from actuarial gains (losses) arising from changes in financial assumptions that result in remeasurements of the net defined benefit liability (asset). Financial assumptions deal with items such as: (a) the discount rate; (b) benefit levels, excluding any cost of the benefits to be met by employees, and future salary; (c) in the case of medical benefits, future medical costs, including claim handling costs (ie the costs that will be incurred in processing and resolving claims, including legal and adjuster's fees); and (d) taxes payable by the plan on contributions relating to service before the reporting date or on benefits resulting from that service. [Refer: Net defined benefit liability (asset)]" } } }, "auth_ref": [ "r15" ] }, "ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment", "crdr": "debit", "presentation": [ "http://cosciensbio.com/role/ScheduleOfPropertyAndEquipmentDetails" ], "lang": { "en-us": { "role": { "label": "Additions" } }, "en": { "role": { "documentation": "The amount of additions to property, plant and equipment other than those acquired through business combinations. [Refer: Total for all business combinations [member]; Property, plant and equipment]" } } }, "auth_ref": [ "r5", "r116" ] }, "ifrs-full_AdjustedWeightedAverageShares": { "xbrltype": "sharesItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "AdjustedWeightedAverageShares", "presentation": [ "http://cosciensbio.com/role/InterimConsolidatedStatementsOfIncomeLossAndComprehensiveIncomeLoss", "http://cosciensbio.com/role/SummaryOfPertinentDataRelatingToComputationOfBasicAndDilutedNetLossPerShareDetails" ], "lang": { "en-us": { "role": { "label": "Weighted average number of shares outstanding (diluted)", "verboseLabel": "Weighted-average shares outstanding (diluted)" } }, "en": { "role": { "documentation": "The weighted average number of ordinary shares outstanding plus the weighted average number of ordinary shares that would be issued on the conversion of all the dilutive potential ordinary shares into ordinary shares. [Refer: Ordinary shares [member]; Weighted average [member]]" } } }, "auth_ref": [ "r29" ] }, "CSCI_AdjustmentsForAmortizationOfDeferredIncome": { "xbrltype": "monetaryItemType", "nsuri": "http://cosciensbio.com/20260331", "localname": "AdjustmentsForAmortizationOfDeferredIncome", "crdr": "debit", "calculation": { "http://cosciensbio.com/role/InterimConsolidatedStatementsOfCashFlows": { "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivities", "weight": 1.0, "order": 7.0 } }, "presentation": [ "http://cosciensbio.com/role/InterimConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Amortization of deferred revenues", "documentation": "Adjustments for amortization of deferred income." } } }, "auth_ref": [] }, "CSCI_AdjustmentsForDecreaseIncreaseInCurrentPrepaymentsAndOtherCurrentAssets": { "xbrltype": "monetaryItemType", "nsuri": "http://cosciensbio.com/20260331", "localname": "AdjustmentsForDecreaseIncreaseInCurrentPrepaymentsAndOtherCurrentAssets", "crdr": "debit", "calculation": { "http://cosciensbio.com/role/SummaryOfChangesInOperatingAssetsAndLiabilitiesDetails": { "parentTag": "ifrs-full_IncreaseDecreaseInWorkingCapital", "weight": -1.0, "order": 3.0 } }, "presentation": [ "http://cosciensbio.com/role/SummaryOfChangesInOperatingAssetsAndLiabilitiesDetails" ], "lang": { "en-us": { "role": { "label": "Prepaid expenses and other current assets", "documentation": "Adjustments for decrease increase in current prepayments and other current assets" } } }, "auth_ref": [] }, "ifrs-full_AdjustmentsForDecreaseIncreaseInInventories": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "AdjustmentsForDecreaseIncreaseInInventories", "crdr": "debit", "calculation": { "http://cosciensbio.com/role/SummaryOfChangesInOperatingAssetsAndLiabilitiesDetails": { "parentTag": "ifrs-full_IncreaseDecreaseInWorkingCapital", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://cosciensbio.com/role/SummaryOfChangesInOperatingAssetsAndLiabilitiesDetails" ], "lang": { "en-us": { "role": { "label": "Inventory" } } }, "auth_ref": [ "r238" ] }, "ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAndOtherReceivables": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "AdjustmentsForDecreaseIncreaseInTradeAndOtherReceivables", "crdr": "debit", "calculation": { "http://cosciensbio.com/role/SummaryOfChangesInOperatingAssetsAndLiabilitiesDetails": { "parentTag": "ifrs-full_IncreaseDecreaseInWorkingCapital", "weight": -1.0, "order": 1.0 } }, "presentation": [ "http://cosciensbio.com/role/SummaryOfChangesInOperatingAssetsAndLiabilitiesDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Trade and other receivables", "label": "Adjustments for decrease (increase) in trade and other receivables" } }, "en": { "role": { "documentation": "Adjustments for decrease (increase) in trade and other receivables to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Trade and other receivables; Profit (loss)]" } } }, "auth_ref": [ "r240" ] }, "ifrs-full_AdjustmentsForDepreciationAndAmortisationExpense": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "AdjustmentsForDepreciationAndAmortisationExpense", "crdr": "debit", "calculation": { "http://cosciensbio.com/role/InterimConsolidatedStatementsOfCashFlows": { "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivities", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://cosciensbio.com/role/InterimConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Depreciation and amortization" } } }, "auth_ref": [ "r239" ] }, "CSCI_AdjustmentsForEmployeeFutureBenefits": { "xbrltype": "monetaryItemType", "nsuri": "http://cosciensbio.com/20260331", "localname": "AdjustmentsForEmployeeFutureBenefits", "crdr": "debit", "calculation": { "http://cosciensbio.com/role/InterimConsolidatedStatementsOfCashFlows": { "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivities", "weight": 1.0, "order": 6.0 } }, "presentation": [ "http://cosciensbio.com/role/InterimConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Employee future benefits", "documentation": "Adjustments for employee future benefits." } } }, "auth_ref": [] }, "ifrs-full_AdjustmentsForIncreaseDecreaseInDeferredIncomeIncludingContractLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "AdjustmentsForIncreaseDecreaseInDeferredIncomeIncludingContractLiabilities", "crdr": "debit", "calculation": { "http://cosciensbio.com/role/SummaryOfChangesInOperatingAssetsAndLiabilitiesDetails": { "parentTag": "ifrs-full_IncreaseDecreaseInWorkingCapital", "weight": -1.0, "order": 5.0 } }, "presentation": [ "http://cosciensbio.com/role/SummaryOfChangesInOperatingAssetsAndLiabilitiesDetails" ], "lang": { "en-us": { "role": { "label": "Deferred revenues" } }, "en": { "role": { "documentation": "Adjustments for the increase (decrease) in deferred income including contract liabilities to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Deferred income including contract liabilities; Profit (loss)]" } } }, "auth_ref": [ "r238" ] }, "ifrs-full_AdjustmentsForIncreaseDecreaseInEmployeeBenefitLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "AdjustmentsForIncreaseDecreaseInEmployeeBenefitLiabilities", "crdr": "debit", "calculation": { "http://cosciensbio.com/role/SummaryOfChangesInOperatingAssetsAndLiabilitiesDetails": { "parentTag": "ifrs-full_IncreaseDecreaseInWorkingCapital", "weight": -1.0, "order": 7.0 } }, "presentation": [ "http://cosciensbio.com/role/SummaryOfChangesInOperatingAssetsAndLiabilitiesDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Employee future benefits", "label": "Adjustments for increase (decrease) in employee benefit liabilities" } }, "en": { "role": { "documentation": "Adjustments for increase (decrease) in employee benefit liabilities to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Profit (loss)]" } } }, "auth_ref": [ "r240" ] }, "CSCI_AdjustmentsForIncreaseDecreaseInProvisions": { "xbrltype": "monetaryItemType", "nsuri": "http://cosciensbio.com/20260331", "localname": "AdjustmentsForIncreaseDecreaseInProvisions", "crdr": "debit", "calculation": { "http://cosciensbio.com/role/SummaryOfChangesInOperatingAssetsAndLiabilitiesDetails": { "parentTag": "ifrs-full_IncreaseDecreaseInWorkingCapital", "weight": -1.0, "order": 6.0 } }, "presentation": [ "http://cosciensbio.com/role/SummaryOfChangesInOperatingAssetsAndLiabilitiesDetails" ], "lang": { "en-us": { "role": { "label": "Provision for restructuring and other costs", "documentation": "Adjustments for increase decrease in provisions." } } }, "auth_ref": [] }, "ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAndOtherPayables": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "AdjustmentsForIncreaseDecreaseInTradeAndOtherPayables", "crdr": "debit", "calculation": { "http://cosciensbio.com/role/SummaryOfChangesInOperatingAssetsAndLiabilitiesDetails": { "parentTag": "ifrs-full_IncreaseDecreaseInWorkingCapital", "weight": -1.0, "order": 4.0 } }, "presentation": [ "http://cosciensbio.com/role/SummaryOfChangesInOperatingAssetsAndLiabilitiesDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Accounts payable and accrued liabilities", "label": "Adjustments for increase (decrease) in trade and other payables" } }, "en": { "role": { "documentation": "Adjustments for increase (decrease) in trade and other payables to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Trade and other payables; Profit (loss)]" } } }, "auth_ref": [ "r240" ] }, "ifrs-full_AdjustmentsForReconcileProfitLossAbstract": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "AdjustmentsForReconcileProfitLossAbstract", "presentation": [ "http://cosciensbio.com/role/InterimConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Items not affecting cash and cash equivalents:" } } }, "auth_ref": [] }, "ifrs-full_AdjustmentsForSharebasedPayments": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "AdjustmentsForSharebasedPayments", "crdr": "debit", "calculation": { "http://cosciensbio.com/role/InterimConsolidatedStatementsOfCashFlows": { "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivities", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://cosciensbio.com/role/InterimConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "verboseLabel": "Share-based compensation costs", "label": "Adjustments for share-based payments" } } }, "auth_ref": [ "r239" ] }, "dei_AmendmentDescription": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "AmendmentDescription", "presentation": [ "http://cosciensbio.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Amendment Description", "documentation": "Description of changes contained within amended document." } } }, "auth_ref": [] }, "dei_AmendmentFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "AmendmentFlag", "presentation": [ "http://cosciensbio.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Amendment Flag", "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission." } } }, "auth_ref": [] }, "CSCI_AmortizationOfPropertyPlantAndEquipment": { "xbrltype": "monetaryItemType", "nsuri": "http://cosciensbio.com/20260331", "localname": "AmortizationOfPropertyPlantAndEquipment", "crdr": "debit", "presentation": [ "http://cosciensbio.com/role/ScheduleOfPropertyAndEquipmentDetails" ], "lang": { "en-us": { "role": { "label": "Amortization", "documentation": "Amortization." } } }, "auth_ref": [] }, "CSCI_AmountRecognizedAsEmployeeFutureBenefitsNet": { "xbrltype": "monetaryItemType", "nsuri": "http://cosciensbio.com/20260331", "localname": "AmountRecognizedAsEmployeeFutureBenefitsNet", "crdr": "debit", "presentation": [ "http://cosciensbio.com/role/SummaryOfNetDefinedBenefitLiabilityAssetDetails" ], "lang": { "en-us": { "role": { "label": "Net amount recognized as Employee future benefits", "documentation": "Net amount recognized as Employee future benefits." } } }, "auth_ref": [] }, "CSCI_AmountsDerecognizedDueToDeconsolidationOfGermanSubsidiariesPropertyPlantAndEquipment": { "xbrltype": "monetaryItemType", "nsuri": "http://cosciensbio.com/20260331", "localname": "AmountsDerecognizedDueToDeconsolidationOfGermanSubsidiariesPropertyPlantAndEquipment", "crdr": "credit", "presentation": [ "http://cosciensbio.com/role/ScheduleOfPropertyAndEquipmentDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Amounts derecognized due to deconsolidation of German subsidiaries", "documentation": "Amounts derecognized due to deconsolidation of German subsidiaries property plant and equipment.", "label": "AmountsDerecognizedDueToDeconsolidationOfGermanSubsidiariesPropertyPlantAndEquipment" } } }, "auth_ref": [] }, "CSCI_AmountsDerecognizedDueToDiscontinuedOperationsPropertyPlantAndEquipment": { "xbrltype": "monetaryItemType", "nsuri": "http://cosciensbio.com/20260331", "localname": "AmountsDerecognizedDueToDiscontinuedOperationsPropertyPlantAndEquipment", "crdr": "credit", "presentation": [ "http://cosciensbio.com/role/ScheduleOfPropertyAndEquipmentDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Amounts derecognized due to discontinued operations", "documentation": "Amounts derecognized due to discontinued operations property plant and equipment.", "label": "AmountsDerecognizedDueToDiscontinuedOperationsPropertyPlantAndEquipment" } } }, "auth_ref": [] }, "dei_AnnualInformationForm": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "AnnualInformationForm", "presentation": [ "http://cosciensbio.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Annual Information Form", "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form." } } }, "auth_ref": [ "r225" ] }, "CSCI_AnnualRoyaltyPercentage": { "xbrltype": "percentItemType", "nsuri": "http://cosciensbio.com/20260331", "localname": "AnnualRoyaltyPercentage", "presentation": [ "http://cosciensbio.com/role/CommitmentsAndContingenciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Annual royalty percentage", "documentation": "Annual royalty percentage." } } }, "auth_ref": [] }, "ifrs-full_Assets": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "Assets", "crdr": "debit", "calculation": { "http://cosciensbio.com/role/InterimConsolidatedStatementsOfFinancialPosition": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://cosciensbio.com/role/InterimConsolidatedStatementsOfFinancialPosition", "http://cosciensbio.com/role/ScheduleOfDiscontinuedAssetsAndLiabilitiesDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Total assets", "label": "Assets" } }, "en": { "role": { "documentation": "The amount of a present economic resource controlled by the entity as a result of past events. Economic resource is a right that has the potential to produce economic benefits." } } }, "auth_ref": [ "r64", "r65", "r66", "r92", "r95", "r146", "r147", "r166" ] }, "ifrs-full_AssetsAbstract": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "AssetsAbstract", "presentation": [ "http://cosciensbio.com/role/InterimConsolidatedStatementsOfFinancialPosition", "http://cosciensbio.com/role/ScheduleOfDiscontinuedAssetsAndLiabilitiesDetails" ], "lang": { "en-us": { "role": { "label": "ASSETS" } } }, "auth_ref": [] }, "CSCI_AssetsEmployeeContributions": { "xbrltype": "monetaryItemType", "nsuri": "http://cosciensbio.com/20260331", "localname": "AssetsEmployeeContributions", "crdr": "debit", "presentation": [ "http://cosciensbio.com/role/SummaryOfNetDefinedBenefitLiabilityAssetDetails" ], "lang": { "en-us": { "role": { "label": "Employee contributions", "documentation": "Assets Employee contributions." } } }, "auth_ref": [] }, "CSCI_AssetsEmployerContributions": { "xbrltype": "monetaryItemType", "nsuri": "http://cosciensbio.com/20260331", "localname": "AssetsEmployerContributions", "crdr": "debit", "presentation": [ "http://cosciensbio.com/role/SummaryOfNetDefinedBenefitLiabilityAssetDetails" ], "lang": { "en-us": { "role": { "label": "Employer contributions", "documentation": "Assets employer contributions." } } }, "auth_ref": [] }, "ifrs-full_AssetsOfBenefitPlan": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "AssetsOfBenefitPlan", "crdr": "debit", "presentation": [ "http://cosciensbio.com/role/SummaryOfNetDefinedBenefitLiabilityAssetDetails" ], "lang": { "en-us": { "role": { "periodStartLabel": "Balances \u2013 Beginning of the period", "periodEndLabel": "Balances \u2013 End of the period", "label": "Assets of benefit plan" } }, "en": { "role": { "documentation": "The amount of assets held by retirement benefit plans. [Refer: Defined benefit plans [domain]]" } } }, "auth_ref": [ "r25" ] }, "dei_AuditedAnnualFinancialStatements": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "AuditedAnnualFinancialStatements", "presentation": [ "http://cosciensbio.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Audited Annual Financial Statements", "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements." } } }, "auth_ref": [ "r225" ] }, "ifrs-full_BasicEarningsLossPerShare": { "xbrltype": "perShareItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "BasicEarningsLossPerShare", "presentation": [ "http://cosciensbio.com/role/InterimConsolidatedStatementsOfIncomeLossAndComprehensiveIncomeLoss", "http://cosciensbio.com/role/ScheduleOfDiscontinuedProfitOrLossDetails", "http://cosciensbio.com/role/SummaryOfPertinentDataRelatingToComputationOfBasicAndDilutedNetLossPerShareDetails" ], "lang": { "en-us": { "role": { "label": "Basic income (loss) per share (note 12)", "verboseLabel": "Basic income (loss) per share" } }, "en": { "role": { "documentation": "The amount of profit (loss) attributable to ordinary equity holders of the parent entity (the numerator) divided by the weighted average number of ordinary shares outstanding during the period (the denominator)." } } }, "auth_ref": [ "r27", "r28" ] }, "ifrs-full_BasicEarningsLossPerShareFromContinuingOperations": { "xbrltype": "perShareItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "BasicEarningsLossPerShareFromContinuingOperations", "presentation": [ "http://cosciensbio.com/role/InterimConsolidatedStatementsOfIncomeLossAndComprehensiveIncomeLoss", "http://cosciensbio.com/role/SummaryOfPertinentDataRelatingToComputationOfBasicAndDilutedNetLossPerShareDetails" ], "lang": { "en-us": { "role": { "label": "Basic loss per share from continuing operations" } }, "en": { "role": { "documentation": "Basic earnings (loss) per share from continuing operations. [Refer: Basic earnings (loss) per share; Continuing operations, unless line item indicates otherwise [member]]" } } }, "auth_ref": [ "r27", "r28" ] }, "ifrs-full_BottomOfRangeMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "BottomOfRangeMember", "presentation": [ "http://cosciensbio.com/role/CommitmentsAndContingenciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Bottom of range [member]" } }, "en": { "role": { "documentation": "This member stands for the bottom of a range." } } }, "auth_ref": [ "r42", "r67", "r72", "r78", "r106", "r194", "r195", "r241" ] }, "ifrs-full_BuildingsMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "BuildingsMember", "presentation": [ "http://cosciensbio.com/role/ScheduleOfPropertyAndEquipmentDetails" ], "lang": { "en-us": { "role": { "label": "Buildings [member]" } }, "en": { "role": { "documentation": "This member stands for a class of plant, property and equipment representing depreciable buildings and similar structures for use in operations. [Refer: Property, plant and equipment]" } } }, "auth_ref": [ "r231" ] }, "ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis", "presentation": [ "http://cosciensbio.com/role/ScheduleOfPropertyAndEquipmentDetails" ], "lang": { "en-us": { "role": { "label": "Carrying amount, accumulated depreciation, amortisation and impairment and gross carrying amount [axis]" } }, "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } } }, "auth_ref": [ "r4", "r9", "r31", "r32", "r34", "r35", "r36", "r37", "r38", "r79", "r85", "r86", "r115", "r119", "r127", "r128", "r130", "r131", "r132", "r133", "r134", "r141", "r142", "r143" ] }, "ifrs-full_CarryingAmountMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "CarryingAmountMember", "presentation": [ "http://cosciensbio.com/role/ScheduleOfPropertyAndEquipmentDetails" ], "auth_ref": [ "r9", "r32", "r34", "r36", "r37", "r79", "r85", "r86", "r119", "r128", "r130", "r132", "r133", "r141", "r142", "r143" ] }, "ifrs-full_CashAndCashEquivalents": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "CashAndCashEquivalents", "crdr": "debit", "calculation": { "http://cosciensbio.com/role/InterimConsolidatedStatementsOfFinancialPosition": { "parentTag": "ifrs-full_CurrentAssets", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://cosciensbio.com/role/InterimConsolidatedStatementsOfCashFlows", "http://cosciensbio.com/role/InterimConsolidatedStatementsOfFinancialPosition", "http://cosciensbio.com/role/ScheduleOfDiscontinuedAssetsAndLiabilitiesDetails", "http://cosciensbio.com/role/ScheduleOfDiscontinuedCashFlowsDetails" ], "lang": { "en-us": { "role": { "label": "Cash and cash equivalents", "periodStartLabel": "Cash and cash equivalents \u2013 Beginning of period", "periodEndLabel": "Cash and cash equivalents \u2013 End of period" } }, "en": { "role": { "documentation": "The amount of cash on hand and demand deposits, along with short-term, highly liquid investments that are readily convertible to known amounts of cash and that are subject to an insignificant risk of changes in value. [Refer: Cash; Cash equivalents]" } } }, "auth_ref": [ "r43", "r61", "r107", "r162" ] }, "ifrs-full_CashFlowsFromUsedInDecreaseIncreaseInRestrictedCashAndCashEquivalents": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "CashFlowsFromUsedInDecreaseIncreaseInRestrictedCashAndCashEquivalents", "crdr": "debit", "calculation": { "http://cosciensbio.com/role/InterimConsolidatedStatementsOfCashFlows": { "parentTag": "ifrs-full_CashFlowsFromUsedInInvestingActivities", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://cosciensbio.com/role/InterimConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Changes in restricted cash equivalents" } }, "en": { "role": { "documentation": "The cash inflow (outflow) due to a decrease (increase) in restricted cash and cash equivalents. [Refer: Restricted cash and cash equivalents]" } } }, "auth_ref": [ "r237" ] }, "ifrs-full_CashFlowsFromUsedInFinancingActivities": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "CashFlowsFromUsedInFinancingActivities", "crdr": "debit", "calculation": { "http://cosciensbio.com/role/InterimConsolidatedStatementsOfCashFlows": { "parentTag": "ifrs-full_IncreaseDecreaseInCashAndCashEquivalents", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://cosciensbio.com/role/InterimConsolidatedStatementsOfCashFlows", "http://cosciensbio.com/role/ScheduleOfDiscontinuedCashFlowsDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Net cash used in financing activities", "label": "Net cash used in financing activities" } }, "en": { "role": { "documentation": "The cash flows from (used in) financing activities, which are activities that result in changes in the size and composition of the contributed equity and borrowings of the entity, from continuing and discontinued operations." } } }, "auth_ref": [ "r39", "r44" ] }, "ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "CashFlowsFromUsedInFinancingActivitiesAbstract", "presentation": [ "http://cosciensbio.com/role/InterimConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Cash flows from financing activities" } } }, "auth_ref": [] }, "ifrs-full_CashFlowsFromUsedInInvestingActivities": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "CashFlowsFromUsedInInvestingActivities", "crdr": "debit", "calculation": { "http://cosciensbio.com/role/InterimConsolidatedStatementsOfCashFlows": { "parentTag": "ifrs-full_IncreaseDecreaseInCashAndCashEquivalents", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://cosciensbio.com/role/InterimConsolidatedStatementsOfCashFlows", "http://cosciensbio.com/role/ScheduleOfDiscontinuedCashFlowsDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Net cash used in investing activities", "label": "Net cash provided by investing activities" } }, "en": { "role": { "documentation": "The cash flows from (used in) investing activities, which are the acquisition and disposal of long-term assets and other investments not included in cash equivalents, from continuing and discontinued operations." } } }, "auth_ref": [ "r39", "r44" ] }, "ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "CashFlowsFromUsedInInvestingActivitiesAbstract", "presentation": [ "http://cosciensbio.com/role/InterimConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Cash flows from investing activities" } } }, "auth_ref": [] }, "ifrs-full_CashFlowsFromUsedInOperatingActivities": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "CashFlowsFromUsedInOperatingActivities", "calculation": { "http://cosciensbio.com/role/InterimConsolidatedStatementsOfCashFlows": { "parentTag": "ifrs-full_IncreaseDecreaseInCashAndCashEquivalents", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://cosciensbio.com/role/BusinessOverviewDetailsNarrative", "http://cosciensbio.com/role/InterimConsolidatedStatementsOfCashFlows", "http://cosciensbio.com/role/ScheduleOfDiscontinuedCashFlowsDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Net cash used in operating activities", "negatedLabel": "Cash flow from operating activities", "label": "Net cash used in operating activities" } } }, "auth_ref": [ "r39", "r44" ] }, "ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "CashFlowsFromUsedInOperatingActivitiesAbstract", "presentation": [ "http://cosciensbio.com/role/InterimConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Cash flows from operating activities" } } }, "auth_ref": [] }, "CSCI_ChangeInFairValueOfWarrantAndDsuLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "http://cosciensbio.com/20260331", "localname": "ChangeInFairValueOfWarrantAndDsuLiabilities", "crdr": "credit", "calculation": { "http://cosciensbio.com/role/InterimConsolidatedStatementsOfIncomeLossAndComprehensiveIncomeLoss": { "parentTag": "ifrs-full_FinanceIncomeCost", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://cosciensbio.com/role/InterimConsolidatedStatementsOfIncomeLossAndComprehensiveIncomeLoss" ], "lang": { "en-us": { "role": { "label": "Change in fair value of warrant and DSU liabilities", "documentation": "Change in fair value of warrant and DSU liabilities." } } }, "auth_ref": [] }, "CSCI_ChangeInFairValueOfWarrants": { "xbrltype": "sharesItemType", "nsuri": "http://cosciensbio.com/20260331", "localname": "ChangeInFairValueOfWarrants", "presentation": [ "http://cosciensbio.com/role/SummaryOfWarrantsActivityReclassifiedEquityDetails" ], "lang": { "en-us": { "role": { "label": "Change in fair value of warrants", "documentation": "Change in fair value of warrants." } } }, "auth_ref": [] }, "CSCI_ChangeInFairValueOfWarrantsValue": { "xbrltype": "monetaryItemType", "nsuri": "http://cosciensbio.com/20260331", "localname": "ChangeInFairValueOfWarrantsValue", "crdr": "credit", "presentation": [ "http://cosciensbio.com/role/SummaryOfWarrantsActivityReclassifiedEquityDetails" ], "lang": { "en-us": { "role": { "label": "Change in fair value of warrants, value", "documentation": "Change in fair value of warrants value." } } }, "auth_ref": [] }, "CSCI_ChangeInFairValueOfWarrantsWeightedAverageExercisePriceOfWarrantsOrRights": { "xbrltype": "perShareItemType", "nsuri": "http://cosciensbio.com/20260331", "localname": "ChangeInFairValueOfWarrantsWeightedAverageExercisePriceOfWarrantsOrRights", "presentation": [ "http://cosciensbio.com/role/SummaryOfWarrantsActivityReclassifiedEquityDetails" ], "lang": { "en-us": { "role": { "label": "Weighted average exercise price, Change in fair value of warrants", "documentation": "Change in fair value of warrants weighted average exercise price of warrants or rights." } } }, "auth_ref": [] }, "ifrs-full_CharacteristicsOfDefinedBenefitPlansAxis": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "CharacteristicsOfDefinedBenefitPlansAxis", "presentation": [ "http://cosciensbio.com/role/SummaryOfNetDefinedBenefitLiabilityAssetDetails" ], "lang": { "en-us": { "role": { "label": "Characteristics of defined benefit plans [axis]" } }, "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } } }, "auth_ref": [ "r186" ] }, "ifrs-full_CharacteristicsOfDefinedBenefitPlansDomain": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "CharacteristicsOfDefinedBenefitPlansDomain", "presentation": [ "http://cosciensbio.com/role/SummaryOfNetDefinedBenefitLiabilityAssetDetails" ], "lang": { "en": { "role": { "documentation": "This member stands for all defined benefit plans when disaggregated by characteristics of defined benefits plans. It also represents the standard value for the 'Characteristics of defined benefit plans' axis if no other member is used." } } }, "auth_ref": [ "r186" ] }, "dei_CityAreaCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "CityAreaCode", "presentation": [ "http://cosciensbio.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "City Area Code", "documentation": "Area code of city" } } }, "auth_ref": [] }, "CSCI_ClassOfWarrantOrRightExercisedWeightedAverageExercisePriceOfWarrantsOrRights": { "xbrltype": "perShareItemType", "nsuri": "http://cosciensbio.com/20260331", "localname": "ClassOfWarrantOrRightExercisedWeightedAverageExercisePriceOfWarrantsOrRights", "presentation": [ "http://cosciensbio.com/role/SummaryOfWarrantsActivityReclassifiedEquityDetails" ], "lang": { "en-us": { "role": { "label": "Weighted average exercise price, exercised", "documentation": "Class of warrant or right exercised weighted average exercise price of warrants or rights." } } }, "auth_ref": [] }, "CSCI_ClassOfWarrantOrRightExercisedWeightedAverageExpiredPriceOfWarrantsOrRights": { "xbrltype": "perShareItemType", "nsuri": "http://cosciensbio.com/20260331", "localname": "ClassOfWarrantOrRightExercisedWeightedAverageExpiredPriceOfWarrantsOrRights", "presentation": [ "http://cosciensbio.com/role/SummaryOfWarrantsActivityReclassifiedEquityDetails" ], "lang": { "en-us": { "role": { "label": "Weighted average exercise price,expired", "documentation": "Class of warrant or right exercised weighted average expired price of warrants or rights." } } }, "auth_ref": [] }, "CSCI_ClassOfWarrantOrRightOutstanding1": { "xbrltype": "sharesItemType", "nsuri": "http://cosciensbio.com/20260331", "localname": "ClassOfWarrantOrRightOutstanding1", "presentation": [ "http://cosciensbio.com/role/ScheduleOfWarrantsOutstandingDetails", "http://cosciensbio.com/role/SummaryOfWarrantsActivityReclassifiedEquityDetails" ], "lang": { "en-us": { "role": { "periodStartLabel": "Warrants outstanding, beginning of year", "periodEndLabel": "Warrants outstanding, ending of year", "label": "Warrant outstanding, Number (in shares)", "documentation": "Class of warrant or right outstanding 1." } } }, "auth_ref": [] }, "CSCI_ClassOfWarrantOrRightOutstandingWeightedAverageExercisePriceOfWarrantsOrRights": { "xbrltype": "perShareItemType", "nsuri": "http://cosciensbio.com/20260331", "localname": "ClassOfWarrantOrRightOutstandingWeightedAverageExercisePriceOfWarrantsOrRights", "presentation": [ "http://cosciensbio.com/role/ScheduleOfWarrantsOutstandingDetails", "http://cosciensbio.com/role/SummaryOfWarrantsActivityReclassifiedEquityDetails" ], "lang": { "en-us": { "role": { "periodStartLabel": "Weighted average exercise price, beginning of year", "periodEndLabel": "Weighted average exercise price, ending of year", "label": "Warrant outstanding, Weighted average exercise price", "documentation": "Class of warrant or right outstanding weighted average exercise price of warrants or rights." } } }, "auth_ref": [] }, "CSCI_ClassOfWarrantOrRightsExercised": { "xbrltype": "sharesItemType", "nsuri": "http://cosciensbio.com/20260331", "localname": "ClassOfWarrantOrRightsExercised", "presentation": [ "http://cosciensbio.com/role/SummaryOfWarrantsActivityReclassifiedEquityDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Warrants, exercised", "documentation": "Class of warrant or rights exercised.", "label": "ClassOfWarrantOrRightsExercised" } } }, "auth_ref": [] }, "CSCI_ClassOfWarrantOrRightsExpired": { "xbrltype": "sharesItemType", "nsuri": "http://cosciensbio.com/20260331", "localname": "ClassOfWarrantOrRightsExpired", "presentation": [ "http://cosciensbio.com/role/SummaryOfWarrantsActivityReclassifiedEquityDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Warrants, expired", "documentation": "Class of warrant or rights expired.", "label": "ClassOfWarrantOrRightsExpired" } } }, "auth_ref": [] }, "ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "ClassesOfPropertyPlantAndEquipmentAxis", "presentation": [ "http://cosciensbio.com/role/ScheduleOfPropertyAndEquipmentDetails" ], "lang": { "en-us": { "role": { "label": "Classes of property, plant and equipment [axis]" } }, "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } } }, "auth_ref": [ "r10", "r120" ] }, "ifrs-full_ClassesOfPropertyPlantAndEquipmentDomain": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "ClassesOfPropertyPlantAndEquipmentDomain", "presentation": [ "http://cosciensbio.com/role/ScheduleOfPropertyAndEquipmentDetails" ], "lang": { "en": { "role": { "documentation": "This member stands for the standard value for the 'Classes of property, plant and equipment' axis if no other member is used." } } }, "auth_ref": [ "r10", "r120" ] }, "CSCI_CompensationExpenses": { "xbrltype": "monetaryItemType", "nsuri": "http://cosciensbio.com/20260331", "localname": "CompensationExpenses", "crdr": "credit", "presentation": [ "http://cosciensbio.com/role/ShareholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Compensation expenses", "documentation": "Compensation expenses." } } }, "auth_ref": [] }, "ifrs-full_ComponentsOfEquityAxis": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "ComponentsOfEquityAxis", "presentation": [ "http://cosciensbio.com/role/InterimConsolidatedStatementsOfChangesInShareholdersEquity", "http://cosciensbio.com/role/SummaryOfShareCapitalDetails" ], "lang": { "en-us": { "role": { "label": "Components of equity [axis]" } }, "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } } }, "auth_ref": [ "r156" ] }, "ifrs-full_ComponentsOfEquityDomain": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "ComponentsOfEquityDomain", "presentation": [ "http://cosciensbio.com/role/InterimConsolidatedStatementsOfChangesInShareholdersEquity", "http://cosciensbio.com/role/SummaryOfShareCapitalDetails" ], "lang": { "en": { "role": { "documentation": "This member stands for the residual interest in the assets of the entity after deducting all its liabilities. It also represents the standard value for the 'Components of equity' axis if no other member is used." } } }, "auth_ref": [ "r156" ] }, "ifrs-full_ComponentsOfOtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTaxAbstract": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "ComponentsOfOtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTaxAbstract", "presentation": [ "http://cosciensbio.com/role/InterimConsolidatedStatementsOfIncomeLossAndComprehensiveIncomeLoss" ], "lang": { "en-us": { "role": { "label": "Items that may be reclassified subsequently to profit or loss:" } } }, "auth_ref": [] }, "ifrs-full_ComponentsOfOtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTaxAbstract": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "ComponentsOfOtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTaxAbstract", "presentation": [ "http://cosciensbio.com/role/InterimConsolidatedStatementsOfIncomeLossAndComprehensiveIncomeLoss" ], "lang": { "en-us": { "role": { "label": "Items that will not be reclassified subsequently to profit or loss:" } } }, "auth_ref": [] }, "ifrs-full_ComprehensiveIncome": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "ComprehensiveIncome", "crdr": "credit", "calculation": { "http://cosciensbio.com/role/InterimConsolidatedStatementsOfIncomeLossAndComprehensiveIncomeLoss": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://cosciensbio.com/role/InterimConsolidatedStatementsOfChangesInShareholdersEquity", "http://cosciensbio.com/role/InterimConsolidatedStatementsOfIncomeLossAndComprehensiveIncomeLoss" ], "lang": { "en-us": { "role": { "label": "Comprehensive profit (loss)", "totalLabel": "Comprehensive income (loss)" } }, "en": { "role": { "documentation": "The amount of change in equity resulting from transactions and other events, other than those changes resulting from transactions with owners in their capacity as owners." } } }, "auth_ref": [ "r50", "r51", "r57", "r126", "r135", "r153", "r175", "r193" ] }, "ifrs-full_ContinuingAndDiscontinuedOperationsAxis": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "ContinuingAndDiscontinuedOperationsAxis", "presentation": [ "http://cosciensbio.com/role/ScheduleOfDiscontinuedAssetsAndLiabilitiesDetails", "http://cosciensbio.com/role/ScheduleOfDiscontinuedCashFlowsDetails", "http://cosciensbio.com/role/ScheduleOfDiscontinuedProfitOrLossDetails" ], "lang": { "en-us": { "role": { "label": "Continuing and discontinued operations [axis]" } }, "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } } }, "auth_ref": [ "r83" ] }, "CSCI_ContinuingOperationsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://cosciensbio.com/20260331", "localname": "ContinuingOperationsAbstract", "presentation": [ "http://cosciensbio.com/role/InterimConsolidatedStatementsOfIncomeLossAndComprehensiveIncomeLoss" ], "lang": { "en-us": { "role": { "label": "Continuing operations" } } }, "auth_ref": [] }, "ifrs-full_ContinuingOperationsMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "ContinuingOperationsMember", "presentation": [ "http://cosciensbio.com/role/ScheduleOfDiscontinuedAssetsAndLiabilitiesDetails", "http://cosciensbio.com/role/ScheduleOfDiscontinuedCashFlowsDetails", "http://cosciensbio.com/role/ScheduleOfDiscontinuedProfitOrLossDetails" ], "lang": { "en": { "role": { "documentation": "This member stands for components of the entity that are not discontinued operations. A component of an entity comprises operations and cash flows that can be clearly distinguished, operationally and for financial reporting purposes, from the rest of the entity. This meaning may be overridden for line items which are either intrinsically related to discontinued operations (or disposal groups held for sale), or which are typically reported for the aggregate of continuing and discontinued. This member also represents the standard value for the 'Continuing and discontinued operations' axis if no other member is used. [Refer: Discontinued operations [member]; Aggregate continuing and discontinued operations [member]]" } } }, "auth_ref": [ "r83" ] }, "ifrs-full_ContractLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "ContractLiabilities", "crdr": "credit", "presentation": [ "http://cosciensbio.com/role/SummaryOfDeferredRevenueDetails" ], "lang": { "en-us": { "role": { "label": "Total" } }, "en": { "role": { "documentation": "The amount of an entity\u2019s obligation to transfer goods or services to a customer for which the entity has received consideration (or the amount is due) from the customer." } } }, "auth_ref": [ "r68", "r69", "r102" ] }, "CSCI_ContributedSurplusMember": { "xbrltype": "domainItemType", "nsuri": "http://cosciensbio.com/20260331", "localname": "ContributedSurplusMember", "presentation": [ "http://cosciensbio.com/role/InterimConsolidatedStatementsOfChangesInShareholdersEquity" ], "lang": { "en-us": { "role": { "label": "Contributed surplus [member]", "documentation": "Contributed surplus [member]" } } }, "auth_ref": [] }, "ifrs-full_CostOfSales": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "CostOfSales", "crdr": "debit", "calculation": { "http://cosciensbio.com/role/InterimConsolidatedStatementsOfIncomeLossAndComprehensiveIncomeLoss": { "parentTag": "ifrs-full_GrossProfit", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://cosciensbio.com/role/InterimConsolidatedStatementsOfIncomeLossAndComprehensiveIncomeLoss", "http://cosciensbio.com/role/ScheduleOfDiscontinuedProfitOrLossDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Cost of sales", "label": "Cost of sales" } } }, "auth_ref": [ "r152", "r184" ] }, "ifrs-full_CounterpartiesAxis": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "CounterpartiesAxis", "presentation": [ "http://cosciensbio.com/role/SummaryOfDeferredRevenueDetails" ], "lang": { "en-us": { "role": { "label": "Counterparties [axis]" } }, "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } } }, "auth_ref": [ "r88" ] }, "ifrs-full_CounterpartiesDomain": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "CounterpartiesDomain", "presentation": [ "http://cosciensbio.com/role/SummaryOfDeferredRevenueDetails" ], "lang": { "en": { "role": { "documentation": "This member stands for the parties to the transaction other than the entity. It also represents the standard value for the 'Counterparties' axis if no other member is used." } } }, "auth_ref": [ "r88" ] }, "dei_CountryRegion": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "CountryRegion", "presentation": [ "http://cosciensbio.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Country Region", "documentation": "Region code of country" } } }, "auth_ref": [] }, "dei_CoverAbstract": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "CoverAbstract", "lang": { "en-us": { "role": { "label": "Cover [Abstract]", "documentation": "Cover page." } } }, "auth_ref": [] }, "ifrs-full_CreationDateAxis": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "CreationDateAxis", "presentation": [ "http://cosciensbio.com/role/ScheduleOfWarrantsOutstandingDetails" ], "lang": { "en-us": { "role": { "label": "Creation date [axis]" } }, "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } } }, "auth_ref": [ "r46", "r48", "r49", "r108", "r110", "r111" ] }, "ifrs-full_CurrentAccruedExpensesAndOtherCurrentLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "CurrentAccruedExpensesAndOtherCurrentLiabilities", "crdr": "credit", "calculation": { "http://cosciensbio.com/role/InterimConsolidatedStatementsOfFinancialPosition": { "parentTag": "ifrs-full_CurrentLiabilities", "weight": 1.0, "order": 1.0 }, "http://cosciensbio.com/role/SummaryOfDetailedInformationAboutAccountsPayableAndAccruedLiabilitiesDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://cosciensbio.com/role/InterimConsolidatedStatementsOfFinancialPosition", "http://cosciensbio.com/role/ScheduleOfDiscontinuedAssetsAndLiabilitiesDetails", "http://cosciensbio.com/role/SummaryOfDetailedInformationAboutAccountsPayableAndAccruedLiabilitiesDetails" ], "lang": { "en-us": { "role": { "label": "Accounts payable and accrued liabilities (note 7)", "totalLabel": "Payables and accrued liabilities", "negatedLabel": "Accounts payable and accrued liabilities" } }, "en": { "role": { "documentation": "The amount of current accrued expenses and other current liabilities. [Refer: Accruals; Other current liabilities]" } } }, "auth_ref": [ "r249" ] }, "ifrs-full_CurrentAssets": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "CurrentAssets", "crdr": "debit", "calculation": { "http://cosciensbio.com/role/InterimConsolidatedStatementsOfFinancialPosition": { "parentTag": "ifrs-full_Assets", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://cosciensbio.com/role/InterimConsolidatedStatementsOfFinancialPosition", "http://cosciensbio.com/role/ScheduleOfDiscontinuedAssetsAndLiabilitiesDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Total current assets", "label": "Current assets [Default Label]" } }, "en": { "role": { "documentation": "The amount of assets that the entity (a) expects to realise or intends to sell or consume in its normal operating cycle; (b) holds primarily for the purpose of trading; (c) expects to realise within twelve months after the reporting period; or (d) classifies as cash or cash equivalents (as defined in IAS 7) unless the asset is restricted from being exchanged or used to settle a liability for at least twelve months after the reporting period. [Refer: Assets]" } } }, "auth_ref": [ "r53", "r167", "r193" ] }, "ifrs-full_CurrentAssetsAbstract": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "CurrentAssetsAbstract", "presentation": [ "http://cosciensbio.com/role/InterimConsolidatedStatementsOfFinancialPosition", "http://cosciensbio.com/role/ScheduleOfDiscontinuedAssetsAndLiabilitiesDetails" ], "lang": { "en-us": { "role": { "label": "Current assets" } } }, "auth_ref": [] }, "ifrs-full_CurrentAssetsOtherThanAssetsOrDisposalGroupsClassifiedAsHeldForSaleOrAsHeldForDistributionToOwners": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "CurrentAssetsOtherThanAssetsOrDisposalGroupsClassifiedAsHeldForSaleOrAsHeldForDistributionToOwners", "crdr": "debit", "calculation": { "http://cosciensbio.com/role/InterimConsolidatedStatementsOfFinancialPosition": { "parentTag": "ifrs-full_CurrentAssets", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://cosciensbio.com/role/InterimConsolidatedStatementsOfFinancialPosition" ], "lang": { "en-us": { "role": { "label": "Assets held for sale" } }, "en": { "role": { "documentation": "The amount of current assets other than non-current assets or disposal groups classified as held for sale or as held for distribution to owners. [Refer: Current assets; Disposal groups classified as held for sale [member]; Non-current assets or disposal groups classified as held for sale; Non-current assets or disposal groups classified as held for distribution to owners]" } } }, "auth_ref": [ "r167" ] }, "ifrs-full_CurrentContractLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "CurrentContractLiabilities", "crdr": "credit", "presentation": [ "http://cosciensbio.com/role/SummaryOfDeferredRevenueDetails" ], "lang": { "en-us": { "role": { "label": "Current" } }, "en": { "role": { "documentation": "The amount of current contract liabilities. [Refer: Contract liabilities]" } } }, "auth_ref": [ "r68" ] }, "dei_CurrentFiscalYearEndDate": { "xbrltype": "gMonthDayItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "CurrentFiscalYearEndDate", "presentation": [ "http://cosciensbio.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Current Fiscal Year End Date", "documentation": "End date of current fiscal year in the format --MM-DD." } } }, "auth_ref": [] }, "ifrs-full_CurrentLeaseLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "CurrentLeaseLiabilities", "crdr": "credit", "calculation": { "http://cosciensbio.com/role/InterimConsolidatedStatementsOfFinancialPosition": { "parentTag": "ifrs-full_CurrentLiabilities", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://cosciensbio.com/role/InterimConsolidatedStatementsOfFinancialPosition", "http://cosciensbio.com/role/ScheduleOfDiscontinuedAssetsAndLiabilitiesDetails" ], "lang": { "en-us": { "role": { "label": "Current portion of lease liabilities", "negatedLabel": "Current portion of lease liabilities" } }, "en": { "role": { "documentation": "The amount of current lease liabilities. [Refer: Lease liabilities]" } } }, "auth_ref": [ "r71" ] }, "ifrs-full_CurrentLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "CurrentLiabilities", "crdr": "credit", "calculation": { "http://cosciensbio.com/role/InterimConsolidatedStatementsOfFinancialPosition": { "parentTag": "ifrs-full_Liabilities", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://cosciensbio.com/role/InterimConsolidatedStatementsOfFinancialPosition", "http://cosciensbio.com/role/ScheduleOfDiscontinuedAssetsAndLiabilitiesDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Total current liabilities", "negatedTotalLabel": "Total current liabilities", "label": "Current liabilities [Default Label]" } }, "en": { "role": { "documentation": "The amount of liabilities that: (a) the entity expects to settle in its normal operating cycle; (b) the entity holds primarily for the purpose of trading; (c) are due to be settled within twelve months after the reporting period; or (d) the entity does not have the right at the end of the reporting period to defer settlement for at least twelve months after the reporting period." } } }, "auth_ref": [ "r55", "r168", "r193" ] }, "ifrs-full_CurrentLiabilitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "CurrentLiabilitiesAbstract", "presentation": [ "http://cosciensbio.com/role/InterimConsolidatedStatementsOfFinancialPosition", "http://cosciensbio.com/role/ScheduleOfDiscontinuedAssetsAndLiabilitiesDetails" ], "lang": { "en-us": { "role": { "label": "Current liabilities" } } }, "auth_ref": [] }, "ifrs-full_CurrentPrepaidExpenses": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "CurrentPrepaidExpenses", "crdr": "debit", "calculation": { "http://cosciensbio.com/role/SummaryOfPrepaidExpensesAndOtherCurrentAssetsDetails": { "parentTag": "ifrs-full_CurrentPrepaymentsAndOtherCurrentAssets", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://cosciensbio.com/role/SummaryOfPrepaidExpensesAndOtherCurrentAssetsDetails" ], "lang": { "en-us": { "role": { "label": "Prepaid insurance" } }, "en": { "role": { "documentation": "The amount recognised as a current asset for expenditures made prior to the period when the economic benefit will be realised." } } }, "auth_ref": [ "r246" ] }, "ifrs-full_CurrentPrepaymentsAndOtherCurrentAssets": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "CurrentPrepaymentsAndOtherCurrentAssets", "crdr": "debit", "calculation": { "http://cosciensbio.com/role/InterimConsolidatedStatementsOfFinancialPosition": { "parentTag": "ifrs-full_CurrentAssets", "weight": 1.0, "order": 4.0 }, "http://cosciensbio.com/role/SummaryOfPrepaidExpensesAndOtherCurrentAssetsDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://cosciensbio.com/role/InterimConsolidatedStatementsOfFinancialPosition", "http://cosciensbio.com/role/ScheduleOfDiscontinuedAssetsAndLiabilitiesDetails", "http://cosciensbio.com/role/SummaryOfPrepaidExpensesAndOtherCurrentAssetsDetails" ], "lang": { "en-us": { "role": { "label": "Prepaid expenses and other assets (note 5)", "totalLabel": "Total", "verboseLabel": "Prepaid expenses and other assets" } }, "en": { "role": { "documentation": "The amount of current prepayments and other current assets. [Refer: Other current assets; Current prepayments]" } } }, "auth_ref": [ "r249" ] }, "ifrs-full_CurrentProvisions": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "CurrentProvisions", "crdr": "credit", "calculation": { "http://cosciensbio.com/role/InterimConsolidatedStatementsOfFinancialPosition": { "parentTag": "ifrs-full_CurrentLiabilities", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://cosciensbio.com/role/InterimConsolidatedStatementsOfFinancialPosition" ], "lang": { "en-us": { "role": { "label": "Provisions" } }, "en": { "role": { "documentation": "The amount of current provisions, including provisions for employee benefits. [Refer: Provisions]" } } }, "auth_ref": [ "r163" ] }, "CSCI_CurrentServiceCostNetDefinedBenefitsLiabilityAsset": { "xbrltype": "monetaryItemType", "nsuri": "http://cosciensbio.com/20260331", "localname": "CurrentServiceCostNetDefinedBenefitsLiabilityAsset", "crdr": "credit", "presentation": [ "http://cosciensbio.com/role/SummaryOfNetDefinedBenefitLiabilityAssetDetails" ], "lang": { "en-us": { "role": { "label": "Current service cost", "documentation": "Current service cost (residual value)." } } }, "auth_ref": [] }, "ifrs-full_CurrentTaxLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "CurrentTaxLiabilities", "crdr": "credit", "calculation": { "http://cosciensbio.com/role/InterimConsolidatedStatementsOfFinancialPosition": { "parentTag": "ifrs-full_CurrentLiabilities", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://cosciensbio.com/role/InterimConsolidatedStatementsOfFinancialPosition", "http://cosciensbio.com/role/ScheduleOfDiscontinuedAssetsAndLiabilitiesDetails" ], "lang": { "en-us": { "role": { "label": "Income taxes payable", "negatedLabel": "Income taxes payable" } }, "en": { "role": { "documentation": "The amount of current tax for current and prior periods to the extent unpaid. Current tax is the amount of income taxes payable (recoverable) in respect of the taxable profit (tax loss) for a period." } } }, "auth_ref": [ "r164" ] }, "ifrs-full_CurrentWarrantLiability": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "CurrentWarrantLiability", "crdr": "credit", "calculation": { "http://cosciensbio.com/role/InterimConsolidatedStatementsOfFinancialPosition": { "parentTag": "ifrs-full_CurrentLiabilities", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://cosciensbio.com/role/InterimConsolidatedStatementsOfFinancialPosition" ], "lang": { "en-us": { "role": { "label": "Warrant liability (note 9)" } }, "en": { "role": { "documentation": "The amount of current warrant liabilities. [Refer: Warrant liability]" } } }, "auth_ref": [ "r249" ] }, "CSCI_DavimedGmbHMember": { "xbrltype": "domainItemType", "nsuri": "http://cosciensbio.com/20260331", "localname": "DavimedGmbHMember", "presentation": [ "http://cosciensbio.com/role/SummaryOfDeferredRevenueDetails" ], "lang": { "en-us": { "role": { "label": "Davimed GmbH [Member]", "documentation": "Davimed GmbH [Member]" } } }, "auth_ref": [] }, "CSCI_DeconsolidationOfGermanSubsidiaries": { "xbrltype": "monetaryItemType", "nsuri": "http://cosciensbio.com/20260331", "localname": "DeconsolidationOfGermanSubsidiaries", "crdr": "credit", "calculation": { "http://cosciensbio.com/role/InterimConsolidatedStatementsOfCashFlows": { "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivities", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://cosciensbio.com/role/InterimConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "negatedLabel": "Deconsolidation of German subsidiaries (note 14)", "documentation": "Deconsolidation of German subsidiaries.", "label": "DeconsolidationOfGermanSubsidiaries" } } }, "auth_ref": [] }, "CSCI_DeconsolidationOfGermanSubsidiariesAssets": { "xbrltype": "monetaryItemType", "nsuri": "http://cosciensbio.com/20260331", "localname": "DeconsolidationOfGermanSubsidiariesAssets", "crdr": "credit", "presentation": [ "http://cosciensbio.com/role/SummaryOfNetDefinedBenefitLiabilityAssetDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Deconsolidation of German subsidiaries", "documentation": "Deconsolidation of German subsidiaries assets.", "label": "DeconsolidationOfGermanSubsidiariesAssets" } } }, "auth_ref": [] }, "ifrs-full_DefaultFinancialStatementsDateMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "DefaultFinancialStatementsDateMember", "presentation": [ "http://cosciensbio.com/role/ScheduleOfWarrantsOutstandingDetails" ], "lang": { "en": { "role": { "documentation": "This member stands for the standard value for the 'Creation date' axis if no other member is used." } } }, "auth_ref": [ "r46", "r48", "r49", "r108", "r110", "r111" ] }, "ifrs-full_DeferredIncomeOtherThanContractLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "DeferredIncomeOtherThanContractLiabilities", "crdr": "credit", "calculation": { "http://cosciensbio.com/role/InterimConsolidatedStatementsOfFinancialPosition": { "parentTag": "ifrs-full_NoncurrentLiabilities", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://cosciensbio.com/role/InterimConsolidatedStatementsOfFinancialPosition", "http://cosciensbio.com/role/ScheduleOfDiscontinuedAssetsAndLiabilitiesDetails" ], "lang": { "en-us": { "role": { "label": "Deferred revenues (note 3)", "negatedLabel": "Deferred revenues (note 3)" } }, "en": { "role": { "documentation": "The amount of liabilities representing income that has been received (or the amount is due) but is not yet earned, other than contract liabilities. [Refer: Contract liabilities]" } } }, "auth_ref": [ "r249", "r250" ] }, "CSCI_DepositsNonCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://cosciensbio.com/20260331", "localname": "DepositsNonCurrent", "crdr": "debit", "calculation": { "http://cosciensbio.com/role/InterimConsolidatedStatementsOfFinancialPosition": { "parentTag": "ifrs-full_NoncurrentAssets", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://cosciensbio.com/role/InterimConsolidatedStatementsOfFinancialPosition" ], "lang": { "en-us": { "role": { "label": "Deposits", "documentation": "Deposits non current." } } }, "auth_ref": [] }, "CSCI_DepreciatedAssets": { "xbrltype": "monetaryItemType", "nsuri": "http://cosciensbio.com/20260331", "localname": "DepreciatedAssets", "crdr": "debit", "presentation": [ "http://cosciensbio.com/role/PropertyAndEquipmentDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Depreciated assets", "documentation": "Depreciated assets." } } }, "auth_ref": [] }, "ifrs-full_DescriptionOfAccountingPolicyForDiscontinuedOperationsExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "DescriptionOfAccountingPolicyForDiscontinuedOperationsExplanatory", "presentation": [ "http://cosciensbio.com/role/BasisOfPresentationPolicies" ], "lang": { "en-us": { "role": { "verboseLabel": "Discontinued operations", "label": "Description of accounting policy for discontinued operations [text block]" } }, "en": { "role": { "documentation": "The description of the entity's material accounting policy information for discontinued operations. [Refer: Discontinued operations [member]]" } } }, "auth_ref": [ "r247" ] }, "CSCI_DescriptionOfAccountingPolicyForLandOfControlExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "http://cosciensbio.com/20260331", "localname": "DescriptionOfAccountingPolicyForLandOfControlExplanatory", "presentation": [ "http://cosciensbio.com/role/BasisOfPresentationPolicies" ], "lang": { "en-us": { "role": { "label": "Loss of control", "documentation": "Description of accounting policy for land of control explanatory." } } }, "auth_ref": [] }, "ifrs-full_DescriptionOfInitialApplicationOfStandardsOrInterpretations": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "DescriptionOfInitialApplicationOfStandardsOrInterpretations", "presentation": [ "http://cosciensbio.com/role/BasisOfPresentationPolicies" ], "lang": { "en-us": { "role": { "label": "New standards and amendments" } } }, "auth_ref": [ "r47", "r109" ] }, "ifrs-full_DilutedEarningsLossPerShare": { "xbrltype": "perShareItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "DilutedEarningsLossPerShare", "presentation": [ "http://cosciensbio.com/role/InterimConsolidatedStatementsOfIncomeLossAndComprehensiveIncomeLoss", "http://cosciensbio.com/role/ScheduleOfDiscontinuedProfitOrLossDetails", "http://cosciensbio.com/role/SummaryOfPertinentDataRelatingToComputationOfBasicAndDilutedNetLossPerShareDetails" ], "lang": { "en-us": { "role": { "label": "Diluted income (loss) per share (note 12)", "verboseLabel": "Diluted income (loss) per share" } }, "en": { "role": { "documentation": "The amount of profit (loss) attributable to ordinary equity holders of the parent entity (the numerator), divided by the weighted average number of ordinary shares outstanding during the period (the denominator), both adjusted for the effects of all dilutive potential ordinary shares. [Refer: Ordinary shares [member]; Weighted average [member]]" } } }, "auth_ref": [ "r27", "r28" ] }, "ifrs-full_DilutedEarningsLossPerShareFromContinuingOperations": { "xbrltype": "perShareItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "DilutedEarningsLossPerShareFromContinuingOperations", "presentation": [ "http://cosciensbio.com/role/InterimConsolidatedStatementsOfIncomeLossAndComprehensiveIncomeLoss", "http://cosciensbio.com/role/SummaryOfPertinentDataRelatingToComputationOfBasicAndDilutedNetLossPerShareDetails" ], "lang": { "en-us": { "role": { "label": "Diluted loss per share from continuing operations" } }, "en": { "role": { "documentation": "Diluted earnings (loss) per share from continuing operations. [Refer: Continuing operations, unless line item indicates otherwise [member]; Diluted earnings (loss) per share]" } } }, "auth_ref": [ "r27", "r28" ] }, "ifrs-full_DisclosureOfAccountingJudgementsAndEstimatesExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "DisclosureOfAccountingJudgementsAndEstimatesExplanatory", "presentation": [ "http://cosciensbio.com/role/BasisOfPresentationPolicies" ], "lang": { "en-us": { "role": { "label": "Critical accounting estimates and judgements" } }, "en": { "role": { "documentation": "The disclosure of judgements that management has made in the process of applying the entity's accounting policies that have the most significant effect on amounts recognised in the financial statements along with information about the assumptions that the entity makes about the future, and other major sources of estimation uncertainty at the end of the reporting period, that have a significant risk of resulting in a material adjustment to the carrying amounts of assets and liabilities within the next year. [Refer: Carrying amount [member]]" } } }, "auth_ref": [ "r243" ] }, "ifrs-full_DisclosureOfAnalysisOfSingleAmountOfDiscontinuedOperationsTable": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "DisclosureOfAnalysisOfSingleAmountOfDiscontinuedOperationsTable", "presentation": [ "http://cosciensbio.com/role/ScheduleOfDiscontinuedAssetsAndLiabilitiesDetails", "http://cosciensbio.com/role/ScheduleOfDiscontinuedCashFlowsDetails", "http://cosciensbio.com/role/ScheduleOfDiscontinuedProfitOrLossDetails" ], "lang": { "en-us": { "role": { "label": "Disclosure of analysis of single amount of discontinued operations [table]" } }, "en": { "role": { "documentation": "Schedule disclosing information related to the analysis of the single amount of discontinued operations." } } }, "auth_ref": [ "r82" ] }, "CSCI_DisclosureOfAssetsAndLiabilitiesOfDisposalGroupClassifiedAsHeldForSaleAndDiscontinuedOperationsExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "http://cosciensbio.com/20260331", "localname": "DisclosureOfAssetsAndLiabilitiesOfDisposalGroupClassifiedAsHeldForSaleAndDiscontinuedOperationsExplanatory", "presentation": [ "http://cosciensbio.com/role/DiscontinuedOperationsTables" ], "lang": { "en-us": { "role": { "label": "Schedule of discontinued assets and liabilities", "documentation": "Disclosure of assets and liabilities of disposal group classified as held for sale and discontinued operations explanatory." } } }, "auth_ref": [] }, "ifrs-full_DisclosureOfBasisOfConsolidationExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "DisclosureOfBasisOfConsolidationExplanatory", "presentation": [ "http://cosciensbio.com/role/BasisOfPresentation" ], "lang": { "en-us": { "role": { "label": "Basis of presentation" } }, "en": { "role": { "documentation": "The disclosure of the basis used for consolidation." } } }, "auth_ref": [ "r243" ] }, "ifrs-full_DisclosureOfBasisOfPreparationOfFinancialStatementsExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "DisclosureOfBasisOfPreparationOfFinancialStatementsExplanatory", "presentation": [ "http://cosciensbio.com/role/BusinessOverview" ], "lang": { "en-us": { "role": { "label": "Business overview" } } }, "auth_ref": [ "r243" ] }, "ifrs-full_DisclosureOfCashFlowStatementExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "DisclosureOfCashFlowStatementExplanatory", "presentation": [ "http://cosciensbio.com/role/SupplementalDisclosureOfCashFlowInformation" ], "lang": { "en-us": { "role": { "label": "Supplemental disclosure of cash flow information" } }, "en": { "role": { "documentation": "The entire disclosure for a statement of cash flows." } } }, "auth_ref": [ "r45" ] }, "CSCI_DisclosureOfCashFlowsFromDiscontinuedOperationsExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "http://cosciensbio.com/20260331", "localname": "DisclosureOfCashFlowsFromDiscontinuedOperationsExplanatory", "presentation": [ "http://cosciensbio.com/role/DiscontinuedOperationsTables" ], "lang": { "en-us": { "role": { "label": "Schedule of discontinued cash flows", "documentation": "Disclosure of cash flows from discontinued operations explanatory." } } }, "auth_ref": [] }, "ifrs-full_DisclosureOfClassesOfShareCapitalExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "DisclosureOfClassesOfShareCapitalExplanatory", "presentation": [ "http://cosciensbio.com/role/ShareholdersEquityTables" ], "lang": { "en-us": { "role": { "label": "Summary of share capital" } }, "en": { "role": { "documentation": "The disclosure of classes of share capital. [Refer: Classes of share capital [domain]]" } } }, "auth_ref": [ "r103", "r148", "r172" ] }, "ifrs-full_DisclosureOfCommitmentsAndContingentLiabilitiesExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "DisclosureOfCommitmentsAndContingentLiabilitiesExplanatory", "presentation": [ "http://cosciensbio.com/role/CommitmentsAndContingencies" ], "lang": { "en-us": { "role": { "label": "Commitments and Contingencies" } }, "en": { "role": { "documentation": "The disclosure of commitments and contingent liabilities. [Refer: Classes of contingent liabilities [domain]]" } } }, "auth_ref": [ "r243" ] }, "ifrs-full_DisclosureOfDefinedBenefitPlansTable": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "DisclosureOfDefinedBenefitPlansTable", "presentation": [ "http://cosciensbio.com/role/SummaryOfNetDefinedBenefitLiabilityAssetDetails" ], "lang": { "en-us": { "role": { "label": "Disclosure of defined benefit plans [table]" } }, "en": { "role": { "documentation": "Schedule disclosing information related to defined benefit plans." } } }, "auth_ref": [ "r12", "r121" ] }, "ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "DisclosureOfDetailedInformationAboutBorrowingsTable", "presentation": [ "http://cosciensbio.com/role/CommitmentsAndContingenciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Disclosure of detailed information about borrowings [table]" } }, "en": { "role": { "documentation": "Schedule disclosing information related to details of borrowings." } } }, "auth_ref": [ "r241" ] }, "CSCI_DisclosureOfDetailedInformationAboutDeferredRevenueExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "http://cosciensbio.com/20260331", "localname": "DisclosureOfDetailedInformationAboutDeferredRevenueExplanatory", "presentation": [ "http://cosciensbio.com/role/RevenueTables" ], "lang": { "en-us": { "role": { "label": "Summary of deferred revenue", "documentation": "Disclosure of detailed information about deferred revenue explanatory." } } }, "auth_ref": [] }, "CSCI_DisclosureOfDetailedInformationAboutPayablesAndAccruedLiabilitiesExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "http://cosciensbio.com/20260331", "localname": "DisclosureOfDetailedInformationAboutPayablesAndAccruedLiabilitiesExplanatory", "presentation": [ "http://cosciensbio.com/role/AccountsPayableAndAccruedLiabilitiesTables" ], "lang": { "en-us": { "role": { "label": "Summary of detailed information about accounts payable and accrued liabilities", "documentation": "Disclosure of detailed information about payables and accrued liabilities explanatory." } } }, "auth_ref": [] }, "ifrs-full_DisclosureOfDiscontinuedOperationsExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "DisclosureOfDiscontinuedOperationsExplanatory", "presentation": [ "http://cosciensbio.com/role/DiscontinuedOperations" ], "lang": { "en-us": { "role": { "verboseLabel": "Discontinued operations", "label": "Disclosure of discontinued operations [text block]" } }, "en": { "role": { "documentation": "The disclosure of discontinued operations. [Refer: Discontinued operations [member]]" } } }, "auth_ref": [ "r243" ] }, "ifrs-full_DisclosureOfEmployeeBenefitsExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "DisclosureOfEmployeeBenefitsExplanatory", "presentation": [ "http://cosciensbio.com/role/EmployeeFutureBenefits" ], "lang": { "en-us": { "role": { "verboseLabel": "Employee future benefits", "label": "Disclosure of employee benefits [text block]" } }, "en": { "role": { "documentation": "The entire disclosure for employee benefits." } } }, "auth_ref": [ "r20" ] }, "ifrs-full_DisclosureOfEntitysReportableSegmentsExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "DisclosureOfEntitysReportableSegmentsExplanatory", "presentation": [ "http://cosciensbio.com/role/SegmentInformation" ], "lang": { "en-us": { "role": { "label": "Segment information" } }, "en": { "role": { "documentation": "The entire disclosure for operating segments." } } }, "auth_ref": [ "r101" ] }, "ifrs-full_DisclosureOfIncomeTaxExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "DisclosureOfIncomeTaxExplanatory", "presentation": [ "http://cosciensbio.com/role/NetIncomeLossPerShare" ], "lang": { "en-us": { "role": { "label": "Net income (loss) per share" } }, "en": { "role": { "documentation": "The entire disclosure for income taxes." } } }, "auth_ref": [ "r3" ] }, "ifrs-full_DisclosureOfInstrumentsWithPotentialFutureDilutiveEffectNotIncludedInCalculationOfDilutedEarningsPerShareTable": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "DisclosureOfInstrumentsWithPotentialFutureDilutiveEffectNotIncludedInCalculationOfDilutedEarningsPerShareTable", "presentation": [ "http://cosciensbio.com/role/ScheduleOfWarrantsOutstandingDetails", "http://cosciensbio.com/role/SummaryOfPertinentDataRelatingToComputationOfBasicAndDilutedNetLossPerShareDetails" ], "lang": { "en-us": { "role": { "label": "Disclosure of instruments with potential future dilutive effect not included in calculation of diluted earnings per share [table]" } }, "en": { "role": { "documentation": "Schedule disclosing instruments with potential future dilutive effect not included in calculation of diluted earnings per share." } } }, "auth_ref": [ "r236" ] }, "ifrs-full_DisclosureOfInventoriesExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "DisclosureOfInventoriesExplanatory", "presentation": [ "http://cosciensbio.com/role/Inventories" ], "lang": { "en-us": { "role": { "label": "Inventories" } }, "en": { "role": { "documentation": "The entire disclosure for inventories." } } }, "auth_ref": [ "r22" ] }, "CSCI_DisclosureOfInventoryExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "http://cosciensbio.com/20260331", "localname": "DisclosureOfInventoryExplanatory", "presentation": [ "http://cosciensbio.com/role/InventoriesTables" ], "lang": { "en-us": { "role": { "label": "Schedule of inventories", "documentation": "Disclosure of inventory explanatory." } } }, "auth_ref": [] }, "ifrs-full_DisclosureOfMajorCustomersTable": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "DisclosureOfMajorCustomersTable", "presentation": [ "http://cosciensbio.com/role/SegmentInformationDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Disclosure of major customers [table]" } }, "en": { "role": { "documentation": "Schedule disclosing information related to the entity's major customers." } } }, "auth_ref": [ "r100" ] }, "ifrs-full_DisclosureOfNetDefinedBenefitLiabilityAssetAbstract": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "DisclosureOfNetDefinedBenefitLiabilityAssetAbstract", "presentation": [ "http://cosciensbio.com/role/SummaryOfNetDefinedBenefitLiabilityAssetDetails" ], "lang": { "en-us": { "role": { "label": "Change in plan liabilities" } } }, "auth_ref": [] }, "ifrs-full_DisclosureOfNetDefinedBenefitLiabilityAssetExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "DisclosureOfNetDefinedBenefitLiabilityAssetExplanatory", "presentation": [ "http://cosciensbio.com/role/EmployeeFutureBenefitsTables" ], "lang": { "en-us": { "role": { "label": "Summary of net defined benefit liability asset" } }, "en": { "role": { "documentation": "The disclosure of a net defined benefit liability (asset). [Refer: Net defined benefit liability (asset)]" } } }, "auth_ref": [ "r13", "r122" ] }, "ifrs-full_DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsExplanatory", "presentation": [ "http://cosciensbio.com/role/ShareholdersEquityTables" ], "lang": { "en-us": { "role": { "label": "Summary of number and weighted average exercise prices of options" } }, "en": { "role": { "documentation": "The disclosure of the number and weighted average exercise prices of share options. [Refer: Weighted average [member]]" } } }, "auth_ref": [ "r77", "r140" ] }, "ifrs-full_DisclosureOfOffsettingOfFinancialAssetsTable": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "DisclosureOfOffsettingOfFinancialAssetsTable", "presentation": [ "http://cosciensbio.com/role/SummaryOfDeferredRevenueDetails" ], "lang": { "en-us": { "role": { "label": "Disclosure of offsetting of financial assets [table]" } }, "en": { "role": { "documentation": "Schedule disclosing information related to the offsetting of financial assets." } } }, "auth_ref": [ "r84" ] }, "CSCI_DisclosureOfPrepaidExpensesAndOtherCurrentAssetsExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "http://cosciensbio.com/20260331", "localname": "DisclosureOfPrepaidExpensesAndOtherCurrentAssetsExplanatory", "presentation": [ "http://cosciensbio.com/role/PrepaidExpensesAndOtherAssetsTables" ], "lang": { "en-us": { "role": { "label": "Summary of prepaid expenses and other current assets", "documentation": "Disclosure of prepaid expenses and other current assets explanatory." } } }, "auth_ref": [] }, "ifrs-full_DisclosureOfPrepaymentsAndOtherAssetsExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "DisclosureOfPrepaymentsAndOtherAssetsExplanatory", "presentation": [ "http://cosciensbio.com/role/PrepaidExpensesAndOtherAssets" ], "lang": { "en-us": { "role": { "label": "Prepaid expenses and other assets" } }, "en": { "role": { "documentation": "The disclosure of prepayments and other assets. [Refer: Other assets; Prepayments]" } } }, "auth_ref": [ "r243" ] }, "ifrs-full_DisclosureOfPropertyPlantAndEquipmentExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "DisclosureOfPropertyPlantAndEquipmentExplanatory", "presentation": [ "http://cosciensbio.com/role/PropertyAndEquipment" ], "lang": { "en-us": { "role": { "label": "Property and equipment" } }, "en": { "role": { "documentation": "The entire disclosure for property, plant and equipment." } } }, "auth_ref": [ "r11" ] }, "CSCI_DisclosureOfPropertyPlantAndEquipmentsExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "http://cosciensbio.com/20260331", "localname": "DisclosureOfPropertyPlantAndEquipmentsExplanatory", "presentation": [ "http://cosciensbio.com/role/PropertyAndEquipmentTables" ], "lang": { "en-us": { "role": { "label": "Schedule of property and equipment", "documentation": "Disclosure of property plant and equipments explanatory." } } }, "auth_ref": [] }, "CSCI_DisclosureOfRangeOfExercisePricesOfOutstandingShareWarrantsExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "http://cosciensbio.com/20260331", "localname": "DisclosureOfRangeOfExercisePricesOfOutstandingShareWarrantsExplanatory", "presentation": [ "http://cosciensbio.com/role/WarrantsTables" ], "lang": { "en-us": { "role": { "label": "Schedule of warrants outstanding", "documentation": "Disclosure of range of exercise prices of outstanding share warrants." } } }, "auth_ref": [] }, "ifrs-full_DisclosureOfReconciliationOfChangesInGoodwillTable": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "DisclosureOfReconciliationOfChangesInGoodwillTable", "presentation": [ "http://cosciensbio.com/role/ScheduleOfPropertyAndEquipmentDetails" ], "lang": { "en-us": { "role": { "label": "Disclosure of reconciliation of changes in goodwill [table]" } }, "en": { "role": { "documentation": "Schedule disclosing information related to the reconciliation of changes in goodwill." } } }, "auth_ref": [ "r79", "r141" ] }, "ifrs-full_DisclosureOfRevenueExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "DisclosureOfRevenueExplanatory", "presentation": [ "http://cosciensbio.com/role/Revenue" ], "lang": { "en-us": { "role": { "label": "Revenue" } }, "en": { "role": { "documentation": "The entire disclosure for revenue." } } }, "auth_ref": [ "r243" ] }, "ifrs-full_DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory", "presentation": [ "http://cosciensbio.com/role/ShareholdersEquity" ], "lang": { "en-us": { "role": { "verboseLabel": "Shareholders\u2019 equity", "label": "Disclosure of share capital, reserves and other equity interest [text block]" } }, "en": { "role": { "documentation": "The entire disclosure for share capital, reserves and other equity interest." } } }, "auth_ref": [ "r104", "r149", "r173" ] }, "CSCI_DisclosureOfStatementOfProfitOrLossFromDiscontinuedOperationsExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "http://cosciensbio.com/20260331", "localname": "DisclosureOfStatementOfProfitOrLossFromDiscontinuedOperationsExplanatory", "presentation": [ "http://cosciensbio.com/role/DiscontinuedOperationsTables" ], "lang": { "en-us": { "role": { "label": "Schedule of discontinued profit or loss", "documentation": "Disclosure of statement of profit or loss from discontinued operations explanatory." } } }, "auth_ref": [] }, "ifrs-full_DisclosureOfTradeAndOtherPayablesExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "DisclosureOfTradeAndOtherPayablesExplanatory", "presentation": [ "http://cosciensbio.com/role/AccountsPayableAndAccruedLiabilities" ], "lang": { "en-us": { "role": { "label": "Accounts payable and accrued liabilities" } }, "en": { "role": { "documentation": "The disclosure of trade and other payables. [Refer: Trade and other payables]" } } }, "auth_ref": [ "r243" ] }, "CSCI_DisclosureOfWarrantsActivityReclassifiedIntoEquityExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "http://cosciensbio.com/20260331", "localname": "DisclosureOfWarrantsActivityReclassifiedIntoEquityExplanatory", "presentation": [ "http://cosciensbio.com/role/WarrantsTables" ], "lang": { "en-us": { "role": { "label": "Summary of warrants activity reclassified equity", "documentation": "Disclosure of warrants activity reclassified into equity." } } }, "auth_ref": [] }, "CSCI_DisclosureWarrantsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://cosciensbio.com/20260331", "localname": "DisclosureWarrantsAbstract", "lang": { "en-us": { "role": { "label": "Warrants", "verboseLabel": "Summary Of Warrants Activity Reclassified Equity" } } }, "auth_ref": [] }, "CSCI_DisclosureWarrantsExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "http://cosciensbio.com/20260331", "localname": "DisclosureWarrantsExplanatory", "presentation": [ "http://cosciensbio.com/role/Warrants" ], "lang": { "en-us": { "role": { "verboseLabel": "Warrants", "documentation": "Disclosure warrants explanatory.", "label": "DisclosureWarrantsExplanatory" } } }, "auth_ref": [] }, "CSCI_DisclosureofChangesInOperatingAssetsAndLiabilitiesTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://cosciensbio.com/20260331", "localname": "DisclosureofChangesInOperatingAssetsAndLiabilitiesTableTextBlock", "presentation": [ "http://cosciensbio.com/role/SupplementalDisclosureOfCashFlowInformationTables" ], "lang": { "en-us": { "role": { "label": "Summary of changes in operating assets and liabilities", "documentation": "Disclosure of changes in operating assets and liabilities table text block." } } }, "auth_ref": [] }, "CSCI_DiscontinuedOperationsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://cosciensbio.com/20260331", "localname": "DiscontinuedOperationsAbstract", "presentation": [ "http://cosciensbio.com/role/InterimConsolidatedStatementsOfIncomeLossAndComprehensiveIncomeLoss" ], "lang": { "en-us": { "role": { "label": "Discontinued operations" } } }, "auth_ref": [] }, "ifrs-full_DiscontinuedOperationsMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "DiscontinuedOperationsMember", "presentation": [ "http://cosciensbio.com/role/ScheduleOfDiscontinuedAssetsAndLiabilitiesDetails", "http://cosciensbio.com/role/ScheduleOfDiscontinuedCashFlowsDetails", "http://cosciensbio.com/role/ScheduleOfDiscontinuedProfitOrLossDetails" ], "lang": { "en-us": { "role": { "label": "Discontinued operations [member]" } }, "en": { "role": { "documentation": "This member stands for a component of an entity that either has been disposed of or is classified as held for sale, and that: (a) represents a separate major line of business or geographical area of operations; (b) is part of a single co-ordinated plan to dispose of a separate major line of business or geographical area of operations; or (c) is a subsidiary acquired exclusively with a view to resale. A component of an entity comprises operations and cash flows that can be clearly distinguished, operationally and for financial reporting purposes, from the rest of the entity. [Refer: Total for all subsidiaries [member]]" } } }, "auth_ref": [ "r83" ] }, "ifrs-full_DisposalsPropertyPlantAndEquipment": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "DisposalsPropertyPlantAndEquipment", "crdr": "credit", "presentation": [ "http://cosciensbio.com/role/ScheduleOfPropertyAndEquipmentDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Disposals", "label": "Disposals, property, plant and equipment" } }, "en": { "role": { "documentation": "The decrease in property, plant and equipment resulting from disposals. [Refer: Property, plant and equipment]" } } }, "auth_ref": [ "r6", "r117" ] }, "dei_DocumentAccountingStandard": { "xbrltype": "accountingStandardItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "DocumentAccountingStandard", "presentation": [ "http://cosciensbio.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Accounting Standard", "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'." } } }, "auth_ref": [ "r224" ] }, "dei_DocumentAnnualReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "DocumentAnnualReport", "presentation": [ "http://cosciensbio.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Annual Report", "documentation": "Boolean flag that is true only for a form used as an annual report." } } }, "auth_ref": [ "r222", "r224", "r225" ] }, "dei_DocumentFiscalPeriodFocus": { "xbrltype": "fiscalPeriodItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "DocumentFiscalPeriodFocus", "presentation": [ "http://cosciensbio.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Fiscal Period Focus", "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY." } } }, "auth_ref": [] }, "dei_DocumentFiscalYearFocus": { "xbrltype": "gYearItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "DocumentFiscalYearFocus", "presentation": [ "http://cosciensbio.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Fiscal Year Focus", "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006." } } }, "auth_ref": [] }, "dei_DocumentPeriodEndDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "DocumentPeriodEndDate", "presentation": [ "http://cosciensbio.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Period End Date", "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD." } } }, "auth_ref": [] }, "dei_DocumentPeriodStartDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "DocumentPeriodStartDate", "presentation": [ "http://cosciensbio.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Period Start Date", "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format." } } }, "auth_ref": [] }, "dei_DocumentQuarterlyReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "DocumentQuarterlyReport", "presentation": [ "http://cosciensbio.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Quarterly Report", "documentation": "Boolean flag that is true only for a form used as an quarterly report." } } }, "auth_ref": [ "r223" ] }, "dei_DocumentRegistrationStatement": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "DocumentRegistrationStatement", "presentation": [ "http://cosciensbio.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Registration Statement", "documentation": "Boolean flag that is true only for a form used as a registration statement." } } }, "auth_ref": [ "r211" ] }, "dei_DocumentShellCompanyEventDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "DocumentShellCompanyEventDate", "presentation": [ "http://cosciensbio.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Shell Company Event Date", "documentation": "Date of event requiring a shell company report." } } }, "auth_ref": [ "r224" ] }, "dei_DocumentShellCompanyReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "DocumentShellCompanyReport", "presentation": [ "http://cosciensbio.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Shell Company Report", "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act." } } }, "auth_ref": [ "r224" ] }, "dei_DocumentTransitionReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "DocumentTransitionReport", "presentation": [ "http://cosciensbio.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Transition Report", "documentation": "Boolean flag that is true only for a form used as a transition report." } } }, "auth_ref": [ "r226" ] }, "dei_DocumentType": { "xbrltype": "submissionTypeItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "DocumentType", "presentation": [ "http://cosciensbio.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Type", "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'." } } }, "auth_ref": [] }, "dei_DocumentsIncorporatedByReferenceTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "DocumentsIncorporatedByReferenceTextBlock", "presentation": [ "http://cosciensbio.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Documents Incorporated by Reference [Text Block]", "documentation": "Documents incorporated by reference." } } }, "auth_ref": [ "r214" ] }, "ifrs-full_EarningsPerShareExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "EarningsPerShareExplanatory", "presentation": [ "http://cosciensbio.com/role/NetIncomeLossPerShareTables" ], "lang": { "en-us": { "role": { "label": "Summary of pertinent data relating to computation of basic and diluted net loss per share" } }, "en": { "role": { "documentation": "The disclosure of earnings per share." } } }, "auth_ref": [ "r27" ] }, "ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "EffectOfExchangeRateChangesOnCashAndCashEquivalents", "crdr": "debit", "calculation": { "http://cosciensbio.com/role/InterimConsolidatedStatementsOfCashFlows": { "parentTag": "ifrs-full_IncreaseDecreaseInCashAndCashEquivalents", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://cosciensbio.com/role/InterimConsolidatedStatementsOfCashFlows", "http://cosciensbio.com/role/ScheduleOfDiscontinuedCashFlowsDetails" ], "lang": { "en-us": { "role": { "label": "Effect of exchange rate changes on cash and cash equivalents" } }, "en": { "role": { "documentation": "The effect of exchange rate changes on cash and cash equivalents held or due in a foreign currency. [Refer: Cash and cash equivalents]" } } }, "auth_ref": [ "r40", "r41" ] }, "dei_EntityAddressAddressLine1": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "EntityAddressAddressLine1", "presentation": [ "http://cosciensbio.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line One", "documentation": "Address Line 1 such as Attn, Building Name, Street Name" } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine2": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "EntityAddressAddressLine2", "presentation": [ "http://cosciensbio.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line Two", "documentation": "Address Line 2 such as Street or Suite number" } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine3": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "EntityAddressAddressLine3", "presentation": [ "http://cosciensbio.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line Three", "documentation": "Address Line 3 such as an Office Park" } } }, "auth_ref": [] }, "dei_EntityAddressCityOrTown": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "EntityAddressCityOrTown", "presentation": [ "http://cosciensbio.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, City or Town", "documentation": "Name of the City or Town" } } }, "auth_ref": [] }, "dei_EntityAddressCountry": { "xbrltype": "countryCodeItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "EntityAddressCountry", "presentation": [ "http://cosciensbio.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Country", "documentation": "ISO 3166-1 alpha-2 country code." } } }, "auth_ref": [] }, "dei_EntityAddressPostalZipCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "EntityAddressPostalZipCode", "presentation": [ "http://cosciensbio.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Postal Zip Code", "documentation": "Code for the postal or zip code" } } }, "auth_ref": [] }, "dei_EntityAddressStateOrProvince": { "xbrltype": "stateOrProvinceItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "EntityAddressStateOrProvince", "presentation": [ "http://cosciensbio.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, State or Province", "documentation": "Name of the state or province." } } }, "auth_ref": [] }, "dei_EntityBankruptcyProceedingsReportingCurrent": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "EntityBankruptcyProceedingsReportingCurrent", "presentation": [ "http://cosciensbio.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Bankruptcy Proceedings, Reporting Current", "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not. Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element." } } }, "auth_ref": [ "r217" ] }, "dei_EntityCentralIndexKey": { "xbrltype": "centralIndexKeyItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "EntityCentralIndexKey", "presentation": [ "http://cosciensbio.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Central Index Key", "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK." } } }, "auth_ref": [ "r213" ] }, "dei_EntityCommonStockSharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "EntityCommonStockSharesOutstanding", "presentation": [ "http://cosciensbio.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Common Stock, Shares Outstanding", "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument." } } }, "auth_ref": [] }, "dei_EntityCurrentReportingStatus": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "EntityCurrentReportingStatus", "presentation": [ "http://cosciensbio.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Current Reporting Status", "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure." } } }, "auth_ref": [] }, "dei_EntityEmergingGrowthCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "EntityEmergingGrowthCompany", "presentation": [ "http://cosciensbio.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Emerging Growth Company", "documentation": "Indicate if registrant meets the emerging growth company criteria." } } }, "auth_ref": [ "r213" ] }, "dei_EntityExTransitionPeriod": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "EntityExTransitionPeriod", "presentation": [ "http://cosciensbio.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Elected Not To Use the Extended Transition Period", "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards." } } }, "auth_ref": [ "r230" ] }, "dei_EntityFileNumber": { "xbrltype": "fileNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "EntityFileNumber", "presentation": [ "http://cosciensbio.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity File Number", "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen." } } }, "auth_ref": [] }, "dei_EntityFilerCategory": { "xbrltype": "filerCategoryItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "EntityFilerCategory", "presentation": [ "http://cosciensbio.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Filer Category", "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure." } } }, "auth_ref": [ "r213" ] }, "dei_EntityIncorporationStateCountryCode": { "xbrltype": "edgarStateCountryItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "EntityIncorporationStateCountryCode", "presentation": [ "http://cosciensbio.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Incorporation, State or Country Code", "documentation": "Two-character EDGAR code representing the state or country of incorporation." } } }, "auth_ref": [] }, "dei_EntityInteractiveDataCurrent": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "EntityInteractiveDataCurrent", "presentation": [ "http://cosciensbio.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Interactive Data Current", "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files)." } } }, "auth_ref": [ "r227" ] }, "dei_EntityPrimarySicNumber": { "xbrltype": "sicNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "EntityPrimarySicNumber", "presentation": [ "http://cosciensbio.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Primary SIC Number", "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity." } } }, "auth_ref": [ "r225" ] }, "dei_EntityPublicFloat": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "EntityPublicFloat", "crdr": "credit", "presentation": [ "http://cosciensbio.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Public Float", "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter." } } }, "auth_ref": [] }, "dei_EntityRegistrantName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "EntityRegistrantName", "presentation": [ "http://cosciensbio.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Registrant Name", "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC." } } }, "auth_ref": [ "r213" ] }, "dei_EntityShellCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "EntityShellCompany", "presentation": [ "http://cosciensbio.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Shell Company", "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act." } } }, "auth_ref": [ "r213" ] }, "dei_EntitySmallBusiness": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "EntitySmallBusiness", "presentation": [ "http://cosciensbio.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Small Business", "documentation": "Indicates that the company is a Smaller Reporting Company (SRC)." } } }, "auth_ref": [ "r213" ] }, "dei_EntityTaxIdentificationNumber": { "xbrltype": "employerIdItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "EntityTaxIdentificationNumber", "presentation": [ "http://cosciensbio.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Tax Identification Number", "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS." } } }, "auth_ref": [ "r213" ] }, "dei_EntityVoluntaryFilers": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "EntityVoluntaryFilers", "presentation": [ "http://cosciensbio.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Voluntary Filers", "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act." } } }, "auth_ref": [] }, "dei_EntityWellKnownSeasonedIssuer": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "EntityWellKnownSeasonedIssuer", "presentation": [ "http://cosciensbio.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Well-known Seasoned Issuer", "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A." } } }, "auth_ref": [ "r228" ] }, "CSCI_EquipmentNotAvailableForUseMember": { "xbrltype": "domainItemType", "nsuri": "http://cosciensbio.com/20260331", "localname": "EquipmentNotAvailableForUseMember", "presentation": [ "http://cosciensbio.com/role/ScheduleOfPropertyAndEquipmentDetails" ], "lang": { "en-us": { "role": { "label": "Equipment Not Available For Use [Member]", "documentation": "Equipment Not Available For Use [Member]" } } }, "auth_ref": [] }, "CSCI_EquipmentsMember": { "xbrltype": "domainItemType", "nsuri": "http://cosciensbio.com/20260331", "localname": "EquipmentsMember", "presentation": [ "http://cosciensbio.com/role/ScheduleOfPropertyAndEquipmentDetails" ], "lang": { "en-us": { "role": { "label": "Equipments [Member]", "documentation": "Equipments [Member]" } } }, "auth_ref": [] }, "ifrs-full_EquityAbstract": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "EquityAbstract", "presentation": [ "http://cosciensbio.com/role/InterimConsolidatedStatementsOfFinancialPosition" ], "lang": { "en-us": { "role": { "label": "Shareholders\u2019 equity" } } }, "auth_ref": [] }, "ifrs-full_EquityAndLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "EquityAndLiabilities", "crdr": "credit", "calculation": { "http://cosciensbio.com/role/InterimConsolidatedStatementsOfFinancialPosition": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://cosciensbio.com/role/InterimConsolidatedStatementsOfFinancialPosition" ], "lang": { "en-us": { "role": { "totalLabel": "Total liabilities and shareholders\u2019 equity", "label": "Equity and liabilities" } }, "en": { "role": { "documentation": "The amount of the entity's equity and liabilities. [Refer: Equity; Liabilities]" } } }, "auth_ref": [ "r166" ] }, "ifrs-full_EquityAttributableToOwnersOfParent": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "EquityAttributableToOwnersOfParent", "crdr": "credit", "calculation": { "http://cosciensbio.com/role/InterimConsolidatedStatementsOfFinancialPosition": { "parentTag": "ifrs-full_EquityAndLiabilities", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://cosciensbio.com/role/InterimConsolidatedStatementsOfChangesInShareholdersEquity", "http://cosciensbio.com/role/InterimConsolidatedStatementsOfFinancialPosition", "http://cosciensbio.com/role/SummaryOfShareCapitalDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Total shareholders\u2019 equity", "periodStartLabel": "Beginning balance", "periodEndLabel": "Ending balance", "label": "Equity attributable to owners of parent" } }, "en": { "role": { "documentation": "The amount of equity attributable to the owners of the parent. This specifically excludes non-controlling interest." } } }, "auth_ref": [ "r165" ] }, "dei_Extension": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "Extension", "presentation": [ "http://cosciensbio.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Extension", "documentation": "Extension number for local phone number." } } }, "auth_ref": [] }, "ifrs-full_FinanceCosts": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "FinanceCosts", "crdr": "debit", "calculation": { "http://cosciensbio.com/role/InterimConsolidatedStatementsOfIncomeLossAndComprehensiveIncomeLoss": { "parentTag": "ifrs-full_FinanceIncomeCost", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://cosciensbio.com/role/InterimConsolidatedStatementsOfIncomeLossAndComprehensiveIncomeLoss", "http://cosciensbio.com/role/ScheduleOfDiscontinuedProfitOrLossDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Finance costs", "label": "Finance costs" } } }, "auth_ref": [ "r177" ] }, "ifrs-full_FinanceIncomeCost": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "FinanceIncomeCost", "crdr": "credit", "calculation": { "http://cosciensbio.com/role/InterimConsolidatedStatementsOfIncomeLossAndComprehensiveIncomeLoss": { "parentTag": "ifrs-full_ProfitLossBeforeTax", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://cosciensbio.com/role/InterimConsolidatedStatementsOfIncomeLossAndComprehensiveIncomeLoss" ], "lang": { "en-us": { "role": { "totalLabel": "Other income (loss)", "label": "Finance income (cost)" } } }, "auth_ref": [ "r251" ] }, "ifrs-full_FinishedGoods": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "FinishedGoods", "crdr": "debit", "calculation": { "http://cosciensbio.com/role/ScheduleOfInventoriesDetails": { "parentTag": "ifrs-full_Inventories", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://cosciensbio.com/role/ScheduleOfInventoriesDetails" ], "lang": { "en-us": { "role": { "label": "Finished goods" } }, "en": { "role": { "documentation": "A classification of current inventory representing the amount of goods that have completed the production process and are held for sale in the ordinary course of business. [Refer: Inventories]" } } }, "auth_ref": [ "r201", "r208", "r235" ] }, "ifrs-full_GainLossOnRemeasurementOfNetDefinedBenefitLiabilityAsset": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "GainLossOnRemeasurementOfNetDefinedBenefitLiabilityAsset", "crdr": "debit", "presentation": [ "http://cosciensbio.com/role/SummaryOfNetDefinedBenefitLiabilityAssetDetails" ], "lang": { "en-us": { "role": { "label": "Actuarial gain (loss) on defined benefit plans in other comprehensive loss" } }, "en": { "role": { "documentation": "The decrease (increase) in a net defined benefit liability (asset) resulting from the remeasurement of that net defined benefit liability (asset). [Refer: Net defined benefit liability (asset)]" } } }, "auth_ref": [ "r16", "r124" ] }, "ifrs-full_GainLossOnRemeasurementOfNetDefinedBenefitLiabilityAssetAbstract": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "GainLossOnRemeasurementOfNetDefinedBenefitLiabilityAssetAbstract", "presentation": [ "http://cosciensbio.com/role/SummaryOfNetDefinedBenefitLiabilityAssetDetails" ], "lang": { "en-us": { "role": { "label": "Amounts recognized:" } } }, "auth_ref": [] }, "ifrs-full_GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss", "crdr": "credit", "calculation": { "http://cosciensbio.com/role/InterimConsolidatedStatementsOfIncomeLossAndComprehensiveIncomeLoss": { "parentTag": "ifrs-full_FinanceIncomeCost", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://cosciensbio.com/role/InterimConsolidatedStatementsOfIncomeLossAndComprehensiveIncomeLoss", "http://cosciensbio.com/role/ScheduleOfDiscontinuedProfitOrLossDetails" ], "lang": { "en-us": { "role": { "label": "Foreign exchange gain (loss)" } }, "en": { "role": { "documentation": "The amount of exchange differences recognised in profit or loss that arise from foreign currency transactions, excluding those arising on financial instruments measured at fair value through profit or loss in accordance with IFRS 9. [Refer: At fair value [member]; Classes of financial instruments [domain]]" } } }, "auth_ref": [ "r24", "r125", "r157" ] }, "ifrs-full_GainsLossesRecognisedWhenControlInSubsidiaryIsLost": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "GainsLossesRecognisedWhenControlInSubsidiaryIsLost", "crdr": "credit", "presentation": [ "http://cosciensbio.com/role/ScheduleOfDiscontinuedAssetsAndLiabilitiesDetails", "http://cosciensbio.com/role/ScheduleOfDiscontinuedProfitOrLossDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Gain on deconsolidation", "label": "Gain on deconsolidation" } }, "en": { "role": { "documentation": "The gains (losses) recognised in association with the loss of control over a subsidiary, which are attributable to the former controlling interest." } } }, "auth_ref": [ "r52", "r145" ] }, "ifrs-full_GrossCarryingAmountMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "GrossCarryingAmountMember", "presentation": [ "http://cosciensbio.com/role/ScheduleOfPropertyAndEquipmentDetails" ], "lang": { "en-us": { "role": { "label": "Gross carrying amount [member]" } } }, "auth_ref": [ "r4", "r31", "r35", "r38", "r79", "r86", "r87", "r115", "r127", "r131", "r134", "r143", "r144", "r197" ] }, "ifrs-full_GrossProfit": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "GrossProfit", "crdr": "credit", "calculation": { "http://cosciensbio.com/role/InterimConsolidatedStatementsOfIncomeLossAndComprehensiveIncomeLoss": { "parentTag": "ifrs-full_ProfitLossFromOperatingActivities", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://cosciensbio.com/role/InterimConsolidatedStatementsOfIncomeLossAndComprehensiveIncomeLoss", "http://cosciensbio.com/role/ScheduleOfDiscontinuedProfitOrLossDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Gross profit", "label": "Gross profit" } } }, "auth_ref": [ "r204" ] }, "CSCI_IfrsStatementLineItems": { "xbrltype": "stringItemType", "nsuri": "http://cosciensbio.com/20260331", "localname": "IfrsStatementLineItems", "presentation": [ "http://cosciensbio.com/role/CommitmentsAndContingenciesDetailsNarrative", "http://cosciensbio.com/role/InterimConsolidatedStatementsOfChangesInShareholdersEquity", "http://cosciensbio.com/role/ScheduleOfDiscontinuedAssetsAndLiabilitiesDetails", "http://cosciensbio.com/role/ScheduleOfDiscontinuedCashFlowsDetails", "http://cosciensbio.com/role/ScheduleOfDiscontinuedProfitOrLossDetails", "http://cosciensbio.com/role/ScheduleOfPropertyAndEquipmentDetails", "http://cosciensbio.com/role/ScheduleOfWarrantsOutstandingDetails", "http://cosciensbio.com/role/SegmentInformationDetailsNarrative", "http://cosciensbio.com/role/SummaryOfDeferredRevenueDetails", "http://cosciensbio.com/role/SummaryOfNetDefinedBenefitLiabilityAssetDetails", "http://cosciensbio.com/role/SummaryOfPertinentDataRelatingToComputationOfBasicAndDilutedNetLossPerShareDetails", "http://cosciensbio.com/role/SummaryOfShareCapitalDetails" ], "lang": { "en-us": { "role": { "label": "IfrsStatementLineItems [Line Items]" } } }, "auth_ref": [] }, "CSCI_ImpactOfForeignExchangeRateChangesAssetsOfBenefitPlan": { "xbrltype": "monetaryItemType", "nsuri": "http://cosciensbio.com/20260331", "localname": "ImpactOfForeignExchangeRateChangesAssetsOfBenefitPlan", "crdr": "debit", "presentation": [ "http://cosciensbio.com/role/SummaryOfNetDefinedBenefitLiabilityAssetDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Impact of foreign exchange rate changes", "documentation": "Impact of foreign exchange rate changes assets of benefit plan.", "label": "Impact of foreign exchange rate changes [Default Label]" } } }, "auth_ref": [] }, "CSCI_ImpairmentDescription": { "xbrltype": "stringItemType", "nsuri": "http://cosciensbio.com/20260331", "localname": "ImpairmentDescription", "presentation": [ "http://cosciensbio.com/role/PropertyAndEquipmentDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Impairment description", "documentation": "Impairment description." } } }, "auth_ref": [] }, "CSCI_ImpairmentLossRecognisedInProfitOrLossPropertyAndEquipment": { "xbrltype": "monetaryItemType", "nsuri": "http://cosciensbio.com/20260331", "localname": "ImpairmentLossRecognisedInProfitOrLossPropertyAndEquipment", "crdr": "debit", "presentation": [ "http://cosciensbio.com/role/ScheduleOfPropertyAndEquipmentDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Impairment", "documentation": "Impairment of property and equipment.", "label": "ImpairmentLossRecognisedInProfitOrLossPropertyAndEquipment" } } }, "auth_ref": [] }, "ifrs-full_IncomeStatementAbstract": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "IncomeStatementAbstract", "lang": { "en-us": { "role": { "label": "Profit or loss [abstract]" } } }, "auth_ref": [] }, "ifrs-full_IncomeTaxExpenseContinuingOperations": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "IncomeTaxExpenseContinuingOperations", "crdr": "debit", "calculation": { "http://cosciensbio.com/role/InterimConsolidatedStatementsOfIncomeLossAndComprehensiveIncomeLoss": { "parentTag": "ifrs-full_ProfitLossFromContinuingOperations", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://cosciensbio.com/role/InterimConsolidatedStatementsOfIncomeLossAndComprehensiveIncomeLoss" ], "lang": { "en-us": { "role": { "negatedLabel": "Income tax recovery (expense)", "label": "Tax expense (income)" } } }, "auth_ref": [ "r0", "r1", "r2", "r26", "r63", "r91", "r112", "r113", "r114", "r178" ] }, "ifrs-full_IncreaseDecreaseInCashAndCashEquivalents": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "IncreaseDecreaseInCashAndCashEquivalents", "crdr": "debit", "calculation": { "http://cosciensbio.com/role/InterimConsolidatedStatementsOfCashFlows": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://cosciensbio.com/role/InterimConsolidatedStatementsOfCashFlows", "http://cosciensbio.com/role/ScheduleOfDiscontinuedCashFlowsDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Net change in cash and cash equivalents", "label": "Net change in cash and cash equivalents" } }, "en": { "role": { "documentation": "The increase (decrease) in cash and cash equivalents after the effect of exchange rate changes on cash and cash equivalents held in foreign currencies. [Refer: Cash and cash equivalents; Effect of exchange rate changes on cash and cash equivalents]" } } }, "auth_ref": [ "r43", "r107" ] }, "CSCI_IncreaseDecreaseInFairValueOfWarrantAndDSULiabilities": { "xbrltype": "monetaryItemType", "nsuri": "http://cosciensbio.com/20260331", "localname": "IncreaseDecreaseInFairValueOfWarrantAndDSULiabilities", "crdr": "debit", "calculation": { "http://cosciensbio.com/role/InterimConsolidatedStatementsOfCashFlows": { "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivities", "weight": 1.0, "order": 8.0 } }, "presentation": [ "http://cosciensbio.com/role/InterimConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "verboseLabel": "Change in fair value of warrant and DSU liabilities", "documentation": "Change in fair value of warrant and DSU liabilities.", "label": "IncreaseDecreaseInFairValueOfWarrantAndDSULiabilities" } } }, "auth_ref": [] }, "CSCI_IncreaseDecreaseInNetAssetAvailableForBenefit": { "xbrltype": "monetaryItemType", "nsuri": "http://cosciensbio.com/20260331", "localname": "IncreaseDecreaseInNetAssetAvailableForBenefit", "crdr": "credit", "presentation": [ "http://cosciensbio.com/role/SummaryOfNetDefinedBenefitLiabilityAssetDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Benefits paid", "documentation": "Increase (decrease) in net asset available for benefit.", "label": "IncreaseDecreaseInNetAssetAvailableForBenefit" } } }, "auth_ref": [] }, "ifrs-full_IncreaseDecreaseInWorkingCapital": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "IncreaseDecreaseInWorkingCapital", "crdr": "credit", "calculation": { "http://cosciensbio.com/role/InterimConsolidatedStatementsOfCashFlows": { "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivities", "weight": -1.0, "order": 10.0 }, "http://cosciensbio.com/role/SummaryOfChangesInOperatingAssetsAndLiabilitiesDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://cosciensbio.com/role/InterimConsolidatedStatementsOfCashFlows", "http://cosciensbio.com/role/SummaryOfChangesInOperatingAssetsAndLiabilitiesDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Changes in operating assets and liabilities (note 11)", "negatedTotalLabel": "Increase (decrease) in operating assets and liabilities", "label": "Increase (decrease) in working capital" } }, "en": { "role": { "documentation": "The increase (decrease) in working capital." } } }, "auth_ref": [ "r240" ] }, "ifrs-full_IncreaseDecreaseThroughBusinessCombinationsAndDisposalsNetDefinedBenefitLiabilityAsset": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "IncreaseDecreaseThroughBusinessCombinationsAndDisposalsNetDefinedBenefitLiabilityAsset", "crdr": "credit", "presentation": [ "http://cosciensbio.com/role/SummaryOfNetDefinedBenefitLiabilityAssetDetails" ], "lang": { "en-us": { "role": { "label": "Deconsolidation of German subsidiaries" } }, "en": { "role": { "documentation": "The increase (decrease) in the net defined benefit liability (asset) resulting from business combinations and disposals. [Refer: Total for all business combinations [member]; Net defined benefit liability (asset)]" } } }, "auth_ref": [ "r19" ] }, "ifrs-full_IncreaseDecreaseThroughChangesInForeignExchangeRatesNetDefinedBenefitLiabilityAsset": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "IncreaseDecreaseThroughChangesInForeignExchangeRatesNetDefinedBenefitLiabilityAsset", "crdr": "credit", "presentation": [ "http://cosciensbio.com/role/SummaryOfNetDefinedBenefitLiabilityAssetDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Impact of foreign exchange rate changes", "label": "Increase (decrease) in net defined benefit liability (asset) resulting from changes in foreign exchange rates, net defined benefit liability (asset)" } }, "en": { "role": { "documentation": "The increase (decrease) in the net defined benefit liability (asset) resulting from changes in foreign exchange rates. [Refer: Net defined benefit liability (asset)]" } } }, "auth_ref": [ "r17" ] }, "ifrs-full_IncreaseDecreaseThroughExerciseOfWarrantsEquity": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "IncreaseDecreaseThroughExerciseOfWarrantsEquity", "crdr": "credit", "presentation": [ "http://cosciensbio.com/role/InterimConsolidatedStatementsOfChangesInShareholdersEquity" ], "lang": { "en-us": { "role": { "label": "Exercise of warrants" } }, "en": { "role": { "documentation": "The increase (decrease) in equity resulting from the exercise of warrants." } } }, "auth_ref": [ "r244" ] }, "ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment", "crdr": "debit", "presentation": [ "http://cosciensbio.com/role/ScheduleOfPropertyAndEquipmentDetails" ], "lang": { "en-us": { "role": { "label": "Impact of foreign exchange rate changes" } }, "en": { "role": { "documentation": "The increase (decrease) in property, plant and equipment resulting from net exchange differences arising on the translation of the financial statements from the functional currency into a different presentation currency, including the translation of a foreign operation into the presentation currency of the reporting entity. [Refer: Property, plant and equipment]" } } }, "auth_ref": [ "r8" ] }, "ifrs-full_IncreaseDecreaseThroughOtherChangesPropertyPlantAndEquipment": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "IncreaseDecreaseThroughOtherChangesPropertyPlantAndEquipment", "crdr": "debit", "presentation": [ "http://cosciensbio.com/role/ScheduleOfPropertyAndEquipmentDetails" ], "lang": { "en-us": { "role": { "label": "Commissioning of assets" } }, "en": { "role": { "documentation": "The increase (decrease) in property, plant and equipment resulting from changes that the entity does not separately disclose in the same statement or note. [Refer: Property, plant and equipment]" } } }, "auth_ref": [ "r7", "r118" ] }, "ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "IncreaseDecreaseThroughSharebasedPaymentTransactions", "crdr": "credit", "presentation": [ "http://cosciensbio.com/role/InterimConsolidatedStatementsOfChangesInShareholdersEquity" ], "lang": { "en-us": { "role": { "label": "Share-based compensation costs" } }, "en": { "role": { "documentation": "The increase (decrease) in equity resulting from share-based payment transactions. [Refer: Equity]" } } }, "auth_ref": [ "r155" ] }, "ifrs-full_IntangibleAssetsOtherThanGoodwill": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "IntangibleAssetsOtherThanGoodwill", "crdr": "debit", "calculation": { "http://cosciensbio.com/role/InterimConsolidatedStatementsOfFinancialPosition": { "parentTag": "ifrs-full_NoncurrentAssets", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://cosciensbio.com/role/InterimConsolidatedStatementsOfFinancialPosition" ], "lang": { "en-us": { "role": { "label": "Intangible assets" } }, "en": { "role": { "documentation": "The amount of identifiable non-monetary assets without physical substance. This amount does not include goodwill. [Refer: Goodwill]" } } }, "auth_ref": [ "r32", "r128", "r159" ] }, "ifrs-full_InterestExpenseIncomeNetDefinedBenefitLiabilityAsset": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "InterestExpenseIncomeNetDefinedBenefitLiabilityAsset", "crdr": "credit", "presentation": [ "http://cosciensbio.com/role/SummaryOfNetDefinedBenefitLiabilityAssetDetails" ], "lang": { "en-us": { "role": { "label": "Interest cost" } } }, "auth_ref": [ "r14", "r123" ] }, "CSCI_InterestIncomeFromPlanAssets": { "xbrltype": "monetaryItemType", "nsuri": "http://cosciensbio.com/20260331", "localname": "InterestIncomeFromPlanAssets", "crdr": "debit", "presentation": [ "http://cosciensbio.com/role/SummaryOfNetDefinedBenefitLiabilityAssetDetails" ], "lang": { "en-us": { "role": { "label": "Interest income from plan assets", "documentation": "Interest income from plan assets." } } }, "auth_ref": [] }, "ifrs-full_Inventories": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "Inventories", "crdr": "debit", "calculation": { "http://cosciensbio.com/role/InterimConsolidatedStatementsOfFinancialPosition": { "parentTag": "ifrs-full_CurrentAssets", "weight": 1.0, "order": 3.0 }, "http://cosciensbio.com/role/ScheduleOfInventoriesDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://cosciensbio.com/role/InterimConsolidatedStatementsOfFinancialPosition", "http://cosciensbio.com/role/ScheduleOfDiscontinuedAssetsAndLiabilitiesDetails", "http://cosciensbio.com/role/ScheduleOfInventoriesDetails" ], "lang": { "en-us": { "role": { "label": "Inventories (note 4)", "totalLabel": "Inventories", "verboseLabel": "Inventories" } }, "en": { "role": { "documentation": "The amount of current inventories. [Refer: Inventories]" } } }, "auth_ref": [ "r21", "r105", "r160", "r206" ] }, "CSCI_InventoriesExpensedToCostOfGoodsSold": { "xbrltype": "monetaryItemType", "nsuri": "http://cosciensbio.com/20260331", "localname": "InventoriesExpensedToCostOfGoodsSold", "crdr": "debit", "presentation": [ "http://cosciensbio.com/role/InventoriesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Inventories expensed to cost of goods sold", "documentation": "Inventories expensed to cost of goods sold." } } }, "auth_ref": [] }, "ifrs-full_IssuedCapital": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "IssuedCapital", "crdr": "credit", "calculation": { "http://cosciensbio.com/role/InterimConsolidatedStatementsOfFinancialPosition": { "parentTag": "ifrs-full_EquityAttributableToOwnersOfParent", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://cosciensbio.com/role/InterimConsolidatedStatementsOfFinancialPosition" ], "lang": { "en-us": { "role": { "label": "Share capital (note 10)" } }, "en": { "role": { "documentation": "The nominal value of capital issued." } } }, "auth_ref": [ "r202", "r209" ] }, "ifrs-full_IssuedCapitalMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "IssuedCapitalMember", "presentation": [ "http://cosciensbio.com/role/InterimConsolidatedStatementsOfChangesInShareholdersEquity", "http://cosciensbio.com/role/SummaryOfShareCapitalDetails" ], "lang": { "en-us": { "role": { "label": "Issued capital [member]" } }, "en": { "role": { "documentation": "This member stands for a component of equity representing issued capital." } } }, "auth_ref": [ "r156" ] }, "CSCI_JuneTwoThousandTwentyFourMember": { "xbrltype": "domainItemType", "nsuri": "http://cosciensbio.com/20260331", "localname": "JuneTwoThousandTwentyFourMember", "presentation": [ "http://cosciensbio.com/role/ScheduleOfWarrantsOutstandingDetails" ], "lang": { "en-us": { "role": { "label": "June 2024 [member]", "documentation": "June 2024 [member]" } } }, "auth_ref": [] }, "ifrs-full_LeaseholdImprovementsMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "LeaseholdImprovementsMember", "presentation": [ "http://cosciensbio.com/role/ScheduleOfPropertyAndEquipmentDetails" ], "lang": { "en-us": { "role": { "label": "Leasehold improvements [member]" } }, "en": { "role": { "documentation": "This member stands for a class of property, plant and equipment representing improvements to assets held under a lease agreement." } } }, "auth_ref": [ "r231" ] }, "ifrs-full_Liabilities": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "Liabilities", "crdr": "credit", "calculation": { "http://cosciensbio.com/role/InterimConsolidatedStatementsOfFinancialPosition": { "parentTag": "ifrs-full_EquityAndLiabilities", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://cosciensbio.com/role/InterimConsolidatedStatementsOfFinancialPosition", "http://cosciensbio.com/role/ScheduleOfDiscontinuedAssetsAndLiabilitiesDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Total liabilities", "negatedTotalLabel": "Total liabilities", "label": "Liabilities" } }, "en": { "role": { "documentation": "The amount of a present obligation of the entity to transfer an economic resource as a result of past events. Economic resource is a right that has the potential to produce economic benefits." } } }, "auth_ref": [ "r64", "r65", "r66", "r92", "r96", "r146", "r147", "r166" ] }, "ifrs-full_LiabilitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "LiabilitiesAbstract", "presentation": [ "http://cosciensbio.com/role/InterimConsolidatedStatementsOfFinancialPosition", "http://cosciensbio.com/role/ScheduleOfDiscontinuedAssetsAndLiabilitiesDetails" ], "lang": { "en-us": { "role": { "label": "LIABILITIES" } } }, "auth_ref": [] }, "ifrs-full_LiabilityAssetOfDefinedBenefitPlans": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "LiabilityAssetOfDefinedBenefitPlans", "crdr": "credit", "presentation": [ "http://cosciensbio.com/role/SummaryOfNetDefinedBenefitLiabilityAssetDetails" ], "lang": { "en-us": { "role": { "periodStartLabel": "Balances \u2013 Beginning of the period", "periodEndLabel": "Balances \u2013 End of the period", "label": "Net defined benefit liability (asset)" } }, "en": { "role": { "documentation": "The amount of deficit or surplus in a defined benefit plan, adjusted for any effect of limiting a net defined benefit asset to the asset ceiling. [Refer: Defined benefit plans [domain]]" } } }, "auth_ref": [ "r13", "r122" ] }, "dei_LocalPhoneNumber": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "LocalPhoneNumber", "presentation": [ "http://cosciensbio.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Local Phone Number", "documentation": "Local phone number for entity." } } }, "auth_ref": [] }, "ifrs-full_LossesOnDisposalsOfPropertyPlantAndEquipment": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "LossesOnDisposalsOfPropertyPlantAndEquipment", "crdr": "debit", "calculation": { "http://cosciensbio.com/role/InterimConsolidatedStatementsOfCashFlows": { "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivities", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://cosciensbio.com/role/InterimConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Loss on disposal of property and equipment" } } }, "auth_ref": [ "r182" ] }, "ifrs-full_MajorCustomersAxis": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "MajorCustomersAxis", "presentation": [ "http://cosciensbio.com/role/SegmentInformationDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Major customers [axis]" } }, "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } } }, "auth_ref": [ "r100" ] }, "ifrs-full_MajorCustomersDomain": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "MajorCustomersDomain", "presentation": [ "http://cosciensbio.com/role/SegmentInformationDetailsNarrative" ], "lang": { "en": { "role": { "documentation": "This member stands for customers. It also represents the standard value for the 'Major customers' axis if no other member is used." } } }, "auth_ref": [ "r100" ] }, "CSCI_NKMeditechLimitedMember": { "xbrltype": "domainItemType", "nsuri": "http://cosciensbio.com/20260331", "localname": "NKMeditechLimitedMember", "presentation": [ "http://cosciensbio.com/role/SummaryOfDeferredRevenueDetails" ], "lang": { "en-us": { "role": { "label": "NK Meditech Limited [member]", "documentation": "NK Meditech Limited [member]" } } }, "auth_ref": [] }, "ifrs-full_NetAssetsLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "NetAssetsLiabilities", "crdr": "debit", "presentation": [ "http://cosciensbio.com/role/ScheduleOfDiscontinuedAssetsAndLiabilitiesDetails" ], "lang": { "en-us": { "role": { "label": "Carrying amount of net liabilities deconsolidated" } }, "en": { "role": { "documentation": "The amount of assets less the amount of liabilities." } } }, "auth_ref": [ "r192", "r246" ] }, "CSCI_NetLiabilityOfFundedPlans": { "xbrltype": "monetaryItemType", "nsuri": "http://cosciensbio.com/20260331", "localname": "NetLiabilityOfFundedPlans", "crdr": "debit", "presentation": [ "http://cosciensbio.com/role/SummaryOfNetDefinedBenefitLiabilityAssetDetails" ], "lang": { "en-us": { "role": { "label": "Net liability of the funded plans", "documentation": "Net liability of the funded plans." } } }, "auth_ref": [] }, "CSCI_NetLiabilityOfUnfundedPlans": { "xbrltype": "monetaryItemType", "nsuri": "http://cosciensbio.com/20260331", "localname": "NetLiabilityOfUnfundedPlans", "crdr": "debit", "presentation": [ "http://cosciensbio.com/role/SummaryOfNetDefinedBenefitLiabilityAssetDetails" ], "lang": { "en-us": { "role": { "label": "Net liability of the unfunded plans", "documentation": "Net liability of the unfunded plans." } } }, "auth_ref": [] }, "dei_NoTradingSymbolFlag": { "xbrltype": "trueItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "NoTradingSymbolFlag", "presentation": [ "http://cosciensbio.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "No Trading Symbol Flag", "documentation": "Boolean flag that is true only for a security having no trading symbol." } } }, "auth_ref": [] }, "ifrs-full_NoncurrentAssets": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "NoncurrentAssets", "crdr": "debit", "calculation": { "http://cosciensbio.com/role/InterimConsolidatedStatementsOfFinancialPosition": { "parentTag": "ifrs-full_Assets", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://cosciensbio.com/role/InterimConsolidatedStatementsOfFinancialPosition", "http://cosciensbio.com/role/ScheduleOfDiscontinuedAssetsAndLiabilitiesDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Total non-current assets", "label": "Non-current assets [Default Label]" } }, "en": { "role": { "documentation": "The amount of assets that do not meet the definition of current assets. [Refer: Current assets]" } } }, "auth_ref": [ "r54", "r167", "r193" ] }, "ifrs-full_NoncurrentAssetsAbstract": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "NoncurrentAssetsAbstract", "presentation": [ "http://cosciensbio.com/role/InterimConsolidatedStatementsOfFinancialPosition", "http://cosciensbio.com/role/ScheduleOfDiscontinuedAssetsAndLiabilitiesDetails" ], "lang": { "en-us": { "role": { "label": "Non-current assets" } } }, "auth_ref": [] }, "ifrs-full_NoncurrentContractLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "NoncurrentContractLiabilities", "crdr": "credit", "presentation": [ "http://cosciensbio.com/role/SummaryOfDeferredRevenueDetails" ], "lang": { "en-us": { "role": { "label": "Non-Current" } }, "en": { "role": { "documentation": "The amount of non-current contract liabilities. [Refer: Contract liabilities]" } } }, "auth_ref": [ "r68" ] }, "ifrs-full_NoncurrentLeaseLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "NoncurrentLeaseLiabilities", "crdr": "credit", "calculation": { "http://cosciensbio.com/role/InterimConsolidatedStatementsOfFinancialPosition": { "parentTag": "ifrs-full_NoncurrentLiabilities", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://cosciensbio.com/role/InterimConsolidatedStatementsOfFinancialPosition", "http://cosciensbio.com/role/ScheduleOfDiscontinuedAssetsAndLiabilitiesDetails" ], "lang": { "en-us": { "role": { "label": "Lease liabilities", "negatedLabel": "Lease liabilities" } }, "en": { "role": { "documentation": "The amount of non-current lease liabilities. [Refer: Lease liabilities]" } } }, "auth_ref": [ "r71" ] }, "ifrs-full_NoncurrentLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "NoncurrentLiabilities", "crdr": "credit", "calculation": { "http://cosciensbio.com/role/InterimConsolidatedStatementsOfFinancialPosition": { "parentTag": "ifrs-full_Liabilities", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://cosciensbio.com/role/InterimConsolidatedStatementsOfFinancialPosition", "http://cosciensbio.com/role/ScheduleOfDiscontinuedAssetsAndLiabilitiesDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Total non-current liabilities", "negatedTotalLabel": "Total non-current liabilities", "label": "Non-current liabilities [Default Label]" } }, "en": { "role": { "documentation": "The amount of liabilities that do not meet the definition of current liabilities. [Refer: Current liabilities]" } } }, "auth_ref": [ "r56", "r168", "r193" ] }, "ifrs-full_NoncurrentLiabilitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "NoncurrentLiabilitiesAbstract", "presentation": [ "http://cosciensbio.com/role/InterimConsolidatedStatementsOfFinancialPosition", "http://cosciensbio.com/role/ScheduleOfDiscontinuedAssetsAndLiabilitiesDetails" ], "lang": { "en-us": { "role": { "label": "Non-current liabilities" } } }, "auth_ref": [] }, "ifrs-full_NoncurrentProvisions": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "NoncurrentProvisions", "crdr": "credit", "presentation": [ "http://cosciensbio.com/role/ScheduleOfDiscontinuedAssetsAndLiabilitiesDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Provisions", "label": "Non-current provisions" } }, "en": { "role": { "documentation": "The amount of non-current provisions, including provisions for employee benefits. [Refer: Provisions]" } } }, "auth_ref": [ "r163" ] }, "ifrs-full_NoncurrentProvisionsForEmployeeBenefits": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "NoncurrentProvisionsForEmployeeBenefits", "crdr": "credit", "calculation": { "http://cosciensbio.com/role/InterimConsolidatedStatementsOfFinancialPosition": { "parentTag": "ifrs-full_NoncurrentLiabilities", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://cosciensbio.com/role/InterimConsolidatedStatementsOfFinancialPosition", "http://cosciensbio.com/role/ScheduleOfDiscontinuedAssetsAndLiabilitiesDetails" ], "lang": { "en-us": { "role": { "label": "Employee future benefits (note 8)", "negatedLabel": "Employee future benefits (note 8)" } }, "en": { "role": { "documentation": "The amount of non-current provisions for employee benefits. [Refer: Provisions for employee benefits]" } } }, "auth_ref": [ "r151", "r171" ] }, "ifrs-full_NotesAndOtherExplanatoryInformationAbstract": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "NotesAndOtherExplanatoryInformationAbstract", "lang": { "en-us": { "role": { "label": "Notes and other explanatory information [abstract]" } } }, "auth_ref": [] }, "ifrs-full_NumberOfOutstandingShareOptions": { "xbrltype": "decimalItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "NumberOfOutstandingShareOptions", "presentation": [ "http://cosciensbio.com/role/SummaryOfNumberAndWeightedAverageExercisePricesOfOptionsDetails" ], "lang": { "en-us": { "role": { "periodStartLabel": "Number of stock options, beginning", "periodEndLabel": "Number of stock options, ending", "label": "Number of share options outstanding in share-based payment arrangement" } }, "en": { "role": { "documentation": "The number of share options outstanding in a share-based payment arrangement." } } }, "auth_ref": [ "r73", "r76", "r78", "r136", "r139" ] }, "ifrs-full_NumberOfPotentialOrdinarySharesThatAreAntidilutiveInPeriodPresented": { "xbrltype": "sharesItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "NumberOfPotentialOrdinarySharesThatAreAntidilutiveInPeriodPresented", "presentation": [ "http://cosciensbio.com/role/SummaryOfPertinentDataRelatingToComputationOfBasicAndDilutedNetLossPerShareDetails" ], "lang": { "en-us": { "role": { "label": "Anti-dilutive shares" } }, "en": { "role": { "documentation": "Number of potential ordinary shares that are antidilutive in the period presented." } } }, "auth_ref": [ "r236" ] }, "ifrs-full_NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement": { "xbrltype": "decimalItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement", "presentation": [ "http://cosciensbio.com/role/SummaryOfNumberAndWeightedAverageExercisePricesOfOptionsDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Number of stock options, cancelled/forfeited", "label": "Number of share options forfeited in share-based payment arrangement" } }, "en": { "role": { "documentation": "The number of share options forfeited in a share-based payment arrangement." } } }, "auth_ref": [ "r75", "r138" ] }, "ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement": { "xbrltype": "decimalItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "NumberOfShareOptionsGrantedInSharebasedPaymentArrangement", "presentation": [ "http://cosciensbio.com/role/SummaryOfShareCapitalDetails" ], "lang": { "en-us": { "role": { "label": "Granted, shares" } }, "en": { "role": { "documentation": "The number of share options granted in a share-based payment arrangement." } } }, "auth_ref": [ "r74", "r137" ] }, "CSCI_NumberOfSharesGrantedValue": { "xbrltype": "monetaryItemType", "nsuri": "http://cosciensbio.com/20260331", "localname": "NumberOfSharesGrantedValue", "crdr": "credit", "presentation": [ "http://cosciensbio.com/role/SummaryOfShareCapitalDetails" ], "lang": { "en-us": { "role": { "label": "Granted, amount", "documentation": "Number if shares granted value." } } }, "auth_ref": [] }, "ifrs-full_NumberOfSharesIssued": { "xbrltype": "sharesItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "NumberOfSharesIssued", "presentation": [ "http://cosciensbio.com/role/SummaryOfShareCapitalDetails" ], "lang": { "en-us": { "role": { "periodStartLabel": "Beginning balance, shares", "periodEndLabel": "Ending balance, shares", "label": "Number of shares issued" } }, "en": { "role": { "documentation": "The number of shares issued by the entity." } } }, "auth_ref": [ "r244" ] }, "ifrs-full_OfficeEquipmentMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "OfficeEquipmentMember", "presentation": [ "http://cosciensbio.com/role/ScheduleOfPropertyAndEquipmentDetails" ], "lang": { "en-us": { "role": { "label": "Office equipment [member]" } }, "en": { "role": { "documentation": "This member stands for a class of property, plant and equipment representing equipment used to support office functions, not specifically used in the production process. [Refer: Property, plant and equipment]" } } }, "auth_ref": [ "r185" ] }, "CSCI_OneCustomerMember": { "xbrltype": "domainItemType", "nsuri": "http://cosciensbio.com/20260331", "localname": "OneCustomerMember", "presentation": [ "http://cosciensbio.com/role/SegmentInformationDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "One customer [member]", "documentation": "One customer [member]" } } }, "auth_ref": [] }, "ifrs-full_OperatingExpense": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "OperatingExpense", "crdr": "debit", "calculation": { "http://cosciensbio.com/role/InterimConsolidatedStatementsOfIncomeLossAndComprehensiveIncomeLoss": { "parentTag": "ifrs-full_ProfitLossFromOperatingActivities", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://cosciensbio.com/role/InterimConsolidatedStatementsOfIncomeLossAndComprehensiveIncomeLoss", "http://cosciensbio.com/role/ScheduleOfDiscontinuedProfitOrLossDetails" ], "lang": { "en-us": { "role": { "negatedTotalLabel": "Total operating expenses", "totalLabel": "Total operating expenses", "label": "Operating expense" } } }, "auth_ref": [ "r251" ] }, "ifrs-full_OtherAdjustmentsForNoncashItems": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "OtherAdjustmentsForNoncashItems", "crdr": "debit", "calculation": { "http://cosciensbio.com/role/InterimConsolidatedStatementsOfCashFlows": { "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivities", "weight": 1.0, "order": 9.0 } }, "presentation": [ "http://cosciensbio.com/role/InterimConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Other non-cash items" } } }, "auth_ref": [ "r239" ] }, "ifrs-full_OtherAssets": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "OtherAssets", "crdr": "debit", "calculation": { "http://cosciensbio.com/role/SummaryOfPrepaidExpensesAndOtherCurrentAssetsDetails": { "parentTag": "ifrs-full_CurrentPrepaymentsAndOtherCurrentAssets", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://cosciensbio.com/role/SummaryOfPrepaidExpensesAndOtherCurrentAssetsDetails" ], "lang": { "en-us": { "role": { "label": "Other" } }, "en": { "role": { "documentation": "The amount of assets that the entity does not separately disclose in the same statement or note." } } }, "auth_ref": [ "r249" ] }, "CSCI_OtherBenefitPlansMember": { "xbrltype": "domainItemType", "nsuri": "http://cosciensbio.com/20260331", "localname": "OtherBenefitPlansMember", "presentation": [ "http://cosciensbio.com/role/SummaryOfNetDefinedBenefitLiabilityAssetDetails" ], "lang": { "en-us": { "role": { "label": "Other benefit plans [member]", "documentation": "Other benefit plans [member]" } } }, "auth_ref": [] }, "ifrs-full_OtherComprehensiveIncomeAbstract": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "OtherComprehensiveIncomeAbstract", "presentation": [ "http://cosciensbio.com/role/InterimConsolidatedStatementsOfIncomeLossAndComprehensiveIncomeLoss" ], "lang": { "en-us": { "role": { "label": "Other comprehensive income (loss):" } } }, "auth_ref": [] }, "ifrs-full_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation", "crdr": "credit", "calculation": { "http://cosciensbio.com/role/InterimConsolidatedStatementsOfIncomeLossAndComprehensiveIncomeLoss": { "parentTag": "ifrs-full_ComprehensiveIncome", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://cosciensbio.com/role/InterimConsolidatedStatementsOfChangesInShareholdersEquity", "http://cosciensbio.com/role/InterimConsolidatedStatementsOfIncomeLossAndComprehensiveIncomeLoss" ], "lang": { "en-us": { "role": { "label": "Foreign currency translation adjustments" } }, "en": { "role": { "documentation": "The amount of other comprehensive income, net of tax, after reclassification adjustments, related to exchange differences when financial statements of foreign operations are translated. [Refer: Other comprehensive income]" } } }, "auth_ref": [ "r169", "r180" ] }, "ifrs-full_OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans", "crdr": "credit", "calculation": { "http://cosciensbio.com/role/InterimConsolidatedStatementsOfIncomeLossAndComprehensiveIncomeLoss": { "parentTag": "ifrs-full_ComprehensiveIncome", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://cosciensbio.com/role/InterimConsolidatedStatementsOfChangesInShareholdersEquity", "http://cosciensbio.com/role/InterimConsolidatedStatementsOfIncomeLossAndComprehensiveIncomeLoss" ], "lang": { "en-us": { "role": { "label": "Actuarial gain on defined benefit plan", "verboseLabel": "Actuarial gain (loss) on defined benefit plans (note 8)" } }, "en": { "role": { "documentation": "The amount of other comprehensive income, net of tax, related to gains (losses) on remeasurements of defined benefit plans, which comprise actuarial gains and losses; the return on plan assets, excluding amounts included in net interest on the net defined benefit liability (asset); and any change in the effect of the asset ceiling, excluding amounts included in net interest on the net defined benefit liability (asset). [Refer: Other comprehensive income; Defined benefit plans [domain]; Plan assets [member]; Net defined benefit liability (asset)] [Contrast: Decrease (increase) in net defined benefit liability (asset) resulting from gain (loss) on remeasurement in other comprehensive income]" } } }, "auth_ref": [ "r169", "r180", "r233" ] }, "ifrs-full_OtherCurrentPayables": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "OtherCurrentPayables", "crdr": "credit", "calculation": { "http://cosciensbio.com/role/SummaryOfDetailedInformationAboutAccountsPayableAndAccruedLiabilitiesDetails": { "parentTag": "ifrs-full_CurrentAccruedExpensesAndOtherCurrentLiabilities", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://cosciensbio.com/role/SummaryOfDetailedInformationAboutAccountsPayableAndAccruedLiabilitiesDetails" ], "lang": { "en-us": { "role": { "label": "Other accrued liabilities" } }, "en": { "role": { "documentation": "The amount of current payables that the entity does not separately disclose in the same statement or note." } } }, "auth_ref": [ "r249" ] }, "CSCI_OtherIncomeExpenses": { "xbrltype": "monetaryItemType", "nsuri": "http://cosciensbio.com/20260331", "localname": "OtherIncomeExpenses", "crdr": "credit", "calculation": { "http://cosciensbio.com/role/InterimConsolidatedStatementsOfIncomeLossAndComprehensiveIncomeLoss": { "parentTag": "ifrs-full_FinanceIncomeCost", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://cosciensbio.com/role/InterimConsolidatedStatementsOfIncomeLossAndComprehensiveIncomeLoss", "http://cosciensbio.com/role/ScheduleOfDiscontinuedProfitOrLossDetails" ], "lang": { "en-us": { "role": { "label": "Other income", "documentation": "Other income (expenses)." } } }, "auth_ref": [] }, "dei_OtherReportingStandardItemNumber": { "xbrltype": "otherReportingStandardItemNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "OtherReportingStandardItemNumber", "presentation": [ "http://cosciensbio.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Other Reporting Standard Item Number", "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS." } } }, "auth_ref": [ "r224" ] }, "ifrs-full_PaymentsInRespectOfSettlementsNetDefinedBenefitLiabilityAsset": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "PaymentsInRespectOfSettlementsNetDefinedBenefitLiabilityAsset", "crdr": "debit", "presentation": [ "http://cosciensbio.com/role/SummaryOfNetDefinedBenefitLiabilityAssetDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Benefits paid", "label": "Decrease (increase) in net defined benefit liability (asset) resulting from payments in respect of settlements" } }, "en": { "role": { "documentation": "The decrease (increase) in the net defined benefit liability (asset) resulting from payments from the plan in respect of settlements. [Refer: Decrease (increase) in net defined benefit liability (asset) resulting from gains (losses) arising from settlements; Net defined benefit liability (asset); Defined benefit plans [domain]]" } } }, "auth_ref": [ "r18" ] }, "ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities", "crdr": "credit", "calculation": { "http://cosciensbio.com/role/InterimConsolidatedStatementsOfCashFlows": { "parentTag": "ifrs-full_CashFlowsFromUsedInFinancingActivities", "weight": -1.0, "order": 1.0 } }, "presentation": [ "http://cosciensbio.com/role/InterimConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "negatedLabel": "Payments on lease liabilities", "label": "Payments of lease liabilities, classified as financing activities" } }, "en": { "role": { "documentation": "The cash outflow for payment of lease liabilities, classified as financing activities. [Refer: Lease liabilities]" } } }, "auth_ref": [ "r191" ] }, "ifrs-full_PensionDefinedBenefitPlansMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "PensionDefinedBenefitPlansMember", "presentation": [ "http://cosciensbio.com/role/SummaryOfNetDefinedBenefitLiabilityAssetDetails" ], "lang": { "en-us": { "role": { "label": "Pension defined benefit plans [member]" } }, "en": { "role": { "documentation": "This member stands for pension defined benefit plans. [Refer: Defined benefit plans [domain]]" } } }, "auth_ref": [ "r234" ] }, "ifrs-full_PercentageOfEntitysRevenue": { "xbrltype": "percentItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "PercentageOfEntitysRevenue", "presentation": [ "http://cosciensbio.com/role/SegmentInformationDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Revenue percentage" } } }, "auth_ref": [ "r242" ] }, "CSCI_PercentageOfExemptionRate": { "xbrltype": "percentItemType", "nsuri": "http://cosciensbio.com/20260331", "localname": "PercentageOfExemptionRate", "presentation": [ "http://cosciensbio.com/role/BusinessOverviewDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Exemption percentage", "documentation": "Percentage of exemption rate." } } }, "auth_ref": [] }, "CSCI_PercentageOfTariffsIssued": { "xbrltype": "percentItemType", "nsuri": "http://cosciensbio.com/20260331", "localname": "PercentageOfTariffsIssued", "presentation": [ "http://cosciensbio.com/role/BusinessOverviewDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Tariff percentage", "documentation": "Percentage of tariffs issued." } } }, "auth_ref": [] }, "CSCI_PercentageOfTradeAndOtherReceivables": { "xbrltype": "percentItemType", "nsuri": "http://cosciensbio.com/20260331", "localname": "PercentageOfTradeAndOtherReceivables", "presentation": [ "http://cosciensbio.com/role/SegmentInformationDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Trade and other receivables percentage", "documentation": "Percentage of trade and other receivables." } } }, "auth_ref": [] }, "CSCI_PharmanoviaMember": { "xbrltype": "domainItemType", "nsuri": "http://cosciensbio.com/20260331", "localname": "PharmanoviaMember", "presentation": [ "http://cosciensbio.com/role/SummaryOfDeferredRevenueDetails" ], "lang": { "en-us": { "role": { "label": "Pharmanovia [member]", "documentation": "Pharmanovia [member]" } } }, "auth_ref": [] }, "CSCI_PostemploymentBenefitExpenseDefinedBenefitPlan": { "xbrltype": "monetaryItemType", "nsuri": "http://cosciensbio.com/20260331", "localname": "PostemploymentBenefitExpenseDefinedBenefitPlan", "crdr": "debit", "presentation": [ "http://cosciensbio.com/role/SummaryOfNetDefinedBenefitLiabilityAssetDetails" ], "lang": { "en-us": { "role": { "label": "In net loss", "documentation": "Postemployment benefit expense defined benefit plans." } } }, "auth_ref": [] }, "dei_PreCommencementIssuerTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "PreCommencementIssuerTenderOffer", "presentation": [ "http://cosciensbio.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Pre-commencement Issuer Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act." } } }, "auth_ref": [ "r218" ] }, "dei_PreCommencementTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "PreCommencementTenderOffer", "presentation": [ "http://cosciensbio.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Pre-commencement Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act." } } }, "auth_ref": [ "r220" ] }, "CSCI_PrepaidResearchAndDevelopment": { "xbrltype": "monetaryItemType", "nsuri": "http://cosciensbio.com/20260331", "localname": "PrepaidResearchAndDevelopment", "crdr": "debit", "calculation": { "http://cosciensbio.com/role/SummaryOfPrepaidExpensesAndOtherCurrentAssetsDetails": { "parentTag": "ifrs-full_CurrentPrepaymentsAndOtherCurrentAssets", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://cosciensbio.com/role/SummaryOfPrepaidExpensesAndOtherCurrentAssetsDetails" ], "lang": { "en-us": { "role": { "label": "Prepaid research and development", "documentation": "Prepaid research and development." } } }, "auth_ref": [] }, "CSCI_ProceedsFromDeconsolidationOfGermanSubsidiaries": { "xbrltype": "monetaryItemType", "nsuri": "http://cosciensbio.com/20260331", "localname": "ProceedsFromDeconsolidationOfGermanSubsidiaries", "crdr": "credit", "calculation": { "http://cosciensbio.com/role/InterimConsolidatedStatementsOfCashFlows": { "parentTag": "ifrs-full_CashFlowsFromUsedInInvestingActivities", "weight": -1.0, "order": 1.0 } }, "presentation": [ "http://cosciensbio.com/role/InterimConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "negatedLabel": "Deconsolidation of German subsidiaries (note 14)", "documentation": "Proceeds from deconsolidation of German subsidiaries.", "label": "ProceedsFromDeconsolidationOfGermanSubsidiaries" } } }, "auth_ref": [] }, "ifrs-full_ProceedsFromSalesOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "ProceedsFromSalesOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities", "crdr": "debit", "calculation": { "http://cosciensbio.com/role/InterimConsolidatedStatementsOfCashFlows": { "parentTag": "ifrs-full_CashFlowsFromUsedInInvestingActivities", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://cosciensbio.com/role/InterimConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Proceeds on disposal of property and equipment" } }, "en": { "role": { "documentation": "The cash inflow from sales of property, plant and equipment, classified as investing activities. [Refer: Property, plant and equipment]" } } }, "auth_ref": [ "r190" ] }, "ifrs-full_ProfitLoss": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "ProfitLoss", "crdr": "credit", "calculation": { "http://cosciensbio.com/role/InterimConsolidatedStatementsOfIncomeLossAndComprehensiveIncomeLoss": { "parentTag": "ifrs-full_ComprehensiveIncome", "weight": 1.0, "order": 1.0 }, "http://cosciensbio.com/role/InterimConsolidatedStatementsOfCashFlows": { "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivities", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://cosciensbio.com/role/InterimConsolidatedStatementsOfCashFlows", "http://cosciensbio.com/role/InterimConsolidatedStatementsOfChangesInShareholdersEquity", "http://cosciensbio.com/role/InterimConsolidatedStatementsOfIncomeLossAndComprehensiveIncomeLoss", "http://cosciensbio.com/role/SummaryOfPertinentDataRelatingToComputationOfBasicAndDilutedNetLossPerShareDetails" ], "lang": { "en-us": { "role": { "label": "Net profit (loss)", "totalLabel": "Net income (loss)", "verboseLabel": "Net income (loss) for the period", "terseLabel": "Net income (loss)" } }, "en": { "role": { "documentation": "The total of income less expenses from continuing and discontinued operations, excluding the components of other comprehensive income. [Refer: Other comprehensive income]" } } }, "auth_ref": [ "r50", "r51", "r92", "r94", "r126", "r135", "r154", "r174", "r193", "r196" ] }, "ifrs-full_ProfitLossBeforeTax": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "ProfitLossBeforeTax", "crdr": "credit", "calculation": { "http://cosciensbio.com/role/InterimConsolidatedStatementsOfIncomeLossAndComprehensiveIncomeLoss": { "parentTag": "ifrs-full_ProfitLossFromContinuingOperations", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://cosciensbio.com/role/InterimConsolidatedStatementsOfIncomeLossAndComprehensiveIncomeLoss", "http://cosciensbio.com/role/ScheduleOfDiscontinuedProfitOrLossDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Loss before income taxes from continuing operations", "label": "Profit (loss) before tax" } } }, "auth_ref": [ "r81", "r198", "r199", "r203", "r204" ] }, "ifrs-full_ProfitLossFromContinuingOperations": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "ProfitLossFromContinuingOperations", "crdr": "credit", "calculation": { "http://cosciensbio.com/role/InterimConsolidatedStatementsOfIncomeLossAndComprehensiveIncomeLoss": { "parentTag": "ifrs-full_ProfitLoss", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://cosciensbio.com/role/BusinessOverviewDetailsNarrative", "http://cosciensbio.com/role/InterimConsolidatedStatementsOfIncomeLossAndComprehensiveIncomeLoss", "http://cosciensbio.com/role/SummaryOfPertinentDataRelatingToComputationOfBasicAndDilutedNetLossPerShareDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Net loss from continuing operations", "negatedLabel": "Net loss from continuing operations", "label": "Net loss from continuing operations" } }, "en": { "role": { "documentation": "The profit (loss) from continuing operations. [Refer: Continuing operations, unless line item indicates otherwise [member]; Profit (loss)]" } } }, "auth_ref": [ "r59", "r92", "r94", "r174" ] }, "ifrs-full_ProfitLossFromDiscontinuedOperations": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "ProfitLossFromDiscontinuedOperations", "crdr": "credit", "calculation": { "http://cosciensbio.com/role/InterimConsolidatedStatementsOfIncomeLossAndComprehensiveIncomeLoss": { "parentTag": "ifrs-full_ProfitLoss", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://cosciensbio.com/role/DiscontinuedOperationsDetailsNarrative", "http://cosciensbio.com/role/InterimConsolidatedStatementsOfIncomeLossAndComprehensiveIncomeLoss", "http://cosciensbio.com/role/ScheduleOfDiscontinuedProfitOrLossDetails" ], "lang": { "en-us": { "role": { "label": "Income (loss) from discontinued operations, net of tax (note 14)", "totalLabel": "Income (loss) from discontinued operations, net of tax", "verboseLabel": "(Loss) / profit from discontinued operation" } } }, "auth_ref": [ "r60", "r80", "r179", "r183" ] }, "ifrs-full_ProfitLossFromOperatingActivities": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "ProfitLossFromOperatingActivities", "crdr": "credit", "calculation": { "http://cosciensbio.com/role/InterimConsolidatedStatementsOfIncomeLossAndComprehensiveIncomeLoss": { "parentTag": "ifrs-full_ProfitLossBeforeTax", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://cosciensbio.com/role/InterimConsolidatedStatementsOfIncomeLossAndComprehensiveIncomeLoss", "http://cosciensbio.com/role/ScheduleOfDiscontinuedProfitOrLossDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Loss from continuing operations", "label": "Profit (loss) from operating activities" } } }, "auth_ref": [ "r188", "r251" ] }, "ifrs-full_PropertyPlantAndEquipment": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "PropertyPlantAndEquipment", "crdr": "debit", "calculation": { "http://cosciensbio.com/role/InterimConsolidatedStatementsOfFinancialPosition": { "parentTag": "ifrs-full_NoncurrentAssets", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://cosciensbio.com/role/InterimConsolidatedStatementsOfFinancialPosition", "http://cosciensbio.com/role/ScheduleOfDiscontinuedAssetsAndLiabilitiesDetails", "http://cosciensbio.com/role/ScheduleOfPropertyAndEquipmentDetails" ], "lang": { "en-us": { "role": { "label": "Property and equipment (note 6)", "periodStartLabel": "Property and equipment, Beginning", "periodEndLabel": "Property and equipment, Ending" } }, "en": { "role": { "documentation": "The amount of tangible assets that: (a) are held for use in the production or supply of goods or services, for rental to others, or for administrative purposes; and (b) are expected to be used during more than one period. Note that right-of-use assets are not included. [Contrast: Property, plant and equipment including right-of-use assets]" } } }, "auth_ref": [ "r9", "r119", "r158" ] }, "ifrs-full_PropertyPlantAndEquipmentIncludingRightofuseAssets": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "PropertyPlantAndEquipmentIncludingRightofuseAssets", "crdr": "debit", "presentation": [ "http://cosciensbio.com/role/PropertyAndEquipmentDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Right-of-use, net carrying amount of property and equipment" } }, "en": { "role": { "documentation": "The amount of property, plant and equipment including right-of-use assets whose underlying assets would be presented as property, plant and equipment if they were owned. [Refer: Property, plant and equipment; Right-of-use assets]" } } }, "auth_ref": [ "r70", "r232", "r248" ] }, "ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities", "crdr": "credit", "calculation": { "http://cosciensbio.com/role/InterimConsolidatedStatementsOfCashFlows": { "parentTag": "ifrs-full_CashFlowsFromUsedInInvestingActivities", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://cosciensbio.com/role/InterimConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "negatedLabel": "Purchase of property and equipment", "label": "Purchase of property, plant and equipment, classified as investing activities" } }, "en": { "role": { "documentation": "The cash outflow for the purchases of property, plant and equipment, classified as investing activities. [Refer: Property, plant and equipment]" } } }, "auth_ref": [ "r189" ] }, "ifrs-full_RangeAxis": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "RangeAxis", "presentation": [ "http://cosciensbio.com/role/CommitmentsAndContingenciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Range [axis]" } }, "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } } }, "auth_ref": [ "r42", "r67", "r72", "r78", "r106", "r194", "r195", "r241" ] }, "ifrs-full_RangeDomain": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "RangeDomain", "presentation": [ "http://cosciensbio.com/role/CommitmentsAndContingenciesDetailsNarrative" ], "lang": { "en": { "role": { "documentation": "This member stands for aggregate ranges. It also represents the standard value for the 'Range' axis if no other member is used." } } }, "auth_ref": [ "r42", "r67", "r72", "r78", "r106", "r194", "r195", "r241" ] }, "ifrs-full_RawMaterials": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "RawMaterials", "crdr": "debit", "calculation": { "http://cosciensbio.com/role/ScheduleOfInventoriesDetails": { "parentTag": "ifrs-full_Inventories", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://cosciensbio.com/role/ScheduleOfInventoriesDetails" ], "lang": { "en-us": { "role": { "label": "Raw materials" } }, "en": { "role": { "documentation": "A classification of current inventory representing the amount of assets to be consumed in the production process or in the rendering of services. [Refer: Inventories]" } } }, "auth_ref": [ "r201", "r208", "r235" ] }, "ifrs-full_ReclassificationAdjustmentsOnExchangeDifferencesOnTranslationBeforeTax": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "ReclassificationAdjustmentsOnExchangeDifferencesOnTranslationBeforeTax", "crdr": "debit", "presentation": [ "http://cosciensbio.com/role/ScheduleOfDiscontinuedAssetsAndLiabilitiesDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Carrying amount of net liabilities deconsolidated", "label": "Reclassification adjustments on exchange differences on translation of foreign operations, before tax" } }, "en": { "role": { "documentation": "The amount of reclassification adjustments related to exchange differences when the financial statements of foreign operations are translated, before tax. Reclassification adjustments are amounts reclassified to profit (loss) in the current period that were recognised in other comprehensive income in the current or previous periods. [Refer: Other comprehensive income]" } } }, "auth_ref": [ "r23", "r181" ] }, "CSCI_RemeasurementOfPlanAssets": { "xbrltype": "monetaryItemType", "nsuri": "http://cosciensbio.com/20260331", "localname": "RemeasurementOfPlanAssets", "crdr": "credit", "presentation": [ "http://cosciensbio.com/role/SummaryOfNetDefinedBenefitLiabilityAssetDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Remeasurement of plan assets", "documentation": "Remeasurement of plan assets.", "label": "Remeasurement of plan assets" } } }, "auth_ref": [] }, "ifrs-full_ResearchAndDevelopmentExpense": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "ResearchAndDevelopmentExpense", "crdr": "debit", "calculation": { "http://cosciensbio.com/role/InterimConsolidatedStatementsOfIncomeLossAndComprehensiveIncomeLoss": { "parentTag": "ifrs-full_OperatingExpense", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://cosciensbio.com/role/InterimConsolidatedStatementsOfIncomeLossAndComprehensiveIncomeLoss", "http://cosciensbio.com/role/ScheduleOfDiscontinuedProfitOrLossDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Research and development", "label": "Research and development" } } }, "auth_ref": [ "r33", "r129" ] }, "ifrs-full_RestrictedCashAndCashEquivalents": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "RestrictedCashAndCashEquivalents", "crdr": "debit", "calculation": { "http://cosciensbio.com/role/InterimConsolidatedStatementsOfFinancialPosition": { "parentTag": "ifrs-full_NoncurrentAssets", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://cosciensbio.com/role/InterimConsolidatedStatementsOfFinancialPosition", "http://cosciensbio.com/role/ScheduleOfDiscontinuedAssetsAndLiabilitiesDetails" ], "lang": { "en-us": { "role": { "label": "Restricted cash and cash equivalents" } }, "en": { "role": { "documentation": "The amount of cash and cash equivalents whose use or withdrawal is restricted. [Refer: Cash and cash equivalents]" } } }, "auth_ref": [ "r249" ] }, "ifrs-full_RetainedEarnings": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "RetainedEarnings", "crdr": "credit", "calculation": { "http://cosciensbio.com/role/InterimConsolidatedStatementsOfFinancialPosition": { "parentTag": "ifrs-full_EquityAttributableToOwnersOfParent", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://cosciensbio.com/role/BusinessOverviewDetailsNarrative", "http://cosciensbio.com/role/InterimConsolidatedStatementsOfFinancialPosition" ], "lang": { "en-us": { "role": { "label": "Retained earnings (accumulated deficit)", "negatedLabel": "Accumulated deficit" } }, "en": { "role": { "documentation": "A component of equity representing the entity's cumulative undistributed earnings or deficit." } } }, "auth_ref": [ "r202", "r209", "r210" ] }, "ifrs-full_RetainedEarningsMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "RetainedEarningsMember", "presentation": [ "http://cosciensbio.com/role/InterimConsolidatedStatementsOfChangesInShareholdersEquity" ], "lang": { "en-us": { "role": { "label": "Retained earnings [member]" } }, "en": { "role": { "documentation": "This member stands for a component of equity representing an entity's cumulative undistributed earnings or deficit." } } }, "auth_ref": [ "r156", "r205" ] }, "ifrs-full_Revenue": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "Revenue", "crdr": "credit", "calculation": { "http://cosciensbio.com/role/InterimConsolidatedStatementsOfIncomeLossAndComprehensiveIncomeLoss": { "parentTag": "ifrs-full_GrossProfit", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://cosciensbio.com/role/InterimConsolidatedStatementsOfIncomeLossAndComprehensiveIncomeLoss", "http://cosciensbio.com/role/ScheduleOfDiscontinuedProfitOrLossDetails" ], "lang": { "en-us": { "role": { "label": "Revenues (note 3)", "verboseLabel": "Revenues" } } }, "auth_ref": [ "r58", "r81", "r89", "r93", "r98", "r99", "r100", "r176", "r193", "r203", "r204" ] }, "ifrs-full_RevenueFromInterest": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "RevenueFromInterest", "crdr": "credit", "calculation": { "http://cosciensbio.com/role/InterimConsolidatedStatementsOfIncomeLossAndComprehensiveIncomeLoss": { "parentTag": "ifrs-full_FinanceIncomeCost", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://cosciensbio.com/role/InterimConsolidatedStatementsOfIncomeLossAndComprehensiveIncomeLoss" ], "lang": { "en-us": { "role": { "label": "Interest income" } }, "en": { "role": { "documentation": "The amount of income arising from interest." } } }, "auth_ref": [ "r62", "r90", "r97", "r246" ] }, "ifrs-full_RevenueFromSaleOfGoodsRelatedPartyTransactions": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "RevenueFromSaleOfGoodsRelatedPartyTransactions", "crdr": "credit", "presentation": [ "http://cosciensbio.com/role/RevenueDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Revenue from related party" } } }, "auth_ref": [ "r187", "r200" ] }, "dei_Security12bTitle": { "xbrltype": "securityTitleItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "Security12bTitle", "presentation": [ "http://cosciensbio.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Title of 12(b) Security", "documentation": "Title of a 12(b) registered security." } } }, "auth_ref": [ "r212" ] }, "dei_Security12gTitle": { "xbrltype": "securityTitleItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "Security12gTitle", "presentation": [ "http://cosciensbio.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Title of 12(g) Security", "documentation": "Title of a 12(g) registered security." } } }, "auth_ref": [ "r216" ] }, "dei_SecurityExchangeName": { "xbrltype": "edgarExchangeCodeItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "SecurityExchangeName", "presentation": [ "http://cosciensbio.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Security Exchange Name", "documentation": "Name of the Exchange on which a security is registered." } } }, "auth_ref": [ "r215" ] }, "dei_SecurityReportingObligation": { "xbrltype": "securityReportingObligationItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "SecurityReportingObligation", "presentation": [ "http://cosciensbio.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Security Reporting Obligation", "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act." } } }, "auth_ref": [ "r221" ] }, "ifrs-full_SellingGeneralAndAdministrativeExpense": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "SellingGeneralAndAdministrativeExpense", "crdr": "debit", "calculation": { "http://cosciensbio.com/role/InterimConsolidatedStatementsOfIncomeLossAndComprehensiveIncomeLoss": { "parentTag": "ifrs-full_OperatingExpense", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://cosciensbio.com/role/InterimConsolidatedStatementsOfIncomeLossAndComprehensiveIncomeLoss", "http://cosciensbio.com/role/ScheduleOfDiscontinuedProfitOrLossDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Selling, general and administrative", "label": "Selling, general and administrative" } } }, "auth_ref": [ "r251" ] }, "ifrs-full_SharePremium": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "SharePremium", "crdr": "credit", "calculation": { "http://cosciensbio.com/role/InterimConsolidatedStatementsOfFinancialPosition": { "parentTag": "ifrs-full_EquityAttributableToOwnersOfParent", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://cosciensbio.com/role/InterimConsolidatedStatementsOfFinancialPosition" ], "lang": { "en-us": { "role": { "label": "Contributed surplus" } }, "en": { "role": { "documentation": "The amount received or receivable from the issuance of the entity's shares in excess of nominal value." } } }, "auth_ref": [ "r202", "r209" ] }, "ifrs-full_ShorttermEmployeeBenefitsAccruals": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "ShorttermEmployeeBenefitsAccruals", "crdr": "credit", "calculation": { "http://cosciensbio.com/role/SummaryOfDetailedInformationAboutAccountsPayableAndAccruedLiabilitiesDetails": { "parentTag": "ifrs-full_CurrentAccruedExpensesAndOtherCurrentLiabilities", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://cosciensbio.com/role/SummaryOfDetailedInformationAboutAccountsPayableAndAccruedLiabilitiesDetails" ], "lang": { "en-us": { "role": { "label": "Accrued employee benefits" } }, "en": { "role": { "documentation": "The amount of accruals for employee benefits (other than termination benefits) that are expected to be settled wholly within twelve months after the end of the annual reporting period in which the employees render the related services. [Refer: Accruals classified as current]" } } }, "auth_ref": [ "r250" ] }, "dei_SolicitingMaterial": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "SolicitingMaterial", "presentation": [ "http://cosciensbio.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Soliciting Material", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act." } } }, "auth_ref": [ "r219" ] }, "ifrs-full_StatementOfCashFlowsAbstract": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "StatementOfCashFlowsAbstract", "lang": { "en-us": { "role": { "label": "Statement of cash flows [abstract]" } } }, "auth_ref": [] }, "ifrs-full_StatementOfChangesInEquityAbstract": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "StatementOfChangesInEquityAbstract", "auth_ref": [] }, "ifrs-full_StatementOfChangesInEquityTable": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "StatementOfChangesInEquityTable", "presentation": [ "http://cosciensbio.com/role/InterimConsolidatedStatementsOfChangesInShareholdersEquity", "http://cosciensbio.com/role/SummaryOfShareCapitalDetails" ], "lang": { "en-us": { "role": { "label": "Statement of changes in equity [table]" } }, "en": { "role": { "documentation": "Schedule disclosing information related to changes in equity." } } }, "auth_ref": [ "r156" ] }, "ifrs-full_StatementOfChangesInNetAssetsAvailableForBenefitsAbstract": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "StatementOfChangesInNetAssetsAvailableForBenefitsAbstract", "presentation": [ "http://cosciensbio.com/role/SummaryOfNetDefinedBenefitLiabilityAssetDetails" ], "lang": { "en-us": { "role": { "label": "Change in plan assets" } } }, "auth_ref": [] }, "ifrs-full_StatementOfFinancialPositionAbstract": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "StatementOfFinancialPositionAbstract", "lang": { "en-us": { "role": { "label": "Statement of financial position [abstract]" } } }, "auth_ref": [] }, "CSCI_StockOptionsAndDeferredStockUnitsMember": { "xbrltype": "domainItemType", "nsuri": "http://cosciensbio.com/20260331", "localname": "StockOptionsAndDeferredStockUnitsMember", "presentation": [ "http://cosciensbio.com/role/SummaryOfPertinentDataRelatingToComputationOfBasicAndDilutedNetLossPerShareDetails" ], "lang": { "en-us": { "role": { "label": "Stock options and DSUs [Member]", "documentation": "Stock options and DSUs [Member]" } } }, "auth_ref": [] }, "ifrs-full_TopOfRangeMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "TopOfRangeMember", "presentation": [ "http://cosciensbio.com/role/CommitmentsAndContingenciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Top of range [member]" } }, "en": { "role": { "documentation": "This member stands for top of a range." } } }, "auth_ref": [ "r42", "r67", "r72", "r78", "r106", "r194", "r195", "r241" ] }, "ifrs-full_TradeAndOtherCurrentPayablesToTradeSuppliers": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "TradeAndOtherCurrentPayablesToTradeSuppliers", "crdr": "credit", "calculation": { "http://cosciensbio.com/role/SummaryOfDetailedInformationAboutAccountsPayableAndAccruedLiabilitiesDetails": { "parentTag": "ifrs-full_CurrentAccruedExpensesAndOtherCurrentLiabilities", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://cosciensbio.com/role/SummaryOfDetailedInformationAboutAccountsPayableAndAccruedLiabilitiesDetails" ], "lang": { "en-us": { "role": { "label": "Trade accounts payable" } }, "en": { "role": { "documentation": "The current amount of payment due to suppliers for goods and services used in entity's business. [Refer: Current liabilities; Trade payables]" } } }, "auth_ref": [ "r207", "r250" ] }, "ifrs-full_TradeAndOtherCurrentReceivables": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "TradeAndOtherCurrentReceivables", "crdr": "debit", "calculation": { "http://cosciensbio.com/role/InterimConsolidatedStatementsOfFinancialPosition": { "parentTag": "ifrs-full_CurrentAssets", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://cosciensbio.com/role/InterimConsolidatedStatementsOfFinancialPosition", "http://cosciensbio.com/role/ScheduleOfDiscontinuedAssetsAndLiabilitiesDetails" ], "lang": { "en-us": { "role": { "label": "Trade and other receivables" } }, "en": { "role": { "documentation": "The amount of current trade receivables and current other receivables. [Refer: Current trade receivables; Other current receivables]" } } }, "auth_ref": [ "r150", "r161", "r170" ] }, "dei_TradingSymbol": { "xbrltype": "tradingSymbolItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "TradingSymbol", "presentation": [ "http://cosciensbio.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Trading Symbol", "documentation": "Trading symbol of an instrument as listed on an exchange." } } }, "auth_ref": [] }, "ifrs-full_TypesOfAntidilutiveInstrumentsAxis": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "TypesOfAntidilutiveInstrumentsAxis", "presentation": [ "http://cosciensbio.com/role/ScheduleOfWarrantsOutstandingDetails", "http://cosciensbio.com/role/SummaryOfPertinentDataRelatingToComputationOfBasicAndDilutedNetLossPerShareDetails" ], "lang": { "en-us": { "role": { "label": "Types of antidilutive instruments [axis]" } }, "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } } }, "auth_ref": [ "r30" ] }, "ifrs-full_TypesOfAntidilutiveInstrumentsDomain": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "TypesOfAntidilutiveInstrumentsDomain", "presentation": [ "http://cosciensbio.com/role/ScheduleOfWarrantsOutstandingDetails", "http://cosciensbio.com/role/SummaryOfPertinentDataRelatingToComputationOfBasicAndDilutedNetLossPerShareDetails" ], "lang": { "en": { "role": { "documentation": "This member stands for antidilutive instruments. Instruments are antidilutive when their conversion to ordinary shares would increase earnings per share or decrease loss per share from continuing operations. The calculation of diluted earnings per share does not assume conversion, exercise, or other issue of potential ordinary shares that would have an antidilutive effect on earnings per share. It also represents the standard value for the \u2018Types of antidilutive instruments' axis if no other member is used." } } }, "auth_ref": [ "r30" ] }, "CSCI_UnrecognizedAssetDueToAssetCeiling": { "xbrltype": "monetaryItemType", "nsuri": "http://cosciensbio.com/20260331", "localname": "UnrecognizedAssetDueToAssetCeiling", "crdr": "credit", "presentation": [ "http://cosciensbio.com/role/SummaryOfNetDefinedBenefitLiabilityAssetDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Unrecognized Asset due to Asset Ceiling", "documentation": "Unrecognized asset due to asset ceiling.", "label": "UnrecognizedAssetDueToAssetCeiling" } } }, "auth_ref": [] }, "CSCI_WarrantsAndRightExercised": { "xbrltype": "monetaryItemType", "nsuri": "http://cosciensbio.com/20260331", "localname": "WarrantsAndRightExercised", "crdr": "credit", "presentation": [ "http://cosciensbio.com/role/SummaryOfWarrantsActivityReclassifiedEquityDetails" ], "lang": { "en-us": { "role": { "label": "Warrants outstanding, exercised, value", "documentation": "Warrants and right exercised." } } }, "auth_ref": [] }, "CSCI_WarrantsAndRightExpired": { "xbrltype": "monetaryItemType", "nsuri": "http://cosciensbio.com/20260331", "localname": "WarrantsAndRightExpired", "crdr": "credit", "presentation": [ "http://cosciensbio.com/role/SummaryOfWarrantsActivityReclassifiedEquityDetails" ], "lang": { "en-us": { "role": { "label": "Warrants outstanding, expired, value", "documentation": "Warrants and right expired." } } }, "auth_ref": [] }, "CSCI_WarrantsAndRightOutstanding": { "xbrltype": "monetaryItemType", "nsuri": "http://cosciensbio.com/20260331", "localname": "WarrantsAndRightOutstanding", "crdr": "credit", "presentation": [ "http://cosciensbio.com/role/SummaryOfWarrantsActivityReclassifiedEquityDetails" ], "lang": { "en-us": { "role": { "periodStartLabel": "Warrants outstanding, beginning of year, value", "periodEndLabel": "Warrants outstanding, ending of year, value", "documentation": "Warrants and right outstanding.", "label": "WarrantsAndRightOutstanding" } } }, "auth_ref": [] }, "ifrs-full_WarrantsMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "WarrantsMember", "presentation": [ "http://cosciensbio.com/role/ScheduleOfWarrantsOutstandingDetails", "http://cosciensbio.com/role/SummaryOfPertinentDataRelatingToComputationOfBasicAndDilutedNetLossPerShareDetails" ], "lang": { "en-us": { "role": { "label": "Warrants [member]" } }, "en": { "role": { "documentation": "This member stands for warrants." } } }, "auth_ref": [ "r236" ] }, "ifrs-full_WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019": { "xbrltype": "perShareItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019", "presentation": [ "http://cosciensbio.com/role/SummaryOfNumberAndWeightedAverageExercisePricesOfOptionsDetails" ], "lang": { "en-us": { "role": { "label": "Weighted average exercise price, cancelled/forfeited" } }, "en": { "role": { "documentation": "The weighted average exercise price of share options forfeited in a share-based payment arrangement. [Refer: Weighted average [member]]" } } }, "auth_ref": [ "r75", "r138" ] }, "ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019": { "xbrltype": "perShareItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019", "presentation": [ "http://cosciensbio.com/role/SummaryOfNumberAndWeightedAverageExercisePricesOfOptionsDetails" ], "lang": { "en-us": { "role": { "periodStartLabel": "Weighted average exercise price, beginning", "periodEndLabel": "Weighted average exercise price, ending", "label": "Weighted average exercise price of share options outstanding in share-based payment arrangement" } }, "en": { "role": { "documentation": "The weighted average exercise price of share options outstanding in a share-based payment arrangement. [Refer: Weighted average [member]]" } } }, "auth_ref": [ "r73", "r76", "r136", "r139" ] }, "CSCI_WeightedAverageRemainingContractualLifeOfOutstandingShareWarrant2019": { "xbrltype": "durationItemType", "nsuri": "http://cosciensbio.com/20260331", "localname": "WeightedAverageRemainingContractualLifeOfOutstandingShareWarrant2019", "presentation": [ "http://cosciensbio.com/role/ScheduleOfWarrantsOutstandingDetails" ], "lang": { "en-us": { "role": { "label": "Warrant outstanding, Weighted average remaining contractual life (years)", "documentation": "Weighted average remaining contractual life of outstanding share warrant2019" } } }, "auth_ref": [] }, "ifrs-full_WeightedAverageShares": { "xbrltype": "sharesItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "WeightedAverageShares", "presentation": [ "http://cosciensbio.com/role/InterimConsolidatedStatementsOfIncomeLossAndComprehensiveIncomeLoss", "http://cosciensbio.com/role/SummaryOfPertinentDataRelatingToComputationOfBasicAndDilutedNetLossPerShareDetails" ], "lang": { "en-us": { "role": { "label": "Weighted average number of shares outstanding (basic)", "verboseLabel": "Weighted-average shares outstanding (basic)" } }, "en": { "role": { "documentation": "The number of ordinary shares outstanding at the beginning of the period, adjusted by the number of ordinary shares bought back or issued during the period multiplied by a time-weighting factor." } } }, "auth_ref": [ "r29" ] }, "ifrs-full_WeightedAverageSharesAndAdjustedWeightedAverageSharesAbstract": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "WeightedAverageSharesAndAdjustedWeightedAverageSharesAbstract", "presentation": [ "http://cosciensbio.com/role/SummaryOfPertinentDataRelatingToComputationOfBasicAndDilutedNetLossPerShareDetails" ], "lang": { "en-us": { "role": { "label": "Items excluded from the calculation of diluted net loss per share due to their anti-dilutive effect:" } } }, "auth_ref": [] }, "ifrs-full_WorkInProgress": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "WorkInProgress", "crdr": "debit", "calculation": { "http://cosciensbio.com/role/ScheduleOfInventoriesDetails": { "parentTag": "ifrs-full_Inventories", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://cosciensbio.com/role/ScheduleOfInventoriesDetails" ], "lang": { "en-us": { "role": { "label": "Work in progress" } }, "en": { "role": { "documentation": "A classification of current inventory representing the amount of assets currently in production, which require further processes to be converted into finished goods or services. [Refer: Current finished goods; Inventories]" } } }, "auth_ref": [ "r201", "r208", "r235" ] }, "dei_WrittenCommunications": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "WrittenCommunications", "presentation": [ "http://cosciensbio.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Written Communications", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act." } } }, "auth_ref": [ "r229" ] } } } }, "std_ref": { "r0": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "12", "IssueDate": "2025-01-01", "Paragraph": "79", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=12&code=ifrs-tx-2025-en-r&anchor=para_79&doctype=Standard", "URIDate": "2025-03-27" }, "r1": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "12", "IssueDate": "2025-01-01", "Paragraph": "81", "Subparagraph": "c", "Clause": "i", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=12&code=ifrs-tx-2025-en-r&anchor=para_81_c_i&doctype=Standard", "URIDate": "2025-03-27" }, "r2": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "12", "IssueDate": "2025-01-01", "Paragraph": "81", "Subparagraph": "c", "Clause": "ii", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=12&code=ifrs-tx-2025-en-r&anchor=para_81_c_ii&doctype=Standard", "URIDate": "2025-03-27" }, "r3": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "12", "IssueDate": "2025-01-01", "Section": "Disclosure", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=12&code=ifrs-tx-2025-en-r&doctype=Standard&dita_xref=IAS12_g79-88_TI", "URIDate": "2025-03-27" }, "r4": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "16", "IssueDate": "2025-01-01", "Paragraph": "73", "Subparagraph": "d", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=16&code=ifrs-tx-2025-en-r&anchor=para_73_d&doctype=Standard", "URIDate": "2025-03-27" }, "r5": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "16", "IssueDate": "2025-01-01", "Paragraph": "73", "Subparagraph": "e", "Clause": "i", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=16&code=ifrs-tx-2025-en-r&anchor=para_73_e_i&doctype=Standard", "URIDate": "2025-03-27" }, "r6": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "16", "IssueDate": "2025-01-01", "Paragraph": "73", "Subparagraph": "e", "Clause": "ii", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=16&code=ifrs-tx-2025-en-r&anchor=para_73_e_ii&doctype=Standard", "URIDate": "2025-03-27" }, "r7": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "16", "IssueDate": "2025-01-01", "Paragraph": "73", "Subparagraph": "e", "Clause": "ix", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=16&code=ifrs-tx-2025-en-r&anchor=para_73_e_ix&doctype=Standard", "URIDate": "2025-03-27" }, "r8": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "16", "IssueDate": "2025-01-01", "Paragraph": "73", "Subparagraph": "e", "Clause": "viii", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=16&code=ifrs-tx-2025-en-r&anchor=para_73_e_viii&doctype=Standard", "URIDate": "2025-03-27" }, "r9": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "16", "IssueDate": "2025-01-01", "Paragraph": "73", "Subparagraph": "e", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=16&code=ifrs-tx-2025-en-r&anchor=para_73_e&doctype=Standard", "URIDate": "2025-03-27" }, "r10": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "16", "IssueDate": "2025-01-01", "Paragraph": "73", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=16&code=ifrs-tx-2025-en-r&anchor=para_73&doctype=Standard", "URIDate": "2025-03-27" }, "r11": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "16", "IssueDate": "2025-01-01", "Section": "Disclosure", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=16&code=ifrs-tx-2025-en-r&doctype=Standard&dita_xref=IAS16_g73-79_TI", "URIDate": "2025-03-27" }, "r12": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "19", "IssueDate": "2025-01-01", "Paragraph": "138", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=19&code=ifrs-tx-2025-en-r&anchor=para_138&doctype=Standard", "URIDate": "2025-03-27" }, "r13": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "19", "IssueDate": "2025-01-01", "Paragraph": "140", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=19&code=ifrs-tx-2025-en-r&anchor=para_140_a&doctype=Standard", "URIDate": "2025-03-27" }, "r14": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "19", "IssueDate": "2025-01-01", "Paragraph": "141", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=19&code=ifrs-tx-2025-en-r&anchor=para_141_b&doctype=Standard", "URIDate": "2025-03-27" }, "r15": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "19", "IssueDate": "2025-01-01", "Paragraph": "141", "Subparagraph": "c", "Clause": "iii", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=19&code=ifrs-tx-2025-en-r&anchor=para_141_c_iii&doctype=Standard", "URIDate": "2025-03-27" }, "r16": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "19", "IssueDate": "2025-01-01", "Paragraph": "141", "Subparagraph": "c", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=19&code=ifrs-tx-2025-en-r&anchor=para_141_c&doctype=Standard", "URIDate": "2025-03-27" }, "r17": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "19", "IssueDate": "2025-01-01", "Paragraph": "141", "Subparagraph": "e", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=19&code=ifrs-tx-2025-en-r&anchor=para_141_e&doctype=Standard", "URIDate": "2025-03-27" }, "r18": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "19", "IssueDate": "2025-01-01", "Paragraph": "141", "Subparagraph": "g", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=19&code=ifrs-tx-2025-en-r&anchor=para_141_g&doctype=Standard", "URIDate": "2025-03-27" }, "r19": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "19", "IssueDate": "2025-01-01", "Paragraph": "141", "Subparagraph": "h", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=19&code=ifrs-tx-2025-en-r&anchor=para_141_h&doctype=Standard", "URIDate": "2025-03-27" }, "r20": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "19", "IssueDate": "2025-01-01", "Section": "Scope", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=19&code=ifrs-tx-2025-en-r&doctype=Standard&dita_xref=IAS19_g2-7_TI", "URIDate": "2025-03-27" }, "r21": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "2", "IssueDate": "2025-01-01", "Paragraph": "36", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=2&code=ifrs-tx-2025-en-r&anchor=para_36_b&doctype=Standard", "URIDate": "2025-03-27" }, "r22": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "2", "IssueDate": "2025-01-01", "Section": "Disclosure", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=2&code=ifrs-tx-2025-en-r&doctype=Standard&dita_xref=IAS02_g36-39_TI", "URIDate": "2025-03-27" }, "r23": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "21", "IssueDate": "2025-01-01", "Paragraph": "48", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=21&code=ifrs-tx-2025-en-r&anchor=para_48&doctype=Standard", "URIDate": "2025-03-27" }, "r24": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "21", "IssueDate": "2025-01-01", "Paragraph": "52", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=21&code=ifrs-tx-2025-en-r&anchor=para_52_a&doctype=Standard", "URIDate": "2025-03-27" }, "r25": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "26", "IssueDate": "2025-01-01", "Paragraph": "35", "Subparagraph": "a", "Clause": "i", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=26&code=ifrs-tx-2025-en-r&anchor=para_35_a_i&doctype=Standard", "URIDate": "2025-03-27" }, "r26": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "26", "IssueDate": "2025-01-01", "Paragraph": "35", "Subparagraph": "b", "Clause": "viii", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=26&code=ifrs-tx-2025-en-r&anchor=para_35_b_viii&doctype=Standard", "URIDate": "2025-03-27" }, "r27": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "33", "IssueDate": "2025-01-01", "Paragraph": "66", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=33&code=ifrs-tx-2025-en-r&anchor=para_66&doctype=Standard", "URIDate": "2025-03-27" }, "r28": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "33", "IssueDate": "2025-01-01", "Paragraph": "67", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=33&code=ifrs-tx-2025-en-r&anchor=para_67&doctype=Standard", "URIDate": "2025-03-27" }, "r29": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "33", "IssueDate": "2025-01-01", "Paragraph": "70", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=33&code=ifrs-tx-2025-en-r&anchor=para_70_b&doctype=Standard", "URIDate": "2025-03-27" }, "r30": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "33", "IssueDate": "2025-01-01", "Paragraph": "70", "Subparagraph": "c", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=33&code=ifrs-tx-2025-en-r&anchor=para_70_c&doctype=Standard", "URIDate": "2025-03-27" }, "r31": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "38", "IssueDate": "2025-01-01", "Paragraph": "118", "Subparagraph": "c", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=38&code=ifrs-tx-2025-en-r&anchor=para_118_c&doctype=Standard", "URIDate": "2025-03-27" }, "r32": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "38", "IssueDate": "2025-01-01", "Paragraph": "118", "Subparagraph": "e", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=38&code=ifrs-tx-2025-en-r&anchor=para_118_e&doctype=Standard", "URIDate": "2025-03-27" }, "r33": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "38", "IssueDate": "2025-01-01", "Paragraph": "126", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=38&code=ifrs-tx-2025-en-r&anchor=para_126&doctype=Standard", "URIDate": "2025-03-27" }, "r34": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "40", "IssueDate": "2025-01-01", "Paragraph": "76", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=40&code=ifrs-tx-2025-en-r&anchor=para_76&doctype=Standard", "URIDate": "2025-03-27" }, "r35": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "40", "IssueDate": "2025-01-01", "Paragraph": "79", "Subparagraph": "c", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=40&code=ifrs-tx-2025-en-r&anchor=para_79_c&doctype=Standard", "URIDate": "2025-03-27" }, "r36": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "40", "IssueDate": "2025-01-01", "Paragraph": "79", "Subparagraph": "d", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=40&code=ifrs-tx-2025-en-r&anchor=para_79_d&doctype=Standard", "URIDate": "2025-03-27" }, "r37": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "41", "IssueDate": "2025-01-01", "Paragraph": "50", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=41&code=ifrs-tx-2025-en-r&anchor=para_50&doctype=Standard", "URIDate": "2025-03-27" }, "r38": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "41", "IssueDate": "2025-01-01", "Paragraph": "54", "Subparagraph": "f", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=41&code=ifrs-tx-2025-en-r&anchor=para_54_f&doctype=Standard", "URIDate": "2025-03-27" }, "r39": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "7", "IssueDate": "2025-01-01", "Paragraph": "10", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2025-en-r&anchor=para_10&doctype=Standard", "URIDate": "2025-03-27" }, "r40": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "7", "IssueDate": "2025-01-01", "Paragraph": "25", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2025-en-r&anchor=para_25&doctype=Standard", "URIDate": "2025-03-27" }, "r41": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "7", "IssueDate": "2025-01-01", "Paragraph": "28", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2025-en-r&anchor=para_28&doctype=Standard", "URIDate": "2025-03-27" }, "r42": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "7", "IssueDate": "2025-01-01", "Paragraph": "44H", "Subparagraph": "b", "Clause": "iii", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2025-en-r&anchor=para_44H_b_iii&doctype=Standard", "URIDate": "2025-03-27" }, "r43": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "7", "IssueDate": "2025-01-01", "Paragraph": "45", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2025-en-r&anchor=para_45&doctype=Standard", "URIDate": "2025-03-27" }, "r44": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "7", "IssueDate": "2025-01-01", "Paragraph": "50", "Subparagraph": "d", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2025-en-r&anchor=para_50_d&doctype=Standard", "URIDate": "2025-03-27" }, "r45": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "7", "IssueDate": "2025-01-01", "Section": "Presentation of a statement of cash flows", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2025-en-r&doctype=Standard&dita_xref=IAS07_g10-17_TI", "URIDate": "2025-03-27" }, "r46": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "8", "IssueDate": "2025-01-01", "Paragraph": "28", "Subparagraph": "f", "Clause": "i", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=8&code=ifrs-tx-2025-en-r&anchor=para_28_f_i&doctype=Standard", "URIDate": "2025-03-27" }, "r47": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "8", "IssueDate": "2025-01-01", "Paragraph": "28", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=8&code=ifrs-tx-2025-en-r&anchor=para_28&doctype=Standard", "URIDate": "2025-03-27" }, "r48": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "8", "IssueDate": "2025-01-01", "Paragraph": "29", "Subparagraph": "c", "Clause": "i", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=8&code=ifrs-tx-2025-en-r&anchor=para_29_c_i&doctype=Standard", "URIDate": "2025-03-27" }, "r49": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "8", "IssueDate": "2025-01-01", "Paragraph": "49", "Subparagraph": "b", "Clause": "i", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=8&code=ifrs-tx-2025-en-r&anchor=para_49_b_i&doctype=Standard", "URIDate": "2025-03-27" }, "r50": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "1", "IssueDate": "2025-01-01", "Paragraph": "24", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=1&code=ifrs-tx-2025-en-r&anchor=para_24_b&doctype=Standard", "URIDate": "2025-03-27" }, "r51": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "1", "IssueDate": "2025-01-01", "Paragraph": "32", "Subparagraph": "a", "Clause": "ii", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=1&code=ifrs-tx-2025-en-r&anchor=para_32_a_ii&doctype=Standard", "URIDate": "2025-03-27" }, "r52": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "12", "IssueDate": "2025-01-01", "Paragraph": "19", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2025-en-r&anchor=para_19&doctype=Standard", "URIDate": "2025-03-27" }, "r53": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "12", "IssueDate": "2025-01-01", "Paragraph": "B12", "Subparagraph": "b", "Clause": "i", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2025-en-r&anchor=para_B12_b_i&doctype=Appendix&subtype=B", "URIDate": "2025-03-27" }, "r54": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "12", "IssueDate": "2025-01-01", "Paragraph": "B12", "Subparagraph": "b", "Clause": "ii", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2025-en-r&anchor=para_B12_b_ii&doctype=Appendix&subtype=B", "URIDate": "2025-03-27" }, "r55": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "12", "IssueDate": "2025-01-01", "Paragraph": "B12", "Subparagraph": "b", "Clause": "iii", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2025-en-r&anchor=para_B12_b_iii&doctype=Appendix&subtype=B", "URIDate": "2025-03-27" }, "r56": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "12", "IssueDate": "2025-01-01", "Paragraph": "B12", "Subparagraph": "b", "Clause": "iv", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2025-en-r&anchor=para_B12_b_iv&doctype=Appendix&subtype=B", "URIDate": "2025-03-27" }, "r57": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "12", "IssueDate": "2025-01-01", "Paragraph": "B12", "Subparagraph": "b", "Clause": "ix", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2025-en-r&anchor=para_B12_b_ix&doctype=Appendix&subtype=B", "URIDate": "2025-03-27" }, "r58": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "12", "IssueDate": "2025-01-01", "Paragraph": "B12", "Subparagraph": "b", "Clause": "v", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2025-en-r&anchor=para_B12_b_v&doctype=Appendix&subtype=B", "URIDate": "2025-03-27" }, "r59": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "12", "IssueDate": "2025-01-01", "Paragraph": "B12", "Subparagraph": "b", "Clause": "vi", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2025-en-r&anchor=para_B12_b_vi&doctype=Appendix&subtype=B", "URIDate": "2025-03-27" }, "r60": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "12", "IssueDate": "2025-01-01", "Paragraph": "B12", "Subparagraph": "b", "Clause": "vii", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2025-en-r&anchor=para_B12_b_vii&doctype=Appendix&subtype=B", "URIDate": "2025-03-27" }, "r61": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "12", "IssueDate": "2025-01-01", "Paragraph": "B13", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2025-en-r&anchor=para_B13_a&doctype=Appendix&subtype=B", "URIDate": "2025-03-27" }, "r62": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "12", "IssueDate": "2025-01-01", "Paragraph": "B13", "Subparagraph": "e", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2025-en-r&anchor=para_B13_e&doctype=Appendix&subtype=B", "URIDate": "2025-03-27" }, "r63": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "12", "IssueDate": "2025-01-01", "Paragraph": "B13", "Subparagraph": "g", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2025-en-r&anchor=para_B13_g&doctype=Appendix&subtype=B", "URIDate": "2025-03-27" }, "r64": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "13", "IssueDate": "2025-01-01", "Paragraph": "93", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=13&code=ifrs-tx-2025-en-r&anchor=para_93_a&doctype=Standard", "URIDate": "2025-03-27" }, "r65": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "13", "IssueDate": "2025-01-01", "Paragraph": "93", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=13&code=ifrs-tx-2025-en-r&anchor=para_93_b&doctype=Standard", "URIDate": "2025-03-27" }, "r66": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "13", "IssueDate": "2025-01-01", "Paragraph": "93", "Subparagraph": "e", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=13&code=ifrs-tx-2025-en-r&anchor=para_93_e&doctype=Standard", "URIDate": "2025-03-27" }, "r67": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "14", "IssueDate": "2025-01-01", "Paragraph": "33", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=14&code=ifrs-tx-2025-en-r&anchor=para_33_b&doctype=Standard", "URIDate": "2025-03-27" }, "r68": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "15", "IssueDate": "2025-01-01", "Paragraph": "105", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=15&code=ifrs-tx-2025-en-r&anchor=para_105&doctype=Standard", "URIDate": "2025-03-27" }, "r69": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "15", "IssueDate": "2025-01-01", "Paragraph": "116", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=15&code=ifrs-tx-2025-en-r&anchor=para_116_a&doctype=Standard", "URIDate": "2025-03-27" }, "r70": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "16", "IssueDate": "2025-01-01", "Paragraph": "47", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2025-en-r&anchor=para_47_a&doctype=Standard", "URIDate": "2025-03-27" }, "r71": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "16", "IssueDate": "2025-01-01", "Paragraph": "47", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2025-en-r&anchor=para_47_b&doctype=Standard", "URIDate": "2025-03-27" }, "r72": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "17", "IssueDate": "2025-01-01", "Paragraph": "120", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=17&code=ifrs-tx-2025-en-r&anchor=para_120&doctype=Standard", "URIDate": "2025-03-27" }, "r73": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "2", "IssueDate": "2025-01-01", "Paragraph": "45", "Subparagraph": "b", "Clause": "i", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2025-en-r&anchor=para_45_b_i&doctype=Standard", "URIDate": "2025-03-27" }, "r74": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "2", "IssueDate": "2025-01-01", "Paragraph": "45", "Subparagraph": "b", "Clause": "ii", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2025-en-r&anchor=para_45_b_ii&doctype=Standard", "URIDate": "2025-03-27" }, "r75": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "2", "IssueDate": "2025-01-01", "Paragraph": "45", "Subparagraph": "b", "Clause": "iii", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2025-en-r&anchor=para_45_b_iii&doctype=Standard", "URIDate": "2025-03-27" }, "r76": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "2", "IssueDate": "2025-01-01", "Paragraph": "45", "Subparagraph": "b", "Clause": "vi", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2025-en-r&anchor=para_45_b_vi&doctype=Standard", "URIDate": "2025-03-27" }, "r77": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "2", "IssueDate": "2025-01-01", "Paragraph": "45", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2025-en-r&anchor=para_45_b&doctype=Standard", "URIDate": "2025-03-27" }, "r78": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "2", "IssueDate": "2025-01-01", "Paragraph": "45", "Subparagraph": "d", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2025-en-r&anchor=para_45_d&doctype=Standard", "URIDate": "2025-03-27" }, "r79": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "3", "IssueDate": "2025-01-01", "Paragraph": "B67", "Subparagraph": "d", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=3&code=ifrs-tx-2025-en-r&anchor=para_B67_d&doctype=Appendix&subtype=B", "URIDate": "2025-03-27" }, "r80": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "5", "IssueDate": "2025-01-01", "Paragraph": "33", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=5&code=ifrs-tx-2025-en-r&anchor=para_33_a&doctype=Standard", "URIDate": "2025-03-27" }, "r81": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "5", "IssueDate": "2025-01-01", "Paragraph": "33", "Subparagraph": "b", "Clause": "i", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=5&code=ifrs-tx-2025-en-r&anchor=para_33_b_i&doctype=Standard", "URIDate": "2025-03-27" }, "r82": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "5", "IssueDate": "2025-01-01", "Paragraph": "33", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=5&code=ifrs-tx-2025-en-r&anchor=para_33_b&doctype=Standard", "URIDate": "2025-03-27" }, "r83": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "5", "IssueDate": "2025-01-01", "Section": "Presentation and disclosure", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=5&code=ifrs-tx-2025-en-r&doctype=Standard&dita_xref=IFRS05_g30-42_TI", "URIDate": "2025-03-27" }, "r84": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "7", "IssueDate": "2025-01-01", "Paragraph": "13C", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2025-en-r&anchor=para_13C&doctype=Standard", "URIDate": "2025-03-27" }, "r85": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "7", "IssueDate": "2025-01-01", "Paragraph": "35H", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2025-en-r&anchor=para_35H&doctype=Standard", "URIDate": "2025-03-27" }, "r86": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "7", "IssueDate": "2025-01-01", "Paragraph": "35I", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2025-en-r&anchor=para_35I&doctype=Standard", "URIDate": "2025-03-27" }, "r87": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "7", "IssueDate": "2025-01-01", "Paragraph": "35M", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2025-en-r&anchor=para_35M&doctype=Standard", "URIDate": "2025-03-27" }, "r88": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "7", "IssueDate": "2025-01-01", "Paragraph": "B52", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2025-en-r&anchor=para_B52&doctype=Appendix&subtype=B", "URIDate": "2025-03-27" }, "r89": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "8", "IssueDate": "2025-01-01", "Paragraph": "23", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2025-en-r&anchor=para_23_a&doctype=Standard", "URIDate": "2025-03-27" }, "r90": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "8", "IssueDate": "2025-01-01", "Paragraph": "23", "Subparagraph": "c", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2025-en-r&anchor=para_23_c&doctype=Standard", "URIDate": "2025-03-27" }, "r91": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "8", "IssueDate": "2025-01-01", "Paragraph": "23", "Subparagraph": "h", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2025-en-r&anchor=para_23_h&doctype=Standard", "URIDate": "2025-03-27" }, "r92": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "8", "IssueDate": "2025-01-01", "Paragraph": "23", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2025-en-r&anchor=para_23&doctype=Standard", "URIDate": "2025-03-27" }, "r93": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "8", "IssueDate": "2025-01-01", "Paragraph": "28", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2025-en-r&anchor=para_28_a&doctype=Standard", "URIDate": "2025-03-27" }, "r94": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "8", "IssueDate": "2025-01-01", "Paragraph": "28", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2025-en-r&anchor=para_28_b&doctype=Standard", "URIDate": "2025-03-27" }, "r95": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "8", "IssueDate": "2025-01-01", "Paragraph": "28", "Subparagraph": "c", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2025-en-r&anchor=para_28_c&doctype=Standard", "URIDate": "2025-03-27" }, "r96": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "8", "IssueDate": "2025-01-01", "Paragraph": "28", "Subparagraph": "d", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2025-en-r&anchor=para_28_d&doctype=Standard", "URIDate": "2025-03-27" }, "r97": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "8", "IssueDate": "2025-01-01", "Paragraph": "28", "Subparagraph": "e", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2025-en-r&anchor=para_28_e&doctype=Standard", "URIDate": "2025-03-27" }, "r98": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "8", "IssueDate": "2025-01-01", "Paragraph": "32", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2025-en-r&anchor=para_32&doctype=Standard", "URIDate": "2025-03-27" }, "r99": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "8", "IssueDate": "2025-01-01", "Paragraph": "33", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2025-en-r&anchor=para_33_a&doctype=Standard", "URIDate": "2025-03-27" }, "r100": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "8", "IssueDate": "2025-01-01", "Paragraph": "34", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2025-en-r&anchor=para_34&doctype=Standard", "URIDate": "2025-03-27" }, "r101": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "8", "IssueDate": "2025-01-01", "Section": "Disclosure", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2025-en-r&doctype=Standard&dita_xref=IFRS08_g20-24_TI", "URIDate": "2025-03-27" }, "r102": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Effective 2027-01-01", "Name": "IFRS", "Number": "19", "IssueDate": "2025-01-01", "Paragraph": "105", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_105_a&doctype=Standard", "URIDate": "2025-03-27" }, "r103": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Effective 2027-01-01", "Name": "IFRS", "Number": "19", "IssueDate": "2025-01-01", "Paragraph": "160", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_160_a&doctype=Standard", "URIDate": "2025-03-27" }, "r104": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Effective 2027-01-01", "Name": "IFRS", "Number": "19", "IssueDate": "2025-01-01", "Paragraph": "160", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_160&doctype=Standard", "URIDate": "2025-03-27" }, "r105": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Effective 2027-01-01", "Name": "IFRS", "Number": "19", "IssueDate": "2025-01-01", "Paragraph": "164", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_164_b&doctype=Standard", "URIDate": "2025-03-27" }, "r106": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Effective 2027-01-01", "Name": "IFRS", "Number": "19", "IssueDate": "2025-01-01", "Paragraph": "168", "Subparagraph": "b", "Clause": "iii", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_168_b_iii&doctype=Standard", "URIDate": "2025-03-27" }, "r107": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Effective 2027-01-01", "Name": "IFRS", "Number": "19", "IssueDate": "2025-01-01", "Paragraph": "169", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_169&doctype=Standard", "URIDate": "2025-03-27" }, "r108": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Effective 2027-01-01", "Name": "IFRS", "Number": "19", "IssueDate": "2025-01-01", "Paragraph": "178", "Subparagraph": "f", "Clause": "i", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_178_f_i&doctype=Standard", "URIDate": "2025-03-27" }, "r109": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Effective 2027-01-01", "Name": "IFRS", "Number": "19", "IssueDate": "2025-01-01", "Paragraph": "178", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_178&doctype=Standard", "URIDate": "2025-03-27" }, "r110": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Effective 2027-01-01", "Name": "IFRS", "Number": "19", "IssueDate": "2025-01-01", "Paragraph": "179", "Subparagraph": "c", "Clause": "i", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_179_c_i&doctype=Standard", "URIDate": "2025-03-27" }, "r111": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Effective 2027-01-01", "Name": "IFRS", "Number": "19", "IssueDate": "2025-01-01", "Paragraph": "186", "Subparagraph": "b", "Clause": "i", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_186_b_i&doctype=Standard", "URIDate": "2025-03-27" }, "r112": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Effective 2027-01-01", "Name": "IFRS", "Number": "19", "IssueDate": "2025-01-01", "Paragraph": "192", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_192&doctype=Standard", "URIDate": "2025-03-27" }, "r113": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Effective 2027-01-01", "Name": "IFRS", "Number": "19", "IssueDate": "2025-01-01", "Paragraph": "194", "Subparagraph": "c", "Clause": "i", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_194_c_i&doctype=Standard", "URIDate": "2025-03-27" }, "r114": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Effective 2027-01-01", "Name": "IFRS", "Number": "19", "IssueDate": "2025-01-01", "Paragraph": "194", "Subparagraph": "c", "Clause": "ii", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_194_c_ii&doctype=Standard", "URIDate": "2025-03-27" }, "r115": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Effective 2027-01-01", "Name": "IFRS", "Number": "19", "IssueDate": "2025-01-01", "Paragraph": "200", "Subparagraph": "d", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_200_d&doctype=Standard", "URIDate": "2025-03-27" }, "r116": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Effective 2027-01-01", "Name": "IFRS", "Number": "19", "IssueDate": "2025-01-01", "Paragraph": "200", "Subparagraph": "e", "Clause": "i", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_200_e_i&doctype=Standard", "URIDate": "2025-03-27" }, "r117": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Effective 2027-01-01", "Name": "IFRS", "Number": "19", "IssueDate": "2025-01-01", "Paragraph": "200", "Subparagraph": "e", "Clause": "ii", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_200_e_ii&doctype=Standard", "URIDate": "2025-03-27" }, "r118": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Effective 2027-01-01", "Name": "IFRS", "Number": "19", "IssueDate": "2025-01-01", "Paragraph": "200", "Subparagraph": "e", "Clause": "viii", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_200_e_viii&doctype=Standard", "URIDate": "2025-03-27" }, "r119": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Effective 2027-01-01", "Name": "IFRS", "Number": "19", "IssueDate": "2025-01-01", "Paragraph": "200", "Subparagraph": "e", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_200_e&doctype=Standard", "URIDate": "2025-03-27" }, "r120": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Effective 2027-01-01", "Name": "IFRS", "Number": "19", "IssueDate": "2025-01-01", "Paragraph": "200", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_200&doctype=Standard", "URIDate": "2025-03-27" }, "r121": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Effective 2027-01-01", "Name": "IFRS", "Number": "19", "IssueDate": "2025-01-01", "Paragraph": "204", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_204&doctype=Standard", "URIDate": "2025-03-27" }, "r122": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Effective 2027-01-01", "Name": "IFRS", "Number": "19", "IssueDate": "2025-01-01", "Paragraph": "206", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_206_a&doctype=Standard", "URIDate": "2025-03-27" }, "r123": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Effective 2027-01-01", "Name": "IFRS", "Number": "19", "IssueDate": "2025-01-01", "Paragraph": "207", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_207_b&doctype=Standard", "URIDate": "2025-03-27" }, "r124": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Effective 2027-01-01", "Name": "IFRS", "Number": "19", "IssueDate": "2025-01-01", "Paragraph": "207", "Subparagraph": "c", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_207_c&doctype=Standard", "URIDate": "2025-03-27" }, "r125": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Effective 2027-01-01", "Name": "IFRS", "Number": "19", "IssueDate": "2025-01-01", "Paragraph": "218", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_218_a&doctype=Standard", "URIDate": "2025-03-27" }, "r126": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Effective 2027-01-01", "Name": "IFRS", "Number": "19", "IssueDate": "2025-01-01", "Paragraph": "24", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_24_b&doctype=Standard", "URIDate": "2025-03-27" }, "r127": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Effective 2027-01-01", "Name": "IFRS", "Number": "19", "IssueDate": "2025-01-01", "Paragraph": "263", "Subparagraph": "c", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_263_c&doctype=Standard", "URIDate": "2025-03-27" }, "r128": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Effective 2027-01-01", "Name": "IFRS", "Number": "19", "IssueDate": "2025-01-01", "Paragraph": "263", "Subparagraph": "e", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_263_e&doctype=Standard", "URIDate": "2025-03-27" }, "r129": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Effective 2027-01-01", "Name": "IFRS", "Number": "19", "IssueDate": "2025-01-01", "Paragraph": "266", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_266&doctype=Standard", "URIDate": "2025-03-27" }, "r130": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Effective 2027-01-01", "Name": "IFRS", "Number": "19", "IssueDate": "2025-01-01", "Paragraph": "269", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_269&doctype=Standard", "URIDate": "2025-03-27" }, "r131": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Effective 2027-01-01", "Name": "IFRS", "Number": "19", "IssueDate": "2025-01-01", "Paragraph": "271", "Subparagraph": "c", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_271_c&doctype=Standard", "URIDate": "2025-03-27" }, "r132": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Effective 2027-01-01", "Name": "IFRS", "Number": "19", "IssueDate": "2025-01-01", "Paragraph": "271", "Subparagraph": "d", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_271_d&doctype=Standard", "URIDate": "2025-03-27" }, "r133": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Effective 2027-01-01", "Name": "IFRS", "Number": "19", "IssueDate": "2025-01-01", "Paragraph": "273", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_273&doctype=Standard", "URIDate": "2025-03-27" }, "r134": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Effective 2027-01-01", "Name": "IFRS", "Number": "19", "IssueDate": "2025-01-01", "Paragraph": "274", "Subparagraph": "e", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_274_e&doctype=Standard", "URIDate": "2025-03-27" }, "r135": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Effective 2027-01-01", "Name": "IFRS", "Number": "19", "IssueDate": "2025-01-01", "Paragraph": "28", "Subparagraph": "a", "Clause": "ii", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_28_a_ii&doctype=Standard", "URIDate": "2025-03-27" }, "r136": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Effective 2027-01-01", "Name": "IFRS", "Number": "19", "IssueDate": "2025-01-01", "Paragraph": "31", "Subparagraph": "b", "Clause": "i", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_31_b_i&doctype=Standard", "URIDate": "2025-03-27" }, "r137": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Effective 2027-01-01", "Name": "IFRS", "Number": "19", "IssueDate": "2025-01-01", "Paragraph": "31", "Subparagraph": "b", "Clause": "ii", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_31_b_ii&doctype=Standard", "URIDate": "2025-03-27" }, "r138": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Effective 2027-01-01", "Name": "IFRS", "Number": "19", "IssueDate": "2025-01-01", "Paragraph": "31", "Subparagraph": "b", "Clause": "iii", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_31_b_iii&doctype=Standard", "URIDate": "2025-03-27" }, "r139": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Effective 2027-01-01", "Name": "IFRS", "Number": "19", "IssueDate": "2025-01-01", "Paragraph": "31", "Subparagraph": "b", "Clause": "vi", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_31_b_vi&doctype=Standard", "URIDate": "2025-03-27" }, "r140": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Effective 2027-01-01", "Name": "IFRS", "Number": "19", "IssueDate": "2025-01-01", "Paragraph": "31", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_31_b&doctype=Standard", "URIDate": "2025-03-27" }, "r141": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Effective 2027-01-01", "Name": "IFRS", "Number": "19", "IssueDate": "2025-01-01", "Paragraph": "37", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_37&doctype=Standard", "URIDate": "2025-03-27" }, "r142": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Effective 2027-01-01", "Name": "IFRS", "Number": "19", "IssueDate": "2025-01-01", "Paragraph": "66", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_66&doctype=Standard", "URIDate": "2025-03-27" }, "r143": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Effective 2027-01-01", "Name": "IFRS", "Number": "19", "IssueDate": "2025-01-01", "Paragraph": "70", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_70&doctype=Standard", "URIDate": "2025-03-27" }, "r144": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Effective 2027-01-01", "Name": "IFRS", "Number": "19", "IssueDate": "2025-01-01", "Paragraph": "71", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_71&doctype=Standard", "URIDate": "2025-03-27" }, "r145": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Effective 2027-01-01", "Name": "IFRS", "Number": "19", "IssueDate": "2025-01-01", "Paragraph": "81", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_81&doctype=Standard", "URIDate": "2025-03-27" }, "r146": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Effective 2027-01-01", "Name": "IFRS", "Number": "19", "IssueDate": "2025-01-01", "Paragraph": "95", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_95_a&doctype=Standard", "URIDate": "2025-03-27" }, "r147": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Effective 2027-01-01", "Name": "IFRS", "Number": "19", "IssueDate": "2025-01-01", "Paragraph": "95", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_95_b&doctype=Standard", "URIDate": "2025-03-27" }, "r148": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Effective 2027-01-01", "Name": "IFRS", "Number": "19", "IssueDate": "2025-01-01", "Paragraph": "B10", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_B10_a&doctype=Appendix&subtype=B", "URIDate": "2025-03-27" }, "r149": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Effective 2027-01-01", "Name": "IFRS", "Number": "19", "IssueDate": "2025-01-01", "Paragraph": "B10", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_B10&doctype=Appendix&subtype=B", "URIDate": "2025-03-27" }, "r150": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Effective 2027-01-01", "Name": "IFRS", "Number": "19", "IssueDate": "2025-01-01", "Paragraph": "B9", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_B9_b&doctype=Appendix&subtype=B", "URIDate": "2025-03-27" }, "r151": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Effective 2027-01-01", "Name": "IFRS", "Number": "19", "IssueDate": "2025-01-01", "Paragraph": "B9", "Subparagraph": "e", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_B9_e&doctype=Appendix&subtype=B", "URIDate": "2025-03-27" }, "r152": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Expiry date 2027-01-01", "Name": "IAS", "Number": "1", "IssueDate": "2025-01-01", "Paragraph": "103", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_103&doctype=Standard", "URIDate": "2025-03-27" }, "r153": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Expiry date 2027-01-01", "Name": "IAS", "Number": "1", "IssueDate": "2025-01-01", "Paragraph": "106", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_106_a&doctype=Standard", "URIDate": "2025-03-27" }, "r154": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Expiry date 2027-01-01", "Name": "IAS", "Number": "1", "IssueDate": "2025-01-01", "Paragraph": "106", "Subparagraph": "d", "Clause": "i", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_106_d_i&doctype=Standard", "URIDate": "2025-03-27" }, "r155": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Expiry date 2027-01-01", "Name": "IAS", "Number": "1", "IssueDate": "2025-01-01", "Paragraph": "106", "Subparagraph": "d", "Clause": "iii", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_106_d_iii&doctype=Standard", "URIDate": "2025-03-27" }, "r156": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Expiry date 2027-01-01", "Name": "IAS", "Number": "1", "IssueDate": "2025-01-01", "Paragraph": "106", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_106&doctype=Standard", "URIDate": "2025-03-27" }, "r157": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Expiry date 2027-01-01", "Name": "IAS", "Number": "1", "IssueDate": "2025-01-01", "Paragraph": "35", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_35&doctype=Standard", "URIDate": "2025-03-27" }, "r158": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Expiry date 2027-01-01", "Name": "IAS", "Number": "1", "IssueDate": "2025-01-01", "Paragraph": "54", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_54_a&doctype=Standard", "URIDate": "2025-03-27" }, "r159": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Expiry date 2027-01-01", "Name": "IAS", "Number": "1", "IssueDate": "2025-01-01", "Paragraph": "54", "Subparagraph": "c", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_54_c&doctype=Standard", "URIDate": "2025-03-27" }, "r160": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Expiry date 2027-01-01", "Name": "IAS", "Number": "1", "IssueDate": "2025-01-01", "Paragraph": "54", "Subparagraph": "g", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_54_g&doctype=Standard", "URIDate": "2025-03-27" }, "r161": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Expiry date 2027-01-01", "Name": "IAS", "Number": "1", "IssueDate": "2025-01-01", "Paragraph": "54", "Subparagraph": "h", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_54_h&doctype=Standard", "URIDate": "2025-03-27" }, "r162": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Expiry date 2027-01-01", "Name": "IAS", "Number": "1", "IssueDate": "2025-01-01", "Paragraph": "54", "Subparagraph": "i", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_54_i&doctype=Standard", "URIDate": "2025-03-27" }, "r163": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Expiry date 2027-01-01", "Name": "IAS", "Number": "1", "IssueDate": "2025-01-01", "Paragraph": "54", "Subparagraph": "l", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_54_l&doctype=Standard", "URIDate": "2025-03-27" }, "r164": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Expiry date 2027-01-01", "Name": "IAS", "Number": "1", "IssueDate": "2025-01-01", "Paragraph": "54", "Subparagraph": "n", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_54_n&doctype=Standard", "URIDate": "2025-03-27" }, "r165": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Expiry date 2027-01-01", "Name": "IAS", "Number": "1", "IssueDate": "2025-01-01", "Paragraph": "54", "Subparagraph": "r", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_54_r&doctype=Standard", "URIDate": "2025-03-27" }, "r166": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Expiry date 2027-01-01", "Name": "IAS", "Number": "1", "IssueDate": "2025-01-01", "Paragraph": "55", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_55&doctype=Standard", "URIDate": "2025-03-27" }, "r167": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Expiry date 2027-01-01", "Name": "IAS", "Number": "1", "IssueDate": "2025-01-01", "Paragraph": "66", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_66&doctype=Standard", "URIDate": "2025-03-27" }, "r168": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Expiry date 2027-01-01", "Name": "IAS", "Number": "1", "IssueDate": "2025-01-01", "Paragraph": "69", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_69&doctype=Standard", "URIDate": "2025-03-27" }, "r169": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Expiry date 2027-01-01", "Name": "IAS", "Number": "1", "IssueDate": "2025-01-01", "Paragraph": "7", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_7&doctype=Standard", "URIDate": "2025-03-27" }, "r170": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Expiry date 2027-01-01", "Name": "IAS", "Number": "1", "IssueDate": "2025-01-01", "Paragraph": "78", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_78_b&doctype=Standard", "URIDate": "2025-03-27" }, "r171": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Expiry date 2027-01-01", "Name": "IAS", "Number": "1", "IssueDate": "2025-01-01", "Paragraph": "78", "Subparagraph": "d", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_78_d&doctype=Standard", "URIDate": "2025-03-27" }, "r172": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Expiry date 2027-01-01", "Name": "IAS", "Number": "1", "IssueDate": "2025-01-01", "Paragraph": "79", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_79_a&doctype=Standard", "URIDate": "2025-03-27" }, "r173": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Expiry date 2027-01-01", "Name": "IAS", "Number": "1", "IssueDate": "2025-01-01", "Paragraph": "79", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_79&doctype=Standard", "URIDate": "2025-03-27" }, "r174": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Expiry date 2027-01-01", "Name": "IAS", "Number": "1", "IssueDate": "2025-01-01", "Paragraph": "81A", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_81A_a&doctype=Standard", "URIDate": "2025-03-27" }, "r175": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Expiry date 2027-01-01", "Name": "IAS", "Number": "1", "IssueDate": "2025-01-01", "Paragraph": "81A", "Subparagraph": "c", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_81A_c&doctype=Standard", "URIDate": "2025-03-27" }, "r176": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Expiry date 2027-01-01", "Name": "IAS", "Number": "1", "IssueDate": "2025-01-01", "Paragraph": "82", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_82_a&doctype=Standard", "URIDate": "2025-03-27" }, "r177": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Expiry date 2027-01-01", "Name": "IAS", "Number": "1", "IssueDate": "2025-01-01", "Paragraph": "82", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_82_b&doctype=Standard", "URIDate": "2025-03-27" }, "r178": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Expiry date 2027-01-01", "Name": "IAS", "Number": "1", "IssueDate": "2025-01-01", "Paragraph": "82", "Subparagraph": "d", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_82_d&doctype=Standard", "URIDate": "2025-03-27" }, "r179": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Expiry date 2027-01-01", "Name": "IAS", "Number": "1", "IssueDate": "2025-01-01", "Paragraph": "82", "Subparagraph": "ea", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_82_ea&doctype=Standard", "URIDate": "2025-03-27" }, "r180": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Expiry date 2027-01-01", "Name": "IAS", "Number": "1", "IssueDate": "2025-01-01", "Paragraph": "91", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_91_a&doctype=Standard", "URIDate": "2025-03-27" }, "r181": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Expiry date 2027-01-01", "Name": "IAS", "Number": "1", "IssueDate": "2025-01-01", "Paragraph": "92", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_92&doctype=Standard", "URIDate": "2025-03-27" }, "r182": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Expiry date 2027-01-01", "Name": "IAS", "Number": "1", "IssueDate": "2025-01-01", "Paragraph": "98", "Subparagraph": "c", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_98_c&doctype=Standard", "URIDate": "2025-03-27" }, "r183": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Expiry date 2027-01-01", "Name": "IAS", "Number": "1", "IssueDate": "2025-01-01", "Paragraph": "98", "Subparagraph": "e", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_98_e&doctype=Standard", "URIDate": "2025-03-27" }, "r184": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Expiry date 2027-01-01", "Name": "IAS", "Number": "1", "IssueDate": "2025-01-01", "Paragraph": "99", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_99&doctype=Standard", "URIDate": "2025-03-27" }, "r185": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IAS", "Number": "16", "IssueDate": "2025-01-01", "Paragraph": "37", "Subparagraph": "h", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=16&code=ifrs-tx-2025-en-r&anchor=para_37_h&doctype=Standard", "URIDate": "2025-03-27" }, "r186": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IAS", "Number": "19", "IssueDate": "2025-01-01", "Paragraph": "138", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=19&code=ifrs-tx-2025-en-r&anchor=para_138_b&doctype=Standard", "URIDate": "2025-03-27" }, "r187": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IAS", "Number": "24", "IssueDate": "2025-01-01", "Paragraph": "21", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=24&code=ifrs-tx-2025-en-r&anchor=para_21_a&doctype=Standard", "URIDate": "2025-03-27" }, "r188": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IAS", "Number": "32", "IssueDate": "2025-01-01", "Paragraph": "IE33", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=32&code=ifrs-tx-2025-en-r&anchor=para_IE33&doctype=Illustrative%20Examples", "URIDate": "2025-03-27" }, "r189": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IAS", "Number": "7", "IssueDate": "2025-01-01", "Paragraph": "16", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2025-en-r&anchor=para_16_a&doctype=Standard", "URIDate": "2025-03-27" }, "r190": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IAS", "Number": "7", "IssueDate": "2025-01-01", "Paragraph": "16", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2025-en-r&anchor=para_16_b&doctype=Standard", "URIDate": "2025-03-27" }, "r191": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IAS", "Number": "7", "IssueDate": "2025-01-01", "Paragraph": "17", "Subparagraph": "e", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2025-en-r&anchor=para_17_e&doctype=Standard", "URIDate": "2025-03-27" }, "r192": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IFRS", "Number": "1", "IssueDate": "2025-01-01", "Paragraph": "IG63", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=1&code=ifrs-tx-2025-en-r&anchor=para_IG63&doctype=Implementation%20Guidance", "URIDate": "2025-03-27" }, "r193": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IFRS", "Number": "12", "IssueDate": "2025-01-01", "Paragraph": "B10", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2025-en-r&anchor=para_B10_b&doctype=Appendix&subtype=B", "URIDate": "2025-03-27" }, "r194": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IFRS", "Number": "13", "IssueDate": "2025-01-01", "Paragraph": "B6", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=13&code=ifrs-tx-2025-en-r&anchor=para_B6&doctype=Appendix&subtype=B", "URIDate": "2025-03-27" }, "r195": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IFRS", "Number": "13", "IssueDate": "2025-01-01", "Paragraph": "IE63", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=13&code=ifrs-tx-2025-en-r&anchor=para_IE63&doctype=Illustrative%20Examples", "URIDate": "2025-03-27" }, "r196": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IFRS", "Number": "17", "IssueDate": "2025-01-01", "Paragraph": "113", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=17&code=ifrs-tx-2025-en-r&anchor=para_113_b&doctype=Standard", "URIDate": "2025-03-27" }, "r197": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IFRS", "Number": "7", "IssueDate": "2025-01-01", "Paragraph": "35N", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2025-en-r&anchor=para_35N&doctype=Standard", "URIDate": "2025-03-27" }, "r198": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IFRS", "Number": "8", "IssueDate": "2025-01-01", "Paragraph": "23", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2025-en-r&anchor=para_23&doctype=Standard", "URIDate": "2025-03-27" }, "r199": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IFRS", "Number": "8", "IssueDate": "2025-01-01", "Paragraph": "28", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2025-en-r&anchor=para_28_b&doctype=Standard", "URIDate": "2025-03-27" }, "r200": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Note": "Effective 2027-01-01", "Name": "IFRS", "Number": "19", "IssueDate": "2025-01-01", "Paragraph": "234", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_234_a&doctype=Standard", "URIDate": "2025-03-27" }, "r201": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Note": "Effective 2027-01-01", "Name": "IFRS", "Number": "19", "IssueDate": "2025-01-01", "Paragraph": "B9", "Subparagraph": "c", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_B9_c&doctype=Appendix&subtype=B", "URIDate": "2025-03-27" }, "r202": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Note": "Effective 2027-01-01", "Name": "IFRS", "Number": "19", "IssueDate": "2025-01-01", "Paragraph": "B9", "Subparagraph": "f", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_B9_f&doctype=Appendix&subtype=B", "URIDate": "2025-03-27" }, "r203": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Note": "Expiry date 2027-01-01", "Name": "IAS", "Number": "1", "IssueDate": "2025-01-01", "Paragraph": "102", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_102&doctype=Standard", "URIDate": "2025-03-27" }, "r204": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Note": "Expiry date 2027-01-01", "Name": "IAS", "Number": "1", "IssueDate": "2025-01-01", "Paragraph": "103", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_103&doctype=Standard", "URIDate": "2025-03-27" }, "r205": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Note": "Expiry date 2027-01-01", "Name": "IAS", "Number": "1", "IssueDate": "2025-01-01", "Paragraph": "108", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_108&doctype=Standard", "URIDate": "2025-03-27" }, "r206": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Note": "Expiry date 2027-01-01", "Name": "IAS", "Number": "1", "IssueDate": "2025-01-01", "Paragraph": "68", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_68&doctype=Standard", "URIDate": "2025-03-27" }, "r207": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Note": "Expiry date 2027-01-01", "Name": "IAS", "Number": "1", "IssueDate": "2025-01-01", "Paragraph": "70", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_70&doctype=Standard", "URIDate": "2025-03-27" }, "r208": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Note": "Expiry date 2027-01-01", "Name": "IAS", "Number": "1", "IssueDate": "2025-01-01", "Paragraph": "78", "Subparagraph": "c", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_78_c&doctype=Standard", "URIDate": "2025-03-27" }, "r209": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Note": "Expiry date 2027-01-01", "Name": "IAS", "Number": "1", "IssueDate": "2025-01-01", "Paragraph": "78", "Subparagraph": "e", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_78_e&doctype=Standard", "URIDate": "2025-03-27" }, "r210": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Note": "Expiry date 2027-01-01", "Name": "IAS", "Number": "1", "IssueDate": "2025-01-01", "Paragraph": "IG6", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_IG6&doctype=Implementation%20Guidance", "URIDate": "2025-03-27" }, "r211": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12" }, "r212": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b" }, "r213": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b-2" }, "r214": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b-23" }, "r215": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "d1-1" }, "r216": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "g" }, "r217": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12, 13, 15d" }, "r218": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "13e", "Subsection": "4c" }, "r219": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "14a", "Subsection": "12" }, "r220": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "14d", "Subsection": "2b" }, "r221": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "15", "Subsection": "d" }, "r222": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 10-K", "Number": "249", "Section": "310" }, "r223": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 10-Q", "Number": "240", "Section": "308", "Subsection": "a" }, "r224": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Number": "249", "Section": "220", "Subsection": "f" }, "r225": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Number": "249", "Section": "240", "Subsection": "f" }, "r226": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Forms 10-K, 10-Q, 20-F", "Number": "240", "Section": "13", "Subsection": "a-1" }, "r227": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-T", "Number": "232", "Section": "405" }, "r228": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "230", "Section": "405" }, "r229": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "230", "Section": "425" }, "r230": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "7A", "Section": "B", "Subsection": "2" }, "r231": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "IAS", "Number": "16", "IssueDate": "2025-01-01", "Paragraph": "37", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=16&code=ifrs-tx-2025-en-r&anchor=para_37&doctype=Standard", "URIDate": "2025-03-27" }, "r232": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "IAS", "Number": "16", "IssueDate": "2025-01-01", "Paragraph": "73", "Subparagraph": "e", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=16&code=ifrs-tx-2025-en-r&anchor=para_73_e&doctype=Standard", "URIDate": "2025-03-27" }, "r233": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "IAS", "Number": "19", "IssueDate": "2025-01-01", "Paragraph": "135", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=19&code=ifrs-tx-2025-en-r&anchor=para_135_b&doctype=Standard", "URIDate": "2025-03-27" }, "r234": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "IAS", "Number": "19", "IssueDate": "2025-01-01", "Paragraph": "138", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=19&code=ifrs-tx-2025-en-r&anchor=para_138_b&doctype=Standard", "URIDate": "2025-03-27" }, "r235": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "IAS", "Number": "2", "IssueDate": "2025-01-01", "Paragraph": "37", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=2&code=ifrs-tx-2025-en-r&anchor=para_37&doctype=Standard", "URIDate": "2025-03-27" }, "r236": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "IAS", "Number": "33", "IssueDate": "2025-01-01", "Paragraph": "70", "Subparagraph": "c", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=33&code=ifrs-tx-2025-en-r&anchor=para_70_c&doctype=Standard", "URIDate": "2025-03-27" }, "r237": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "IAS", "Number": "7", "IssueDate": "2025-01-01", "Paragraph": "16", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2025-en-r&anchor=para_16&doctype=Standard", "URIDate": "2025-03-27" }, "r238": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "IAS", "Number": "7", "IssueDate": "2025-01-01", "Paragraph": "20", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2025-en-r&anchor=para_20_a&doctype=Standard", "URIDate": "2025-03-27" }, "r239": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "IAS", "Number": "7", "IssueDate": "2025-01-01", "Paragraph": "20", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2025-en-r&anchor=para_20_b&doctype=Standard", "URIDate": "2025-03-27" }, "r240": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "IAS", "Number": "7", "IssueDate": "2025-01-01", "Paragraph": "20", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2025-en-r&anchor=para_20&doctype=Standard", "URIDate": "2025-03-27" }, "r241": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "IFRS", "Number": "7", "IssueDate": "2025-01-01", "Paragraph": "7", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2025-en-r&anchor=para_7&doctype=Standard", "URIDate": "2025-03-27" }, "r242": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "IFRS", "Number": "8", "IssueDate": "2025-01-01", "Paragraph": "34", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2025-en-r&anchor=para_34&doctype=Standard", "URIDate": "2025-03-27" }, "r243": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Note": "Expiry date 2027-01-01", "Name": "IAS", "Number": "1", "IssueDate": "2025-01-01", "Paragraph": "10", "Subparagraph": "e", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_10_e&doctype=Standard", "URIDate": "2025-03-27" }, "r244": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Note": "Expiry date 2027-01-01", "Name": "IAS", "Number": "1", "IssueDate": "2025-01-01", "Paragraph": "106", "Subparagraph": "d", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_106_d&doctype=Standard", "URIDate": "2025-03-27" }, "r245": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Note": "Expiry date 2027-01-01", "Name": "IAS", "Number": "1", "IssueDate": "2025-01-01", "Paragraph": "108", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_108&doctype=Standard", "URIDate": "2025-03-27" }, "r246": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Note": "Expiry date 2027-01-01", "Name": "IAS", "Number": "1", "IssueDate": "2025-01-01", "Paragraph": "112", "Subparagraph": "c", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_112_c&doctype=Standard", "URIDate": "2025-03-27" }, "r247": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Note": "Expiry date 2027-01-01", "Name": "IAS", "Number": "1", "IssueDate": "2025-01-01", "Paragraph": "117", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_117&doctype=Standard", "URIDate": "2025-03-27" }, "r248": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Note": "Expiry date 2027-01-01", "Name": "IAS", "Number": "1", "IssueDate": "2025-01-01", "Paragraph": "54", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_54_a&doctype=Standard", "URIDate": "2025-03-27" }, "r249": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Note": "Expiry date 2027-01-01", "Name": "IAS", "Number": "1", "IssueDate": "2025-01-01", "Paragraph": "55", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_55&doctype=Standard", "URIDate": "2025-03-27" }, "r250": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Note": "Expiry date 2027-01-01", "Name": "IAS", "Number": "1", "IssueDate": "2025-01-01", "Paragraph": "78", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_78&doctype=Standard", "URIDate": "2025-03-27" }, "r251": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Note": "Expiry date 2027-01-01", "Name": "IAS", "Number": "1", "IssueDate": "2025-01-01", "Paragraph": "85", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_85&doctype=Standard", "URIDate": "2025-03-27" } } }